BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy6528
(421 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 173 bits (439), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 96/239 (40%), Positives = 145/239 (60%), Gaps = 11/239 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ + Q+PW V L+ +CGG++IN+++V+TAAHC++ + + A GEY+
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVKITVVA--GEYNT 58
Query: 130 CDTSSKPESRFVIRAIVG---DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP--TVLNN 184
+T + R VIRAI + T + + +DIALL L++ + + + P+C+ N
Sbjct: 59 EETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIADKEYTNI 118
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+ +G V GWG + GR A I++ ++VP++ C ST ++ I NM CAG+ E
Sbjct: 119 FLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTKFT---IYSNMFCAGFHE 175
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KDSCQGDSGGP V E E + + GI+SWG C G G+YT+++RYV WIKEK+K
Sbjct: 176 GGKDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAVKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 169 bits (427), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 145/239 (60%), Gaps = 11/239 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+VGG+ + Q+PW V L+ +CGG+++N+++++TAAHCV+ + + A GE++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVA--GEHNI 58
Query: 130 CDTSSKPESRFVIRAIVG---DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP--TVLNN 184
+T + R VIR I + + +++DIALL L++ + + + P+C+ N
Sbjct: 59 EETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+ +G V GWG + GR A +++ + VP++ C ST ++ I++NM CAG+ E
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTKFT---ITNNMFCAGFHE 175
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G +DSCQGDSGGP V E E + + GI+SWG C G G+YT+++RYV WIKEK+K
Sbjct: 176 GGRDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 169 bits (427), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 145/239 (60%), Gaps = 11/239 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+VGG+ + Q+PW V L+ +CGG+++N+++++TAAHCV+ + + A GE++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVA--GEHNI 58
Query: 130 CDTSSKPESRFVIRAIVG---DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP--TVLNN 184
+T + R VIR I + + +++DIALL L++ + + + P+C+ N
Sbjct: 59 EETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+ +G V GWG + GR A +++ + VP++ C ST ++ I++NM CAG+ E
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFT---ITNNMFCAGFHE 175
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G +DSCQGDSGGP V E E + + GI+SWG C G G+YT+++RYV WIKEK+K
Sbjct: 176 GGRDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 169 bits (427), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 145/239 (60%), Gaps = 11/239 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+VGG+ + Q+PW V L+ +CGG+++N+++++TAAHCV+ + + A GE++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVA--GEHNI 58
Query: 130 CDTSSKPESRFVIRAIVG---DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP--TVLNN 184
+T + R VIR I + + +++DIALL L++ + + + P+C+ N
Sbjct: 59 EETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+ +G V GWG + GR A +++ + VP++ C ST ++ I++NM CAG+ E
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFT---ITNNMFCAGFHE 175
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G +DSCQGDSGGP V E E + + GI+SWG C G G+YT+++RYV WIKEK+K
Sbjct: 176 GGRDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 167 bits (423), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 89/239 (37%), Positives = 144/239 (60%), Gaps = 11/239 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+VGG+ + Q+PW V L+ +CGG+++N+++++TAAHCV+ + + A GE++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVA--GEHNI 58
Query: 130 CDTSSKPESRFVIRAIVG---DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP--TVLNN 184
+T + R VIR I + + +++DIALL L++ + + + P+C+ N
Sbjct: 59 EETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+ +G V GWG + GR A +++ + VP++ C ST ++ I +NM CAG+ E
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFT---IYNNMFCAGFHE 175
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G +DSCQGDSGGP V E E + + GI+SWG C G G+YT+++RYV WIKEK+K
Sbjct: 176 GGRDSCQGDSGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 166 bits (421), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 88/239 (36%), Positives = 144/239 (60%), Gaps = 11/239 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+VGG+ + Q+PW V L+ +CGG+++N+++++TAAHCV+ + + A GE++
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVA--GEHNI 58
Query: 130 CDTSSKPESRFVIRAIVG---DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP--TVLNN 184
+T + R VIR I + + +++DIALL L++ + + + P+C+ N
Sbjct: 59 EETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNI 118
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+ +G V GWG + GR A +++ + VP++ C ST ++ I +NM CAG+ E
Sbjct: 119 FLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFT---IYNNMFCAGFHE 175
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G +DSCQGD+GGP V E E + + GI+SWG C G G+YT+++RYV WIKEK+K
Sbjct: 176 GGRDSCQGDAGGPHVTEVEGTSF-LTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 166 bits (419), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 94/251 (37%), Positives = 135/251 (53%), Gaps = 23/251 (9%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGR-----LWFLIKAT 123
RIVGG+ T + ++PW V L Y CGG+L++ +VLTAAHC R W +
Sbjct: 117 RIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGA 176
Query: 124 FGEYDRCDTSSKPESRFVIRAIVGDFTFSNF--------DNDIALLRLNDRVPIVDIIKP 175
+ +S + ++A+V + F NDIAL+ L+ +P+ + I+P
Sbjct: 177 VAQ------ASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQP 230
Query: 176 VCLPTVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISD 235
VCLP + + V GWG + G+ A ++++ VPI+SN C + Y + +I
Sbjct: 231 VCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGN-QIKP 289
Query: 236 NMMCAGYPEGMKDSCQGDSGGPMVFEREDS---RYEQIGIVSWGAGCGRAGYPGVYTRIT 292
M CAGYPEG D+CQGDSGGP V E S R+ GIVSWG GC A PGVYT+++
Sbjct: 290 KMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVS 349
Query: 293 RYVEWIKEKSK 303
+ EWI + K
Sbjct: 350 DFREWIFQAIK 360
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 166 bits (419), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 94/251 (37%), Positives = 135/251 (53%), Gaps = 23/251 (9%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGR-----LWFLIKAT 123
RIVGG+ T + ++PW V L Y CGG+L++ +VLTAAHC R W +
Sbjct: 117 RIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGA 176
Query: 124 FGEYDRCDTSSKPESRFVIRAIVGDFTFSNF--------DNDIALLRLNDRVPIVDIIKP 175
+ +S + ++A+V + F NDIAL+ L+ +P+ + I+P
Sbjct: 177 VAQ------ASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQP 230
Query: 176 VCLPTVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISD 235
VCLP + + V GWG + G+ A ++++ VPI+SN C + Y + +I
Sbjct: 231 VCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGN-QIKP 289
Query: 236 NMMCAGYPEGMKDSCQGDSGGPMVFEREDS---RYEQIGIVSWGAGCGRAGYPGVYTRIT 292
M CAGYPEG D+CQGDSGGP V E S R+ GIVSWG GC A PGVYT+++
Sbjct: 290 KMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVS 349
Query: 293 RYVEWIKEKSK 303
+ EWI + K
Sbjct: 350 DFREWIFQAIK 360
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 165 bits (417), Expect = 5e-41, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 135/241 (56%), Gaps = 13/241 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSY----FNRFYCGGTLINDRYVLTAAHCVKGRLW---FLIKA 122
IVGG + ++P+ + F+ +CG ++ N+ Y +TA HCV G + ++
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDYENPSGLQI 60
Query: 123 TFGEYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV 181
GE D + V + I+ + F ++ DNDI+LL+L+ + D + P+ LP
Sbjct: 61 VAGELDMSVNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVAPIALPEQ 120
Query: 182 LNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAG 241
+ D +V GWGT E G +++ V VP++S++ CR +Y + I D+M+CAG
Sbjct: 121 GHTATGDV--IVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRA--DYGADEILDSMICAG 176
Query: 242 YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEK 301
PEG KDSCQGDSGGP+ S Y GIVSWG GC R GYPGVYT ++ +V+WIK
Sbjct: 177 VPEGGKDSCQGDSGGPLAASDTGSTY-LAGIVSWGYGCARPGYPGVYTEVSYHVDWIKAN 235
Query: 302 S 302
+
Sbjct: 236 A 236
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 164 bits (414), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 97/282 (34%), Positives = 153/282 (54%), Gaps = 37/282 (13%)
Query: 44 RTRRPSAKEDYPMCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSY-----FNRFYCGGT 98
R RRP + CG +A +I+ G T ++PW + Y F +F CGG+
Sbjct: 3 RNRRPE------LLPNDCGYQVEADKILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGS 56
Query: 99 LINDRYVLTAAHCVKGRLWFLI----KATFGEYDRCDTSSKPESRFVIRAIVGDF----- 149
LIN+RY++TAAHCV GR+ ++ K GE++ T++ P+ +R V D
Sbjct: 57 LINNRYIVTAAHCVAGRVLRVVGALNKVRLGEWN---TATDPDCYGAVRVCVPDKPIDLG 113
Query: 150 ---TFSNFD---------NDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDETGVVMGWG 197
T + D +DIAL+RLN +V + I+PVCLP + V+GWG
Sbjct: 114 IEETIQHPDYVDGSKDRYHDIALIRLNRQVEFTNYIRPVCLPQPNEEVQVGQRLTVVGWG 173
Query: 198 TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGP 257
E +G+ + I + + VP++ + C + + R+ + +CAG E KDSC GDSGGP
Sbjct: 174 RTE-TGQYSTIKQKLAVPVVHAEQCAKTFGAAGVRVRSSQLCAG-GEKAKDSCGGDSGGP 231
Query: 258 MVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
++ ER + ++ G+VS+GA CG G+PG+YT++ +Y +WI+
Sbjct: 232 LLAERANQQFFLEGLVSFGATCGTEGWPGIYTKVGKYRDWIE 273
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 163 bits (413), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 93/246 (37%), Positives = 135/246 (54%), Gaps = 15/246 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ T + ++PW V L Y CGG+L++ +VLTAAHC R L + + +
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSR--WRVFAG 58
Query: 130 CDTSSKPES-RFVIRAIVGDFTFSNF--------DNDIALLRLNDRVPIVDIIKPVCLPT 180
+ P + ++A+V + F NDIAL+ L+ +P+ + I+PVCLP
Sbjct: 59 AVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPA 118
Query: 181 VLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+ + V GWG + G+ A ++++ VPI+SN C + Y + +I M CA
Sbjct: 119 AGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGN-QIKPKMFCA 177
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDS---RYEQIGIVSWGAGCGRAGYPGVYTRITRYVEW 297
GYPEG D+CQGDSGGP V E S R+ GIVSWG GC A PGVYT+++ + EW
Sbjct: 178 GYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREW 237
Query: 298 IKEKSK 303
I + K
Sbjct: 238 IFQAIK 243
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 158 bits (399), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 93/241 (38%), Positives = 134/241 (55%), Gaps = 14/241 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGEYD 128
IVGG+ + PW V L CGGTLIN +V++AAHC K + W + A GE+D
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD 60
Query: 129 RCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
+ +SR V + I+ + ++DIALLRL+ V + D + P+CLP T+
Sbjct: 61 LSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLP---ERTFS 117
Query: 188 DET------GVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNY--SSTRISDNMMC 239
+ T +V GWG L + G A +++ + VP L Q C + S I++ M C
Sbjct: 118 ERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITEYMFC 177
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
AGY +G KDSC+GDSGGP + Y GIVSWG GC G+ GVYTR+++Y+EW++
Sbjct: 178 AGYSDGSKDSCKGDSGGPHATHYRGTWY-LTGIVSWGQGCATVGHFGVYTRVSQYIEWLQ 236
Query: 300 E 300
+
Sbjct: 237 K 237
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 156 bits (395), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 101/251 (40%), Positives = 134/251 (53%), Gaps = 23/251 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYF----NRFY--CGGTLINDRYVLTAAHCVKGRL----WFL 119
+VGG E +PWMV L F NR Y CGG L+N +VLTAAHC K + W L
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRL 60
Query: 120 IKATFGEYDRCDTSSKP-----ESRFVIRAIVGDFTFSNFD-NDIALLRLNDRVPIVDII 173
I FG + S+KP + RFV I+ + S + NDIAL+++ VP I
Sbjct: 61 I---FGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFI 117
Query: 174 KPVCLPTV-LNNTYEDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSST 231
P CLP +T V GWG L+E G R + +++ V ++ + C ST + +
Sbjct: 118 GPGCLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELC-NSTRWYNG 176
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGP-MVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTR 290
RI +CAGYP G D+CQGDSGGP M +R ++ + +GI SWG GC RA PGVYT
Sbjct: 177 RIRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTS 236
Query: 291 ITRYVEWIKEK 301
Y+ WI K
Sbjct: 237 TWPYLNWIASK 247
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 156 bits (394), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 132/241 (54%), Gaps = 12/241 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSY---FNRFYCGGTLINDRYVLTAAHCVKG----RLWFLIKA 122
IVGG + ++PW V L R CGG+LI ++VLTAAHC G +W +
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 123 TFGEYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVL 182
D T P S+ I ++ S ++DIAL++L + + KP+ LP+
Sbjct: 61 ILELSDI--TKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKG 118
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ + V GWG +E G I++ V +P+++N+ C+ Y +I+ M+CAGY
Sbjct: 119 DTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQK--RYQDYKITQRMVCAGY 176
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
EG KD+C+GDSGGP+V + + + +GI SWG GC R PGVYT++ Y++WI EK+
Sbjct: 177 KEGGKDACKGDSGGPLVC-KHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKT 235
Query: 303 K 303
+
Sbjct: 236 Q 236
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 155 bits (393), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 132/241 (54%), Gaps = 12/241 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSY---FNRFYCGGTLINDRYVLTAAHCVKG----RLWFLIKA 122
IVGG + ++PW V L R CGG+LI ++VLTAAHC G +W +
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 123 TFGEYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVL 182
D T P S+ I ++ S ++DIAL++L + + KP+ LP+
Sbjct: 61 ILNLSDI--TKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKG 118
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ + V GWG +E G I++ V +P+++N+ C+ Y +I+ M+CAGY
Sbjct: 119 DTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQK--RYQDYKITQRMVCAGY 176
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
EG KD+C+GDSGGP+V + + + +GI SWG GC R PGVYT++ Y++WI EK+
Sbjct: 177 KEGGKDACKGDSGGPLVC-KHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKT 235
Query: 303 K 303
+
Sbjct: 236 Q 236
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 154 bits (390), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 93/241 (38%), Positives = 132/241 (54%), Gaps = 14/241 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGEYD 128
IVGG+ + PW V L CGGTLIN +V++AAHC K + W + A GE+D
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD 60
Query: 129 RCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
+ +SR V + I+ + ++DIALLRL+ V + D + P+CLP T+
Sbjct: 61 LSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLP---ERTFS 117
Query: 188 DET------GVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNY--SSTRISDNMMC 239
+ T +V GWG L + G A + + VP L Q C + S I++ M C
Sbjct: 118 ERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFC 177
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
AGY +G KDSC+GDSGGP + Y GIVSWG GC G+ GVYTR+++Y+EW++
Sbjct: 178 AGYSDGSKDSCKGDSGGPHATHYRGTWY-LTGIVSWGQGCATVGHFGVYTRVSQYIEWLQ 236
Query: 300 E 300
+
Sbjct: 237 K 237
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 153 bits (386), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 89/246 (36%), Positives = 135/246 (54%), Gaps = 15/246 (6%)
Query: 65 NDATRIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKAT 123
N+ TRIVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++
Sbjct: 11 NNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG 70
Query: 124 FGEYDR-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT 180
DR + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 71 ----DRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPE 126
Query: 181 ---VLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNM 237
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM
Sbjct: 127 RDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNM 183
Query: 238 MCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEW 297
CAGY +D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++W
Sbjct: 184 FCAGYDTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKW 242
Query: 298 IKEKSK 303
I K
Sbjct: 243 IDRSMK 248
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 151 bits (382), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 86/234 (36%), Positives = 134/234 (57%), Gaps = 7/234 (2%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIK--ATFGEY 127
IVGG + +PW+V L Y +R CG +L++ ++++AAHCV GR K A G +
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILGLH 60
Query: 128 DRCDTSSKPESRFVIRAIVGDFTFS--NFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
+ + +S +I IV + ++ DNDIA++ L +V D I+P+ LP
Sbjct: 61 MKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQVF 120
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
+ GWGT+ G A I+++ +VP+LSN+ C+ I++NM+CAGY EG
Sbjct: 121 PPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQM--PEYNITENMICAGYEEG 178
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGDSGGP++ + E++R+ G+ S+G C PGVY R++R+ EWI+
Sbjct: 179 GIDSCQGDSGGPLMCQ-ENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQ 231
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 150 bits (378), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 101/274 (36%), Positives = 146/274 (53%), Gaps = 23/274 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYF----NRFY--CGGTLINDRYVLTAAHC--VKGRL--WFL 119
I+GGQ +PWMV L F NR Y CGG+L+N +++LTAAHC +K ++ W L
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 120 IKATFGEYDRCDTSSKP-----ESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDII 173
I FG + ++KP + R+V + I+ + ++ S+ NDIAL+++ V I
Sbjct: 61 I---FGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFI 117
Query: 174 KPVCLPTVLNNTYE-DETGVVMGWGTLEESGR-PACIIRDVEVPILSNQYCRTSTNYSST 231
P CLP +T V GWG L+E+ R + ++++ V ++ C ST + +
Sbjct: 118 GPGCLPQFRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLC-NSTRWYNG 176
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGP-MVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTR 290
RI +CAGYPEG D+CQGDSGGP M + ++ Y +GI SWG GC RA PGVYT
Sbjct: 177 RIRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTS 236
Query: 291 ITRYVEWIKEKSKEGCFLFFVAYVSVIATTMGAH 324
Y+ WI K + A+T GA
Sbjct: 237 TWSYLNWIASKIGSTAVHMIQLPTASPASTPGAQ 270
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 149 bits (376), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 97/254 (38%), Positives = 138/254 (54%), Gaps = 32/254 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSS 230
CLP ++L Y+ G V GWG L+E+G+P+ +++ V +PI+ C+ ST
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETGQPS-VLQVVNLPIVERPVCKDSTR--- 171
Query: 231 TRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRAGYPG 286
RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC R G G
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 231
Query: 287 VYTRITRYVEWIKE 300
YT + R +WI++
Sbjct: 232 FYTHVFRLKKWIQK 245
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 149 bits (375), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 97/254 (38%), Positives = 138/254 (54%), Gaps = 32/254 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSS 230
CLP ++L Y+ G V GWG L+E+G+P+ +++ V +PI+ C+ ST
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETGQPS-VLQVVNLPIVERPVCKDSTR--- 171
Query: 231 TRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRAGYPG 286
RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC R G G
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 231
Query: 287 VYTRITRYVEWIKE 300
YT + R +WI++
Sbjct: 232 FYTHVFRLKKWIQK 245
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 148 bits (374), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 83/237 (35%), Positives = 134/237 (56%), Gaps = 13/237 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGR-----LWFLIKATF 124
IVGG + +PW+V L + ++ CG +L++ ++++AAHCV GR W KA
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCVYGRNMEPSKW---KAVL 57
Query: 125 GEYDRCD-TSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVL 182
G + + TS + E+R + + ++ + +NDIA++ L +V D I+P+CLP
Sbjct: 58 GLHMASNLTSPQIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQPICLPEEN 117
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ GWG L G A ++++ +VP+LSN+ C+ I++NM+CAGY
Sbjct: 118 QVFPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQM--PEYNITENMVCAGY 175
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
G DSCQGDSGGP++ + E++R+ G+ S+G C PGVY R+ R+ EWI+
Sbjct: 176 EAGGVDSCQGDSGGPLMCQ-ENNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWIQ 231
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 148 bits (374), Expect = 5e-36, Method: Compositional matrix adjust.
Identities = 97/254 (38%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSS 230
CLP ++L Y+ G V GWG L+E G+P+ +++ V +PI+ C+ ST
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKEKGQPS-VLQVVNLPIVERPVCKDSTR--- 171
Query: 231 TRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRAGYPG 286
RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC R G G
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 231
Query: 287 VYTRITRYVEWIKE 300
YT + R +WI++
Sbjct: 232 FYTHVFRLKKWIQK 245
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 147 bits (371), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 131/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 147 bits (371), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 131/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 147 bits (370), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 131/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 147 bits (370), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 131/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 147 bits (370), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 132/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 RCDTSSKP-ESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTAAEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 147 bits (370), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 131/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 147 bits (370), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 131/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 147 bits (370), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 131/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 146 bits (368), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 98/261 (37%), Positives = 139/261 (53%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G PG YT + R +WI++
Sbjct: 232 DRDGKPGFYTHVFRLKKWIQK 252
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 146 bits (368), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 85/241 (35%), Positives = 131/241 (54%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E GR + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGD+GGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDAGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 145 bits (366), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 140/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R + E ++ I ++ N D DIAL++L V D I P
Sbjct: 90 LVR--IGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 147
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 148 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 203
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 204 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 260
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 261 CDRDGKYGFYTHVFRLKKWIQK 282
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 145 bits (365), Expect = 5e-35, Method: Compositional matrix adjust.
Identities = 85/241 (35%), Positives = 130/241 (53%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E G + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 145 bits (365), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 95/254 (37%), Positives = 134/254 (52%), Gaps = 31/254 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSS 230
CLP ++L Y+ G V GWG L+E+ +++ V +PI+ C+ ST
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKDSTR--- 172
Query: 231 TRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRAGYPG 286
RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC R G G
Sbjct: 173 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 232
Query: 287 VYTRITRYVEWIKE 300
YT + R +WI++
Sbjct: 233 FYTHVFRLKKWIQK 246
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 144 bits (364), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 85/241 (35%), Positives = 130/241 (53%), Gaps = 15/241 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGGQ + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VL 182
R + E+ + ++ FT +D DIA+LRL + + P CLP
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAE 116
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +TG+V G+G E G + ++ +EVP + C+ S+++ I+ NM CAGY
Sbjct: 117 STLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFI---ITQNMFCAGY 173
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+D+CQGDSGGP V +D+ Y GIVSWG GC R G G+YT++T +++WI
Sbjct: 174 DTKQEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSM 232
Query: 303 K 303
K
Sbjct: 233 K 233
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 144 bits (364), Expect = 8e-35, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 90 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 147
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 148 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 203
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 204 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 260
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 261 CDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 144 bits (363), Expect = 8e-35, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 90 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 147
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 148 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 203
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 204 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 260
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 261 CDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 144 bits (363), Expect = 8e-35, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 90 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 147
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 148 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 203
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 204 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 260
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 261 CDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 144 bits (363), Expect = 9e-35, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 91
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 92 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 149
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 150 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 205
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 206 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 262
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 263 CDRDGKYGFYTHVFRLKKWIQK 284
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 144 bits (363), Expect = 9e-35, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 91
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 92 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 149
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 150 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 205
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 206 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 262
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 263 CDRDGKYGFYTHVFRLKKWIQK 284
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 144 bits (363), Expect = 9e-35, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 29 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 88
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 89 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 146
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 147 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 202
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 203 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 259
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 260 CDRDGKYGFYTHVFRLKKWIQK 281
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 144 bits (363), Expect = 9e-35, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 165 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 224
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 225 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 282
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 283 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 338
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 339 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 395
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 396 CDRDGKYGFYTHVFRLKKWIQK 417
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 144 bits (363), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 95
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 96 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 153
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 154 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 209
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 210 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 266
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 267 CDRDGKYGFYTHVFRLKKWIQK 288
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 144 bits (362), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 98/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 95
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 96 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 153
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 154 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 209
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 210 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEG 266
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 267 CDRDGKYGFYTHVFRLKKWIQK 288
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 143 bits (361), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 82/233 (35%), Positives = 126/233 (54%), Gaps = 9/233 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGG+ + PW L + N +CGGT++N+ YVLTAAHC+ F ++ +
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHCLHQAKRFTVRVGDRNTE 60
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT---VLNNT 185
+ + ++ + F +D DIA+LRL + + P CLP
Sbjct: 61 Q-EEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEKDWAEATL 119
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
+TG+V G+G E GR + ++ +EVP + C+ S++++ I+ NM CAGY
Sbjct: 120 MTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSFT---ITPNMFCAGYDTQ 176
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
+D+CQGDSGGP V +D+ Y GIVSWG GC R G GVYT+++ +++WI
Sbjct: 177 PEDACQGDSGGPHVTRFKDT-YFVTGIVSWGEGCARKGKFGVYTKVSNFLKWI 228
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 143 bits (361), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 97/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 49 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 108
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 109 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 166
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 167 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 222
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GD+GGP V + ++R+ Q+GIVSWG G
Sbjct: 223 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEG 279
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 280 CDRDGKYGFYTHVFRLKKWIQK 301
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 143 bits (361), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 98/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTTNVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+CQGDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 143 bits (361), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 ARKGKYGFYTHVFRLKKWIQK 252
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 143 bits (361), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 97/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 31 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 90
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 91 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 148
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 149 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 204
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GD+GGP V + ++R+ Q+GIVSWG G
Sbjct: 205 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEG 261
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 262 CDRDGKYGFYTHVFRLKKWIQK 283
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 143 bits (361), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 95/258 (36%), Positives = 132/258 (51%), Gaps = 31/258 (12%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV GQ EV PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 49 RIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDL 108
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R K E ++ I ++ N D DIALL+L + + D I P
Sbjct: 109 LVR--IGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHP 166
Query: 176 VCLP---TVLNNTYEDETGVVMGWGTLEESGRPAC------IIRDVEVPILSNQYCRTST 226
VCLP T + G V GWG E+ + +++ V +P++ C+ ST
Sbjct: 167 VCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKAST 226
Query: 227 NYSSTRISDNMMCAGYPEG---MKDSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRA 282
RI+DNM CAGY G D+C+GDSGGP V + ++R+ Q+GIVSWG GC R
Sbjct: 227 R---IRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRD 283
Query: 283 GYPGVYTRITRYVEWIKE 300
G G YT + R +WI++
Sbjct: 284 GKYGFYTHVFRLKKWIQK 301
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 143 bits (360), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 139/261 (53%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R + E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 143 bits (360), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 139/261 (53%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R + E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 143 bits (360), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 97/262 (37%), Positives = 139/262 (53%), Gaps = 39/262 (14%)
Query: 69 RIVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------F 118
RIV G E+ PW V L CG +LI+DR+VLTAAHC+ W
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 60
Query: 119 LIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKP 175
L++ G++ R E ++ I ++ N D DIAL++L V D I P
Sbjct: 61 LVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 118
Query: 176 VCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYC 222
VCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C
Sbjct: 119 VCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVC 174
Query: 223 RTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAG 278
+ ST RI+DNM CAGY EG + D+C+GD+GGP V + ++R+ Q+GIVSWG G
Sbjct: 175 KDSTR---IRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEG 231
Query: 279 CGRAGYPGVYTRITRYVEWIKE 300
C R G G YT + R +WI++
Sbjct: 232 CDRDGKYGFYTHVFRLKKWIQK 253
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 142 bits (359), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 99/265 (37%), Positives = 140/265 (52%), Gaps = 43/265 (16%)
Query: 70 IVGGQPTEVNQYPWMV------RLSYFNRFYCGGTLINDRYVLTAAHCVKGRLW------ 117
IV G E+ PW V R S RF CG +LI+DR+VLTAAHC+ W
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTE 60
Query: 118 --FLIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDI 172
L++ G++ R E ++ I ++ N D DIAL++L V D
Sbjct: 61 NDLLVR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDY 118
Query: 173 IKPVCLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSN 219
I PVCLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+
Sbjct: 119 IHPVCLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVER 174
Query: 220 QYCRTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSW 275
C+ ST RI+DNM CA Y EG + D+C+GDSGGP V + ++R+ Q+GIVSW
Sbjct: 175 PVCKDSTR---IRITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSW 231
Query: 276 GAGCGRAGYPGVYTRITRYVEWIKE 300
G GC R G G YT + R +WI++
Sbjct: 232 GEGCDRDGKYGFYTHVFRLKKWIQK 256
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 142 bits (359), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 97/259 (37%), Positives = 138/259 (53%), Gaps = 35/259 (13%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW---FL---IK 121
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W F+ +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLL 60
Query: 122 ATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPVCL 178
G++ R E ++ I ++ N D DIAL++L V D I PVCL
Sbjct: 61 VRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCL 120
Query: 179 P------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCRTS 225
P ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+ S
Sbjct: 121 PDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCKDS 176
Query: 226 TNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGR 281
T RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC R
Sbjct: 177 TR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 233
Query: 282 AGYPGVYTRITRYVEWIKE 300
G G YT + R +WI++
Sbjct: 234 DGKYGFYTHVFRLKKWIQK 252
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 142 bits (358), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKIGFYTHVFRLKKWIQK 252
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 142 bits (358), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 81/240 (33%), Positives = 128/240 (53%), Gaps = 8/240 (3%)
Query: 69 RIVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
RIVGG + ++PW V L S R CGG++I ++++LTAAHC G I +
Sbjct: 387 RIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 446
Query: 126 EYDRCDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
+ S F ++ I+ + + DIALL+L V D +P+CLP+ +
Sbjct: 447 GILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGD 506
Query: 184 NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY
Sbjct: 507 RNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYR 564
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
EG KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 565 EGGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 623
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 142 bits (358), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 142 bits (358), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 142 bits (358), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 95/264 (35%), Positives = 138/264 (52%), Gaps = 20/264 (7%)
Query: 50 AKEDYPMCDCSCGETNDAT--RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLT 107
++ P+C+ CG + T RI GGQ + +PW V + G L+ D +VLT
Sbjct: 65 GEKSLPVCEPVCGLSARTTGGRIYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLT 122
Query: 108 AAHCV--KGRLWFLIKATFGEYDRCD---TSSKPESRFVIRAIVGDFTFSNFDNDIALLR 162
AAH V + + G R T + E+ F+ D + FDNDIAL++
Sbjct: 123 AAHAVYEQKHDASALDIRMGTLKRLSPHYTQAWSEAVFIHEGYTHD---AGFDNDIALIK 179
Query: 163 LNDRVPIVDIIKPVCLPTVLNNTY--EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQ 220
LN++V I I P+CLP ++ D+ G GWG L + G A + V++PI+ +Q
Sbjct: 180 LNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQ 238
Query: 221 YCRTSTN---YSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVF-EREDSRYEQIGIVSWG 276
C + Y ++ NM+CAG G KDSC+GDSGG +VF + E R+ GIVSWG
Sbjct: 239 KCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWG 298
Query: 277 A-GCGRAGYPGVYTRITRYVEWIK 299
+ CG AG GVYT++ Y+ WI+
Sbjct: 299 SMNCGEAGQYGVYTKVINYIPWIE 322
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 142 bits (358), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 142 bits (358), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 142 bits (357), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKFGFYTHVFRLKKWIQK 252
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 142 bits (357), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGPLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 141 bits (356), Expect = 5e-34, Method: Compositional matrix adjust.
Identities = 96/254 (37%), Positives = 136/254 (53%), Gaps = 34/254 (13%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSS 230
CLP ++L Y+ G V GWG L+ G+P+ +++ V +PI+ C+ ST
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLK--GQPS-VLQVVNLPIVERPVCKDSTR--- 169
Query: 231 TRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRAGYPG 286
RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC R G G
Sbjct: 170 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 229
Query: 287 VYTRITRYVEWIKE 300
YT + R +WI++
Sbjct: 230 FYTHVFRLKKWIQK 243
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 141 bits (356), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 86/240 (35%), Positives = 130/240 (54%), Gaps = 19/240 (7%)
Query: 64 TNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKAT 123
T+D +IVGG N P+ V L+ + F CGG+LIN ++V++AAHC K R I+
Sbjct: 3 TDDDDKIVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSR----IQVR 57
Query: 124 FGEYDRCDTSSKPESRFVIRAIVG--DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV 181
GE++ D E I+ +F + DNDI L++L+ + + V LP
Sbjct: 58 LGEHNI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRS 116
Query: 182 LNNTYEDETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
++ GWG + SG +++ ++ P+LS+ C++S +I+ NM+C
Sbjct: 117 C--AAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY---PGQITGNMICV 171
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
G+ EG KDSCQGDSGGP+V + GIVSWG GC + PGVYT++ YV WI++
Sbjct: 172 GFLEGGKDSCQGDSGGPVVCNGQLQ-----GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 226
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 141 bits (356), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 94/257 (36%), Positives = 131/257 (50%), Gaps = 31/257 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV GQ EV PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R K E ++ I ++ N D DIALL+L + + D I PV
Sbjct: 61 VR--IGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
Query: 177 CLP---TVLNNTYEDETGVVMGWGTLEESGRPAC------IIRDVEVPILSNQYCRTSTN 227
CLP T + G V GWG E+ + +++ V +P++ C+ ST
Sbjct: 119 CLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTR 178
Query: 228 YSSTRISDNMMCAGYPEG---MKDSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRAG 283
RI+DNM CAGY G D+C+GDSGGP V + ++R+ Q+GIVSWG GC R G
Sbjct: 179 ---IRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDG 235
Query: 284 YPGVYTRITRYVEWIKE 300
G YT + R +WI++
Sbjct: 236 KYGFYTHVFRLKKWIQK 252
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 141 bits (356), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 94/257 (36%), Positives = 131/257 (50%), Gaps = 31/257 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV GQ EV PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R K E ++ I ++ N D DIALL+L + + D I PV
Sbjct: 61 VR--IGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
Query: 177 CLP---TVLNNTYEDETGVVMGWGTLEESGRPAC------IIRDVEVPILSNQYCRTSTN 227
CLP T + G V GWG E+ + +++ V +P++ C+ ST
Sbjct: 119 CLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTR 178
Query: 228 YSSTRISDNMMCAGYPEG---MKDSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRAG 283
RI+DNM CAGY G D+C+GDSGGP V + ++R+ Q+GIVSWG GC R G
Sbjct: 179 ---IRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDG 235
Query: 284 YPGVYTRITRYVEWIKE 300
G YT + R +WI++
Sbjct: 236 KYGFYTHVFRLKKWIQK 252
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 141 bits (356), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 80/239 (33%), Positives = 130/239 (54%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKG-RLWFLIKATFG 125
IVGG + ++PW V L S R CGG++I ++++LTAAHC G +++ G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + V I+ D + + DIALL+L V D +P+CLP+ +
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 141 bits (355), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 96/261 (36%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GD+GGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 140 bits (354), Expect = 9e-34, Method: Compositional matrix adjust.
Identities = 80/239 (33%), Positives = 129/239 (53%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKG-RLWFLIKATFG 125
IVGG + ++PW V L S R CGG++I ++++LTAAHC G +++ G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + V I+ D + + DIALL+L V D +P+CLP+ +
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 140 bits (354), Expect = 9e-34, Method: Compositional matrix adjust.
Identities = 80/239 (33%), Positives = 127/239 (53%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
IVGG + ++PW V L S R CGG++I ++++LTAAHC G I +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 127 YDRCDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
+ S F ++ I+ + + DIALL+L V D +P+CLP+ +
Sbjct: 61 ILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 140 bits (354), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 94/264 (35%), Positives = 138/264 (52%), Gaps = 20/264 (7%)
Query: 50 AKEDYPMCDCSCGETNDAT--RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLT 107
++ P+C+ CG + T +I GGQ + +PW V + G L+ D +VLT
Sbjct: 140 GEKSLPVCEPVCGLSARTTGGQIYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLT 197
Query: 108 AAHCV--KGRLWFLIKATFGEYDRCD---TSSKPESRFVIRAIVGDFTFSNFDNDIALLR 162
AAH V + + G R T + E+ F+ D + FDNDIAL++
Sbjct: 198 AAHAVYEQKHDASALDIRMGTLKRLSPHYTQAWSEAVFIHEGYTHD---AGFDNDIALIK 254
Query: 163 LNDRVPIVDIIKPVCLPTVLNNTY--EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQ 220
LN++V I I P+CLP ++ D+ G GWG L + G A + V++PI+ +Q
Sbjct: 255 LNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQ 313
Query: 221 YCRTSTN---YSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVF-EREDSRYEQIGIVSWG 276
C + Y ++ NM+CAG G KDSC+GDSGG +VF + E R+ GIVSWG
Sbjct: 314 KCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWG 373
Query: 277 A-GCGRAGYPGVYTRITRYVEWIK 299
+ CG AG GVYT++ Y+ WI+
Sbjct: 374 SMNCGEAGQYGVYTKVINYIPWIE 397
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 140 bits (354), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 90/241 (37%), Positives = 127/241 (52%), Gaps = 20/241 (8%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFGEY 127
+VGG ++P+MVRL + N +CGG L VLTAAHCV G I AT G
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVV 60
Query: 128 DRCDTSS-KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV---LN 183
D +S+ K S V++A FT + D AL++L +P+ PT+
Sbjct: 61 DLQSSSAVKVRSTKVLQAP--GFTKETYGKDWALIKL---------AQPINQPTLKIATT 109
Query: 184 NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
Y T V GWG E G + VP +S+ CR+S+++ +++ M+CAGYP
Sbjct: 110 TAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF--ILVANEMICAGYP 167
Query: 244 E-GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
+ G D+CQGDSGGPM + + Q+GIVSWG GC R GYPGVYT ++ + I +
Sbjct: 168 DTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAA 227
Query: 303 K 303
+
Sbjct: 228 R 228
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 140 bits (353), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 96/261 (36%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D +IAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 140 bits (353), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 96/261 (36%), Positives = 137/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+ DSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 140 bits (353), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 80/239 (33%), Positives = 128/239 (53%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKG-RLWFLIKATFG 125
IVGG + ++PW V L S R CGG++I ++++LTAAHC G +++ G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + V I+ D + + DIALL+L V D +P+CLP+ +
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 139 bits (351), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 96/261 (36%), Positives = 137/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+ DSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 139 bits (350), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVS GAGC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 139 bits (350), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 138/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVS GAGC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 139 bits (350), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 84/234 (35%), Positives = 126/234 (53%), Gaps = 19/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ + F CGG+LIN ++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIVG--DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
D E I+ +F + DNDI L++L+ + + V LP
Sbjct: 56 -DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC--AAA 112
Query: 188 DETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
++ GWG + SG +++ ++ P+LSN C++S +I+ NM+C G+ +G
Sbjct: 113 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSY---PGQITGNMICVGFLQGG 169
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V + GIVSWG GC + PGVYT++ YV WI++
Sbjct: 170 KDSCQGDSGGPVVCNGQLQ-----GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 139 bits (350), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 94/261 (36%), Positives = 135/261 (51%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP---EGMKDSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAG+ D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRKGKYGFYTHVFRLKKWIQK 252
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 139 bits (350), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 96/261 (36%), Positives = 137/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
G G YT + R +WI++
Sbjct: 232 RDDGKYGFYTHVFRLKKWIQK 252
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 139 bits (349), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 83/238 (34%), Positives = 130/238 (54%), Gaps = 12/238 (5%)
Query: 70 IVGGQPTEVNQYPWMV--RLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEY 127
IVGG ++PW V R + +CGG++INDR+V+ AAHC++G L+ GE+
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQGEAPALVSLVVGEH 60
Query: 128 DRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
D S+ ++ V V + + + +ND+++++ + + P+C P N+ Y
Sbjct: 61 DSSAASTVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPICAPDPAND-Y 119
Query: 187 EDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
GWGT+ G PA ++R V + I +N +C Y+S I D+M+CA
Sbjct: 120 VYRKSQCSGWGTINSGGVCCPA-VLRYVTLNITTNAFCDAV--YTSDTIYDDMICATDNT 176
Query: 245 GM--KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
GM +DSCQGDSGGP+ + + +GIVSWG GC +GYPGVY+R+ + WI +
Sbjct: 177 GMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCA-SGYPGVYSRVGFHAGWITD 233
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 139 bits (349), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 80/242 (33%), Positives = 123/242 (50%), Gaps = 12/242 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFY-CGGTLINDRYVLTAAHCVKGRLWFLIK------A 122
+VGG + ++PW V L + + CG +LI+ ++++AAHC F A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 123 TFGEYDRCDTSSKPESRFVIRAIVGDFTFSNF--DNDIALLRLNDRVPIVDIIKPVCLPT 180
G +D+ S+ ++ I+ F++F D DIALL L +++P+CLP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD 120
Query: 181 VLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+ + V GWG + G A I++ E+ +++ C N +I+ MMC
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCE---NLLPQQITPRMMCV 177
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
G+ G DSCQGDSGGP+ D R Q G+VSWG GC + PGVYTR+ + +WIKE
Sbjct: 178 GFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE 237
Query: 301 KS 302
+
Sbjct: 238 NT 239
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 138 bits (348), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 84/234 (35%), Positives = 126/234 (53%), Gaps = 19/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ + F CGG+LIN ++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIVG--DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
D E I+ +F + DNDI L++L+ + + V LP
Sbjct: 56 -DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSLPRSC--AAA 112
Query: 188 DETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
++ GWG + SG +++ ++ P+LS+ C++S +I+ NM+C G+ EG
Sbjct: 113 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY---PGQITGNMICVGFLEGG 169
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V + GIVSWG GC + PGVYT++ YV WI++
Sbjct: 170 KDSCQGDSGGPVVCNGQLQ-----GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 138 bits (348), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 127/238 (53%), Gaps = 17/238 (7%)
Query: 65 NDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
+D +IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+
Sbjct: 1 DDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRL 55
Query: 125 GEYDRCDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
GE + + ++IV SN +NDI L++L + + + LPT
Sbjct: 56 GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC- 114
Query: 184 NTYEDETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY
Sbjct: 115 -ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGY 170
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
EG KDSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 LEGGKDSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 223
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 138 bits (348), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 80/242 (33%), Positives = 122/242 (50%), Gaps = 12/242 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFY-CGGTLINDRYVLTAAHCVKGRLWFLIK------A 122
+VGG + ++PW V L + + CG +LI+ ++++AAHC F A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 123 TFGEYDRCDTSSKPESRFVIRAIVGDFTFSNF--DNDIALLRLNDRVPIVDIIKPVCLPT 180
G +D+ S+ ++ I+ F++F D DIALL L +++P+CLP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPD 120
Query: 181 VLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+ + V GWG + G A I++ E+ ++ C N +I+ MMC
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCE---NLLPQQITPRMMCV 177
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
G+ G DSCQGDSGGP+ D R Q G+VSWG GC + PGVYTR+ + +WIKE
Sbjct: 178 GFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE 237
Query: 301 KS 302
+
Sbjct: 238 NT 239
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 138 bits (348), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 128/238 (53%), Gaps = 17/238 (7%)
Query: 65 NDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
+D +IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+
Sbjct: 10 DDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRL 64
Query: 125 GEYDRCDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
GE + + ++IV SN +NDI L++L + + + LPT
Sbjct: 65 GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA 124
Query: 184 NTYEDETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ ++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY
Sbjct: 125 SA--GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGY 179
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
EG KDSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 180 LEGGKDSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 232
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 138 bits (348), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 96/261 (36%), Positives = 136/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEESG-------RPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L E+ +P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLRETWTTNINEIQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+C+GDSGGP V + ++R+ Q+GIVSWG GC
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGC 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 138 bits (348), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 128/238 (53%), Gaps = 17/238 (7%)
Query: 65 NDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
+D +IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+
Sbjct: 16 DDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRL 70
Query: 125 GEYDRCDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
GE + + ++IV SN +NDI L++L + + + LPT
Sbjct: 71 GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA 130
Query: 184 NTYEDETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ ++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY
Sbjct: 131 SA--GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGY 185
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
EG KDSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 186 LEGGKDSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 238
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 138 bits (348), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 86/238 (36%), Positives = 127/238 (53%), Gaps = 17/238 (7%)
Query: 65 NDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
+D +IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+
Sbjct: 2 DDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRL 56
Query: 125 GEYDRCDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
GE + + ++IV SN +NDI L++L + + + LPT
Sbjct: 57 GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC- 115
Query: 184 NTYEDETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY
Sbjct: 116 -ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGY 171
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
EG KDSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 172 LEGGKDSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 224
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 138 bits (348), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 81/234 (34%), Positives = 124/234 (52%), Gaps = 12/234 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGE 126
R+VGG + +PW V L + F + +CGGTLI+ +VLTAAHC+ K K G
Sbjct: 16 RVVGGCVAHPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 75
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + + V R DIALL+L+ I D + P CLP+
Sbjct: 76 HQEVNLEPHVQEIEVSR-----LFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYMVA 130
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+ + GWG + + A ++++ ++P++ N+ C + + R+ +CAG+ G
Sbjct: 131 DRTECFITGWGETQGTFG-AGLLKEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAGG 188
Query: 247 KDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGDSGGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 189 TDSCQGDSGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 240
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 138 bits (347), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 95/258 (36%), Positives = 130/258 (50%), Gaps = 33/258 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIALL+L VP D I PV
Sbjct: 61 VR--IGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
Query: 177 CLP---TVLNNTYEDETGVVMGWGTLEESG-------RPACIIRDVEVPILSNQYCRTST 226
CLP TV + G V GWG L E+ +P+ +++ V +PI+ C+ ST
Sbjct: 119 CLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPS-VLQVVNLPIVERPVCKAST 177
Query: 227 NYSSTRISDNMMCAGYP---EGMKDSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRA 282
RI+DNM CAG+ D+C+GDSGGP V + ++R+ Q+GIVSWG GC R
Sbjct: 178 R---IRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRK 234
Query: 283 GYPGVYTRITRYVEWIKE 300
G G YT + R WI++
Sbjct: 235 GKYGFYTHVFRLKAWIQK 252
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 138 bits (347), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 84/234 (35%), Positives = 126/234 (53%), Gaps = 19/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ + F CGG+LIN ++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIVG--DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
D E I+ +F + DNDI L++L+ + + V LP
Sbjct: 56 -DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC--AAA 112
Query: 188 DETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
++ GWG + SG +++ ++ P+LS+ C++S +I+ NM+C G+ EG
Sbjct: 113 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY---PGQITGNMICVGFLEGG 169
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V + GIVSWG GC + PGVYT++ YV WI++
Sbjct: 170 KDSCQGDSGGPVVCNGQLQ-----GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 138 bits (347), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 79/239 (33%), Positives = 129/239 (53%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKG-RLWFLIKATFG 125
IVGG + ++PW V L S R CGG++I ++++LTAAHC G +++ G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + V I+ D + + DIALL+L V D +P+ LP+ +
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 138 bits (347), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 79/239 (33%), Positives = 129/239 (53%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKG-RLWFLIKATFG 125
IVGG + ++PW V L S R CGG++I ++++LTAAHC G +++ G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + V I+ D + + DIALL+L V D +P+ LP+ +
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 137 bits (346), Expect = 8e-33, Method: Compositional matrix adjust.
Identities = 79/239 (33%), Positives = 127/239 (53%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
IVGG + ++PW V L S R CGG++I ++++LTAAHC G I +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 127 YDRCDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ S F ++ I+ + + DIALL+L V D +P+ LP+ +
Sbjct: 61 ILNQSEIAEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 137 bits (345), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 94/258 (36%), Positives = 130/258 (50%), Gaps = 33/258 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIALL+L VP D I PV
Sbjct: 61 VR--IGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
Query: 177 CLP---TVLNNTYEDETGVVMGWGTLEESG-------RPACIIRDVEVPILSNQYCRTST 226
CLP TV + G V GWG L E+ +P+ +++ V +PI+ C+ ST
Sbjct: 119 CLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPS-VLQVVNLPIVERPVCKAST 177
Query: 227 NYSSTRISDNMMCAGYP---EGMKDSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRA 282
RI+DNM CAG+ D+C+GD+GGP V + ++R+ Q+GIVSWG GC R
Sbjct: 178 R---IRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRK 234
Query: 283 GYPGVYTRITRYVEWIKE 300
G G YT + R WI++
Sbjct: 235 GKYGFYTHVFRLKRWIQK 252
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 137 bits (345), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 79/239 (33%), Positives = 128/239 (53%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKG-RLWFLIKATFG 125
IVGG + ++PW V L S R CGG++I ++++LTAAHC G +++ G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + V I+ D + + DIALL+L V D +P+ LP+ +
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 137 bits (345), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 85/238 (35%), Positives = 128/238 (53%), Gaps = 17/238 (7%)
Query: 65 NDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
+D +IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+
Sbjct: 16 DDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRL 70
Query: 125 GEYDRCDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
GE + + ++IV SN +NDI L++L + + + LPT
Sbjct: 71 GEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCA 130
Query: 184 NTYEDETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ ++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY
Sbjct: 131 SA--GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGY 185
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
EG KDSCQGD+GGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 186 LEGGKDSCQGDAGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 238
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 137 bits (345), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 79/239 (33%), Positives = 126/239 (52%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
IVGG + ++PW V L S R CGG++I ++++LTAAHC G I +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 127 YDRCDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
+ S F ++ I+ + + DIALL+L V D +P+ LP+ +
Sbjct: 61 ILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDR 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 137 bits (345), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 85/233 (36%), Positives = 125/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 137 bits (345), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 84/235 (35%), Positives = 125/235 (53%), Gaps = 14/235 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGE 126
R+VGG + +PW V L + F +CGGTLI+ +VLTAAHC+ K K G
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 79
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + + V R DIALL+L+ I D + P CLP+ N
Sbjct: 80 HQEVNLEPHVQEIEVSR-----LFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVV 133
Query: 187 EDETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
D T + GWG + + A ++++ ++P++ N+ C + + R+ +CAG+ G
Sbjct: 134 ADRTECFITGWGETQGTFG-AGLLKEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAG 191
Query: 246 MKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGDSGGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 192 GTDSCQGDSGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 244
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 137 bits (345), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 84/235 (35%), Positives = 125/235 (53%), Gaps = 14/235 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGE 126
R+VGG + +PW V L + F +CGGTLI+ +VLTAAHC+ K K G
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 76
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + + V R DIALL+L+ I D + P CLP+ N
Sbjct: 77 HQEVNLEPHVQEIEVSR-----LFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVV 130
Query: 187 EDETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
D T + GWG + + A ++++ ++P++ N+ C + + R+ +CAG+ G
Sbjct: 131 ADRTECFITGWGETQGTFG-AGLLKEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAG 188
Query: 246 MKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGDSGGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 189 GTDSCQGDSGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 241
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 137 bits (345), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 83/234 (35%), Positives = 126/234 (53%), Gaps = 19/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ + F CGG+LIN ++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCAANSVPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIVG--DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
D E I+ +F + DNDI L++L+ + + V LP
Sbjct: 56 -DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC--AAA 112
Query: 188 DETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
++ GWG + SG +++ ++ P+LS+ C+++ +I+ NM+C G+ EG
Sbjct: 113 GTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAY---PGQITGNMICVGFLEGG 169
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V + GIVSWG GC + PGVYT++ YV WI++
Sbjct: 170 KDSCQGDSGGPVVCNGQLQ-----GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 137 bits (344), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 83/233 (35%), Positives = 125/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 137 bits (344), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 86/233 (36%), Positives = 125/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + V LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASVSLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCAGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 137 bits (344), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 79/239 (33%), Positives = 125/239 (52%), Gaps = 8/239 (3%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
IVGG + ++PW V L S R CGG++I ++++LTAAHC G I +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 127 YDRCDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
+ S F ++ I+ + + DIALL+L V D +P+ LP+
Sbjct: 61 ILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGER 120
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + + ++ ++P+++N+ C+ Y +I+ M+CAGY E
Sbjct: 121 NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMICAGYRE 178
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G KD+C+GDSGGP+ + + + +GI SWG GC + PGVYT + YV+WI EK++
Sbjct: 179 GGKDACKGDSGGPLSC-KHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 136 bits (343), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 85/233 (36%), Positives = 125/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 136 bits (343), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 83/233 (35%), Positives = 125/233 (53%), Gaps = 19/233 (8%)
Query: 71 VGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDRC 130
VGG N P+ V L+ + F CGG+LIN ++V++AAHC K R I+ GE++
Sbjct: 2 VGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSR----IQVRLGEHNI- 55
Query: 131 DTSSKPESRFVIRAIVG--DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
D E I+ +F + DNDI L++L+ + + V LP
Sbjct: 56 DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC--AAAG 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ P+LS+ C++S +I+ NM+C G+ EG K
Sbjct: 114 TECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY---PGQITGNMICVGFLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG GC + PGVYT++ YV WI++
Sbjct: 171 DSCQGDSGGPVVCNGQLQ-----GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 218
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 136 bits (343), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 95/261 (36%), Positives = 136/261 (52%), Gaps = 39/261 (14%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES-------GRPACIIRDVEVPILSNQYCR 223
CLP ++L Y+ G V GWG L+E+ G+P+ +++ V +PI+ C+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKETWTANVGKGQPS-VLQVVNLPIVERPVCK 174
Query: 224 TSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGC 279
ST RI+DNM CAGY EG + D+ +GDSGGP V + ++R+ Q+GIVSWG G
Sbjct: 175 DSTR---IRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGA 231
Query: 280 GRAGYPGVYTRITRYVEWIKE 300
R G G YT + R +WI++
Sbjct: 232 DRDGKYGFYTHVFRLKKWIQK 252
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 136 bits (342), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 125/235 (53%), Gaps = 14/235 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGE 126
R+VGG + +PW V L + F +CGGTLI+ +VLTAAHC+ K K G
Sbjct: 19 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 78
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + + V R DIALL+L+ I D + P CLP+ N
Sbjct: 79 HQEVNLEPHVQEIEVSR-----LFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVV 132
Query: 187 EDETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
D T + GWG + + A ++++ ++P++ N+ C + + R+ +CAG+ G
Sbjct: 133 ADRTECFITGWGETQGTFG-AGLLKEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAG 190
Query: 246 MKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGD+GGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 191 GTDSCQGDAGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 243
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 136 bits (342), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 130/241 (53%), Gaps = 21/241 (8%)
Query: 64 TNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKAT 123
+D +IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+
Sbjct: 17 VDDDDKIVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVR 71
Query: 124 FGEYDRCDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT 180
GE++ + +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 72 LGEHNI--NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALPS 129
Query: 181 VLNNTYEDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMC 239
+ ++ GWG SG +++ ++ P+L C S +I+DNM+C
Sbjct: 130 --SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVC 184
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
G+ EG KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI+
Sbjct: 185 VGFLEGGKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQ 239
Query: 300 E 300
+
Sbjct: 240 D 240
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 136 bits (342), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 125/235 (53%), Gaps = 14/235 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGE 126
R+VGG + +PW V L + F +CGGTLI+ +VLTAAHC+ K K G
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 79
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + + V R DIALL+L+ I D + P CLP+ N
Sbjct: 80 HQEVNLEPHVQEIEVSR-----LFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVV 133
Query: 187 EDETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
D T + GWG + + A ++++ ++P++ N+ C + + R+ +CAG+ G
Sbjct: 134 ADRTECFITGWGETQGTFG-AGLLKEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAG 191
Query: 246 MKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGD+GGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 192 GTDSCQGDAGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 244
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 136 bits (342), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 85/233 (36%), Positives = 124/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS C+++ +I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAY---PGQITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 136 bits (342), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 125/235 (53%), Gaps = 14/235 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGE 126
R+VGG + +PW V L + F +CGGTLI+ +VLTAAHC+ K K G
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 76
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + + V R DIALL+L+ I D + P CLP+ N
Sbjct: 77 HQEVNLEPHVQEIEVSR-----LFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVV 130
Query: 187 EDETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
D T + GWG + + A ++++ ++P++ N+ C + + R+ +CAG+ G
Sbjct: 131 ADRTECFITGWGETQGTFG-AGLLKEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAG 188
Query: 246 MKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGD+GGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 189 GTDSCQGDAGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 241
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 136 bits (342), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 125/235 (53%), Gaps = 14/235 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGE 126
R+VGG + +PW V L + F +CGGTLI+ +VLTAAHC+ K K G
Sbjct: 18 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 77
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + + V R DIALL+L+ I D + P CLP+ N
Sbjct: 78 HQEVNLEPHVQEIEVSR-----LFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVV 131
Query: 187 EDETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
D T + GWG + + A ++++ ++P++ N+ C + + R+ +CAG+ G
Sbjct: 132 ADRTECFITGWGETQGTFG-AGLLKEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAG 189
Query: 246 MKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGD+GGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 190 GTDSCQGDAGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 242
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 136 bits (342), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 84/235 (35%), Positives = 124/235 (52%), Gaps = 14/235 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGE 126
R+VGG + +PW V L + F +CGGTLI+ +VLTAAHC+ K K G
Sbjct: 561 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 620
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + V V DIALL+L+ I D + P CLP+ N
Sbjct: 621 HQEVNLEP-----HVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVV 674
Query: 187 EDETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
D T + GWG + + A ++++ ++P++ N+ C + + R+ +CAG+ G
Sbjct: 675 ADRTECFITGWGETQGTFG-AGLLKEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAG 732
Query: 246 MKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGDSGGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 733 GTDSCQGDSGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 785
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 135 bits (340), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 89/242 (36%), Positives = 127/242 (52%), Gaps = 18/242 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV--KGRLWFLIKATFGEY 127
I GGQ + +PW V + G L+ D +VLTAAH V + + G
Sbjct: 1 IYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTL 58
Query: 128 DRCD---TSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
R T + E+ F+ D + FDNDIAL++LN++V I I P+CLP
Sbjct: 59 KRLSPHYTQAWSEAVFIHEGYTHD---AGFDNDIALIKLNNKVVINSNITPICLPRKEAE 115
Query: 185 TY--EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTN---YSSTRISDNMMC 239
++ D+ G GWG L + G A + V++PI+ +Q C + Y ++ NM+C
Sbjct: 116 SFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLC 174
Query: 240 AGYPEGMKDSCQGDSGGPMVF-EREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEW 297
AG G KDSC+GDSGG +VF + E R+ GIVSWG+ CG AG GVYT++ Y+ W
Sbjct: 175 AGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPW 234
Query: 298 IK 299
I+
Sbjct: 235 IE 236
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 135 bits (340), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 86/234 (36%), Positives = 126/234 (53%), Gaps = 18/234 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDI-IKPVCLPTVLNNTYE 187
+ ++IV SN +NDI L++L + D + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRVASISLPTSCASA-- 113
Query: 188 DETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG
Sbjct: 114 GTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGG 170
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 KDSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 219
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 135 bits (340), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 95/258 (36%), Positives = 130/258 (50%), Gaps = 33/258 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIALL+L VP D I PV
Sbjct: 61 VR--IGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
Query: 177 CLP---TVLNNTYEDETGVVMGWGTLEESG-------RPACIIRDVEVPILSNQYCRTST 226
CLP TV + G V GWG L E+ +P+ +++ V +PI+ C+ ST
Sbjct: 119 CLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPS-VLQVVNLPIVERPVCKAST 177
Query: 227 NYSSTRISDNMMCAGYP---EGMKDSCQGDSGGPMVFERE-DSRYEQIGIVSWGAGCGRA 282
RI+DNM CAG+ D+C+GDSGGP V + ++R+ Q+GIVS GAGC R
Sbjct: 178 R---IRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRK 234
Query: 283 GYPGVYTRITRYVEWIKE 300
G G YT + R WI++
Sbjct: 235 GKYGFYTHVFRLKRWIQK 252
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 135 bits (339), Expect = 5e-32, Method: Compositional matrix adjust.
Identities = 79/242 (32%), Positives = 122/242 (50%), Gaps = 12/242 (4%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFY-CGGTLINDRYVLTAAHCVKGRLWFLIK------A 122
+VGG + ++PW V L + + CG +LI+ ++++AAHC F A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 123 TFGEYDRCDTSSKPESRFVIRAIVGDFTFSNF--DNDIALLRLNDRVPIVDIIKPVCLPT 180
G +D+ S+ ++ I+ F++F D DIALL L +++P+ LP
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPISLPD 120
Query: 181 VLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+ + V GWG + G A I++ E+ +++ C N +I+ MMC
Sbjct: 121 ASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCE---NLLPQQITPRMMCV 177
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
G+ G DSCQGDSGGP+ D R Q G+VSWG GC + PGVYTR+ + +WIKE
Sbjct: 178 GFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE 237
Query: 301 KS 302
+
Sbjct: 238 NT 239
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 135 bits (339), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 84/233 (36%), Positives = 124/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGD GGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDXGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 135 bits (339), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 84/232 (36%), Positives = 124/232 (53%), Gaps = 17/232 (7%)
Query: 71 VGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDRC 130
VGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 2 VGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 131 DTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 57 VVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA--GT 114
Query: 190 TGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKD 248
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG KD
Sbjct: 115 QCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGGKD 171
Query: 249 SCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
SCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 172 SCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 134 bits (338), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 87/235 (37%), Positives = 128/235 (54%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F ++NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S SS I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEAS---SSFIITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KD+CQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDACQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 134 bits (338), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 87/235 (37%), Positives = 117/235 (49%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKG--RLWFLIKATFGEY 127
IVGG +P++V +S +CGG+L+N VLTAAHCV G + F I+A G
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRA--GSL 58
Query: 128 DRCD---TSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
R TSS R ++S +ND+A+L+L+ +P I L ++
Sbjct: 59 SRTSGGITSSLSSVRV-------HPSYSGNNNDLAILKLSTSIPSGGNIGYARLAASGSD 111
Query: 185 TYEDETGVVMGWGTLEESGRPACI-IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
+ V GWG E G + + V VPI+S CR Y ++ I++ M CAG
Sbjct: 112 PVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCR--AQYGTSAITNQMFCAGVS 169
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
G KDSCQGDSGGP+V DS IG VSWG GC R Y GVY + +I
Sbjct: 170 SGGKDSCQGDSGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 134 bits (338), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 84/233 (36%), Positives = 123/233 (52%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCXKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAG 113
Query: 189 ETGVVMGWGTLEESGRPAC-IIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAG EG K
Sbjct: 114 TQCLISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGXLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 134 bits (338), Expect = 8e-32, Method: Compositional matrix adjust.
Identities = 86/241 (35%), Positives = 129/241 (53%), Gaps = 21/241 (8%)
Query: 64 TNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKAT 123
+D +IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+
Sbjct: 5 VDDDDKIVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVR 59
Query: 124 FGEYDRCDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT 180
GE++ + +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 60 LGEHNI--NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 117
Query: 181 VLNNTYEDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMC 239
++ GWG SG +++ ++ P+L C S +I+DNM+C
Sbjct: 118 SC--APAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVC 172
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
G+ EG KDSCQGD+GGP+V E GIVSWG GC PGVYT++ YV+WI+
Sbjct: 173 VGFLEGGKDSCQGDAGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQ 227
Query: 300 E 300
+
Sbjct: 228 D 228
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 134 bits (338), Expect = 8e-32, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 127/242 (52%), Gaps = 18/242 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV--KGRLWFLIKATFGEY 127
I GGQ + +PW V + G L+ D +VLTAAH V + + G
Sbjct: 1 IYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTL 58
Query: 128 DRCD---TSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
R T + E+ F+ D + FDNDIAL++LN++V I I P+CLP
Sbjct: 59 KRLSPHYTQAWSEAVFIHEGYTHD---AGFDNDIALIKLNNKVVINSNITPICLPRKEAE 115
Query: 185 TY--EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTN---YSSTRISDNMMC 239
++ D+ G GWG L + G A + V++PI+ +Q C + Y ++ NM+C
Sbjct: 116 SFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANMLC 174
Query: 240 AGYPEGMKDSCQGDSGGPMVF-EREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEW 297
AG G KDSC+GD+GG +VF + E R+ GIVSWG+ CG AG GVYT++ Y+ W
Sbjct: 175 AGLESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPW 234
Query: 298 IK 299
I+
Sbjct: 235 IE 236
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 134 bits (337), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 86/235 (36%), Positives = 126/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 134 bits (337), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 87/241 (36%), Positives = 128/241 (53%), Gaps = 21/241 (8%)
Query: 64 TNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKAT 123
+D IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+
Sbjct: 5 VDDDDAIVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVR 59
Query: 124 FGEYDRCDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT 180
GE++ + +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 60 LGEHNI--NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPS 117
Query: 181 VLNNTYEDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMC 239
++ GWG SG +++ ++ P+L C S +I+DNM+C
Sbjct: 118 SC--APAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVC 172
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
G+ EG KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI+
Sbjct: 173 VGFLEGGKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQ 227
Query: 300 E 300
+
Sbjct: 228 D 228
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 134 bits (336), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 86/240 (35%), Positives = 123/240 (51%), Gaps = 19/240 (7%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFGEY 127
+VGG ++P+MVRL + N +CGG L VLTAAHCV G I AT G
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVV 60
Query: 128 DRCDTSS-KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV---LN 183
D +S+ K S V++A FT + D AL++L +P+ PT+
Sbjct: 61 DLQSSSAVKVRSTKVLQAP--GFTKETYGKDWALIKL---------AQPINQPTLKIATT 109
Query: 184 NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
Y T V GWG E G + VP +S+ CR+S+++ +++ M+CAGY
Sbjct: 110 TAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF--ILVANEMICAGYD 167
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
+D+CQGDSGGPM + + Q+GIVSWG GC R G GVYT ++ + I ++
Sbjct: 168 TKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAAR 227
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 134 bits (336), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 86/235 (36%), Positives = 127/235 (54%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F ++NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 133 bits (335), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 87/274 (31%), Positives = 141/274 (51%), Gaps = 25/274 (9%)
Query: 48 PSAKEDYPMCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLT 107
P + P+C + RI+GG ++ +PW V +F+ + GG LIN+ +VLT
Sbjct: 61 PELPKCVPVCGVPREPFEEKQRIIGGSDADIKNFPWQV---FFDNPWAGGALINEYWVLT 117
Query: 108 AAHCVKG--RLWFLIKATFGEYDRCDTSS--KPESRFV---IRAIVGDFTFSNFDNDIAL 160
AAH V+G + +T + R S PE F+ + + +NFDNDIAL
Sbjct: 118 AAHVVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDNDIAL 177
Query: 161 LRLNDRVPIVDIIKPVCLPTVLN--NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILS 218
+RL D V + + P+CLP + N + + G++ GWG E+ R A ++ +P+
Sbjct: 178 VRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRTEKRDR-AVRLKAARLPVAP 236
Query: 219 NQYC------RTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFE--REDSRYEQI 270
+ C + + + + + NM+CAG +GM DSC+GDSGG + + +++
Sbjct: 237 LRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGM-DSCKGDSGGAFAVQDPNDKTKFYAA 295
Query: 271 GIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSKE 304
G+VSWG CG G+YTR+ YV+WI + +E
Sbjct: 296 GLVSWGPQCGTY---GLYTRVKNYVDWIMKTMQE 326
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 133 bits (335), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 83/233 (35%), Positives = 124/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + +NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 133 bits (334), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 86/235 (36%), Positives = 126/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 133 bits (334), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 86/235 (36%), Positives = 116/235 (49%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKG--RLWFLIKATFGEY 127
IVGG +P++V +S +CGG+L+N VLTAAHCV G + F I+A G
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRA--GSL 58
Query: 128 DRCD---TSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
R TSS R ++S +ND+A+L+L+ +P I L ++
Sbjct: 59 SRTSGGITSSLSSVRV-------HPSYSGNNNDLAILKLSTSIPSGGNIGYARLAASGSD 111
Query: 185 TYEDETGVVMGWGTLEESGRPACI-IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
+ V GWG E G + + V VPI+S CR Y ++ I++ M CAG
Sbjct: 112 PVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCR--AQYGTSAITNQMFCAGVS 169
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
G KDSCQGD GGP+V DS IG VSWG GC R Y GVY + +I
Sbjct: 170 SGGKDSCQGDXGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 133 bits (334), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 86/234 (36%), Positives = 116/234 (49%), Gaps = 21/234 (8%)
Query: 71 VGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKG--RLWFLIKATFGEYD 128
VGG +P++V +S +CGG+L+N VLTAAHCV G + F I+A G
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRA--GSLS 59
Query: 129 RCD---TSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
R TSS R ++S +ND+A+L+L+ +P I L ++
Sbjct: 60 RTSGGITSSLSSVRV-------HPSYSGNNNDLAILKLSTSIPSGGNIGYARLAASGSDP 112
Query: 186 YEDETGVVMGWGTLEESGRPACI-IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+ V GWG E G + + V VPI+S CR Y ++ I++ M CAG
Sbjct: 113 VAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRA--QYGTSAITNQMFCAGVSS 170
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
G KDSCQGDSGGP+V DS IG VSWG GC R Y GVY + +I
Sbjct: 171 GGKDSCQGDSGGPIV----DSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 132 bits (333), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 86/245 (35%), Positives = 125/245 (51%), Gaps = 20/245 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF---YCGGTLINDRYVLTAAHCVKGRLWFL--IKATF 124
IVGGQ +++PW V L +R+ +CGG+LI+ ++VLTAAHCV + L ++
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLRVQL 60
Query: 125 GE-YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
E + P SR ++ F DIALL L + V I + V LP
Sbjct: 61 REQHLYYQDQLLPVSRIIVHP---QFYIIQTGADIALLELEEPVNISSRVHTVMLPPASE 117
Query: 184 NTYEDETGVVMGWGTLE--ESGRPACIIRDVEVPILSNQYCRTSTNYSSTR------ISD 235
V GWG ++ E P ++ V+VPI+ N C + + I D
Sbjct: 118 TFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRD 177
Query: 236 NMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYV 295
+M+CAG +DSCQGDSGGP+V + + + Q G+VSWG GC + PG+YTR+T Y+
Sbjct: 178 DMLCAG--NSQRDSCQGDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 296 EWIKE 300
+WI
Sbjct: 235 DWIHH 239
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 132 bits (333), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 86/235 (36%), Positives = 126/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWG-TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG TL +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 132 bits (332), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 83/234 (35%), Positives = 123/234 (52%), Gaps = 14/234 (5%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCV-KGRLWFLIKATFGEY 127
+VGG + +PW V L + F +CGGTLI+ +VLTAAHC+ K K G +
Sbjct: 18 VVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAH 77
Query: 128 DRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
+ + V R DIALL+L+ I D + P CLP+ N
Sbjct: 78 QEVNLEPHVQEIEVSR-----LFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVVA 131
Query: 188 DETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
D T + GWG + + A ++ + ++P++ N+ C + + R+ +CAG+ G
Sbjct: 132 DRTECFITGWGETQGTFG-AGLLMEAQLPVIENKVC-NRYEFLNGRVQSTELCAGHLAGG 189
Query: 247 KDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
DSCQGDSGGP+V FE++ +Y G+ SWG GC R PGVY R++R+V WI+
Sbjct: 190 TDSCQGDSGGPLVCFEKD--KYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 241
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 132 bits (332), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 86/239 (35%), Positives = 121/239 (50%), Gaps = 22/239 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFGEYD 128
+VGG ++P+MVRLS CGG L VLTAAHCV G I AT G D
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 129 RCDTSS-KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV---LNN 184
+S+ K S V++A FT + D AL++L +P+ PT+
Sbjct: 57 LQSSSAVKVRSTKVLQAP--GFTKETYGKDWALIKL---------AQPINQPTLKIATTT 105
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
Y T V GWG E G + VP +S+ CR+S+++ +++ M+CAGY
Sbjct: 106 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF--ILVANEMICAGYDT 163
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
+D+CQGDSGGPM + + Q+GIVSWG GC R G GVYT ++ + I ++
Sbjct: 164 KQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAAR 222
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 86/243 (35%), Positives = 122/243 (50%), Gaps = 23/243 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV----KGRLWFLIKATFG 125
IVGG E ++PW L + CG TLIN ++++AAHC W A+FG
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHCFTTYKNPARW---TASFG 57
Query: 126 EYDRCDTSSKPES--RFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVL 182
+ KP R + R IV + + + D DI+L L+ VP + + VCLP
Sbjct: 58 ------VTIKPSKMKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLP--- 108
Query: 183 NNTYEDETGVVM---GWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMC 239
+ +YE + G VM G+G L+ G +R +V ++ C Y+ I+ M+C
Sbjct: 109 DASYEFQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDA-ITPRMLC 167
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
AG EG D+CQGDSGGP+V + GIVSWG C + PGVYTR+T +WI
Sbjct: 168 AGSLEGKTDACQGDSGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWIT 227
Query: 300 EKS 302
K+
Sbjct: 228 SKT 230
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 85/235 (36%), Positives = 126/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + + LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALPSSC--AP 111
Query: 187 EDETGVVMGWG-TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG TL +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 132 bits (332), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 83/232 (35%), Positives = 124/232 (53%), Gaps = 17/232 (7%)
Query: 71 VGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDRC 130
VGG N P+ V L+ F CGG+LI+ ++V++AAHC K I+ GE +
Sbjct: 2 VGGYTCGANTVPYQVSLNSGYHF-CGGSLIDSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 131 DTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 57 VVEGNEQFISASKSIVHPSYDSNTLNNDIMLIKLKSAASLDSRVASISLPTSCASA--GT 114
Query: 190 TGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKD 248
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAGY EG KD
Sbjct: 115 QCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGYLEGGKD 171
Query: 249 SCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
SCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 172 SCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 132 bits (331), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 85/235 (36%), Positives = 127/235 (54%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ + +FV A + +F +N+I L++L+ V + + V LP+
Sbjct: 56 --NVLEGDEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 132 bits (331), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 85/235 (36%), Positives = 126/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGD+GGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDAGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 131 bits (330), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 85/235 (36%), Positives = 125/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIV WG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVKWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 131 bits (330), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 85/235 (36%), Positives = 126/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +N+I L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 131 bits (330), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 85/235 (36%), Positives = 125/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V E GIV WG GC PGVYT++ YV+WI++
Sbjct: 169 GKDSCQGDSGGPVVCNGELQ-----GIVEWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 131 bits (330), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 83/245 (33%), Positives = 124/245 (50%), Gaps = 20/245 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF---YCGGTLINDRYVLTAAHCVKGRLWFL--IKATF 124
IVGGQ +++PW V L + +CGG+LI+ ++VLTAAHCV + L ++
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQL 60
Query: 125 GE-YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
E + P SR ++ F + DIALL L + V + + V LP
Sbjct: 61 REQHLYYQDQLLPVSRIIVHP---QFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASE 117
Query: 184 NTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSSTR------ISD 235
V GWG ++ R P ++ V+VPI+ N C + + + D
Sbjct: 118 TFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRD 177
Query: 236 NMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYV 295
+M+CAG +DSCQGDSGGP+V + + + Q G+VSWG GC + PG+YTR+T Y+
Sbjct: 178 DMLCAG--NTRRDSCQGDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 296 EWIKE 300
+WI
Sbjct: 235 DWIHH 239
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 131 bits (330), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 83/245 (33%), Positives = 124/245 (50%), Gaps = 20/245 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF---YCGGTLINDRYVLTAAHCVKGRLWFL--IKATF 124
IVGGQ +++PW V L + +CGG+LI+ ++VLTAAHCV + L ++
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQL 60
Query: 125 GE-YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
E + P SR ++ F + DIALL L + V + + V LP
Sbjct: 61 REQHLYYQDQLLPVSRIIVHP---QFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASE 117
Query: 184 NTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSSTR------ISD 235
V GWG ++ R P ++ V+VPI+ N C + + + D
Sbjct: 118 TFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRD 177
Query: 236 NMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYV 295
+M+CAG +DSCQGDSGGP+V + + + Q G+VSWG GC + PG+YTR+T Y+
Sbjct: 178 DMLCAG--NTRRDSCQGDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 296 EWIKE 300
+WI
Sbjct: 235 DWIHH 239
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 131 bits (330), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 83/245 (33%), Positives = 124/245 (50%), Gaps = 20/245 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF---YCGGTLINDRYVLTAAHCVKGRLWFL--IKATF 124
IVGGQ +++PW V L + +CGG+LI+ ++VLTAAHCV + L ++
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQL 60
Query: 125 GE-YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
E + P SR ++ F + DIALL L + V + + V LP
Sbjct: 61 REQHLYYQDQLLPVSRIIVHP---QFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASE 117
Query: 184 NTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSSTR------ISD 235
V GWG ++ R P ++ V+VPI+ N C + + + D
Sbjct: 118 TFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRD 177
Query: 236 NMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYV 295
+M+CAG +DSCQGDSGGP+V + + + Q G+VSWG GC + PG+YTR+T Y+
Sbjct: 178 DMLCAG--NTRRDSCQGDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 296 EWIKE 300
+WI
Sbjct: 235 DWIHH 239
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 131 bits (330), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 80/237 (33%), Positives = 127/237 (53%), Gaps = 14/237 (5%)
Query: 68 TRIVGGQPTEVNQYPWMVRLSYFNRF-YCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
+RIV G+ +PW V L F +CGG+LIN+ +V+TAAHC ++ GE
Sbjct: 14 SRIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GE 70
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNF--DNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
+D+ +S K + + I + + +++ +NDI LL+L+ + VCLP+ ++
Sbjct: 71 FDQGSSSEKIQ-KLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDD 129
Query: 185 TYEDETGVVMGWG-TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
T V GWG T + ++ +P+LSN C+ Y T+I D M+CAG
Sbjct: 130 FAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCK---KYWGTKIKDAMICAG-A 185
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
G+ SC GDSGGP+V ++ + + +GIVSWG+ PGVY R+T V W+++
Sbjct: 186 SGV-SSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ 240
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 131 bits (330), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 80/247 (32%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I GG Q+PW V ++Y CGG+L+++++VL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 130 CDTSSKPESRFVIRAIVGDFTF--SNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
D+ S+ ++ I+ ++ DIALL+L+ + I+P+ LP +
Sbjct: 61 LDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPN 120
Query: 188 DETGVVMGWGTLEES-----GRPACIIRDVEVPILSNQYCRTSTNYSSTR-----ISDNM 237
V GWG + S +P ++ +EVP++S + C + N + + ++M
Sbjct: 121 GLHCTVTGWGHVAPSVSLLTPKP---LQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDM 177
Query: 238 MCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEW 297
+CAGY EG KD+CQGDSGGP+ E Y GIVSWG CG PGVYT + Y W
Sbjct: 178 VCAGYVEGGKDACQGDSGGPLSCPVEGLWY-LTGIVSWGDACGARNRPGVYTLASSYASW 236
Query: 298 IKEKSKE 304
I+ K E
Sbjct: 237 IQSKVTE 243
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 131 bits (330), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 80/247 (32%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I GG Q+PW V ++Y CGG+L+++++VL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 130 CDTSSKPESRFVIRAIVGDFTF--SNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
D+ S+ ++ I+ ++ DIALL+L+ + I+P+ LP +
Sbjct: 61 LDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPN 120
Query: 188 DETGVVMGWGTLEES-----GRPACIIRDVEVPILSNQYCRTSTNYSSTR-----ISDNM 237
V GWG + S +P ++ +EVP++S + C + N + + ++M
Sbjct: 121 GLHCTVTGWGHVAPSVSLLTPKP---LQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDM 177
Query: 238 MCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEW 297
+CAGY EG KD+CQGDSGGP+ E Y GIVSWG CG PGVYT + Y W
Sbjct: 178 VCAGYVEGGKDACQGDSGGPLSCPVEGLWY-LTGIVSWGDACGARNRPGVYTLASSYASW 236
Query: 298 IKEKSKE 304
I+ K E
Sbjct: 237 IQSKVTE 243
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 131 bits (329), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 86/236 (36%), Positives = 126/236 (53%), Gaps = 23/236 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG--RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
++ GWG SG P +++ ++ P+L C S +I+DNM+C G+ E
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPD-LLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLE 167
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
G KDSCQGD GGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 168 GGKDSCQGDCGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 131 bits (329), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 125/245 (51%), Gaps = 20/245 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF---YCGGTLINDRYVLTAAHCVKGRLWFL--IKATF 124
IVGGQ +++PW V L +R+ +CGG+LI+ ++VLTAAHCV + L ++
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLRVQL 60
Query: 125 GE-YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
E + P SR ++ F DIALL L + V I + V LP
Sbjct: 61 REQHLYYQDQLLPVSRIIVHP---QFYIIQTGADIALLELEEPVNISSRVHTVMLPPASE 117
Query: 184 NTYEDETGVVMGWGTLE--ESGRPACIIRDVEVPILSNQYCRTSTNYSSTR------ISD 235
V GWG ++ E P ++ V+VPI+ N C + + I D
Sbjct: 118 TFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRD 177
Query: 236 NMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYV 295
+M+CAG +DSC+GDSGGP+V + + + Q G+VSWG GC + PG+YTR+T Y+
Sbjct: 178 DMLCAG--NSQRDSCKGDSGGPLVC-KVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYL 234
Query: 296 EWIKE 300
+WI
Sbjct: 235 DWIHH 239
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 131 bits (329), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 87/240 (36%), Positives = 122/240 (50%), Gaps = 25/240 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFGEYD 128
+VGG ++P+MVRLS CGG L VLTAAHCV G I AT G D
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 129 RCDTSS-KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV---LNN 184
+S+ K S V++A ++ D AL++L +P+ PT+
Sbjct: 57 LQSSSAVKVRSTKVLQAP----GYNGTGKDWALIKL---------AQPINQPTLKIATTT 103
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
Y T V GWG E G + VP +S+ CR++ Y + +++ +CAGYP+
Sbjct: 104 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSA--YGNELVANEEICAGYPD 161
Query: 245 -GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G D+CQGDSGGPM + + Q+GIVSWG GC R GYPGVYT ++ + I ++
Sbjct: 162 TGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 130 bits (328), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 84/234 (35%), Positives = 123/234 (52%), Gaps = 21/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG E N P+ V L+ F CGG+LIN+++V++A HC K R I+ GE++
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYHF-CGGSLINEQWVVSAGHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +F+ A + + +NDI L++L+ R I + + LPT T
Sbjct: 56 --EVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPAT- 112
Query: 187 EDETGVVMGWGTLEESGRPAC-IIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG ++ ++ P+LS C S +I+ NM C G+ EG
Sbjct: 113 -GTKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCEASY---PGKITSNMFCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
KDSCQGDSGGP+V + G+VSWG GC + PGVYT++ YV+WIK
Sbjct: 169 GKDSCQGDSGGPVVCNGQLQ-----GVVSWGDGCAQKNKPGVYTKVYNYVKWIK 217
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 130 bits (328), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 85/235 (36%), Positives = 125/235 (53%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
K SCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 169 GKSSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 130 bits (327), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 82/243 (33%), Positives = 130/243 (53%), Gaps = 15/243 (6%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVK-GRLWFLIKATFGEY 127
RI+GG + +PW+ + Y +C G+L++ +V++AAHC + G++
Sbjct: 35 RIIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQH 93
Query: 128 DRCDTSSKPESRFVIRAIVGDFTFSNF---DNDIALLRLN---DRVPI-VDIIKPVCLPT 180
T+ ++ F I + +S F D+D+ L+RL DR ++P+CLP
Sbjct: 94 FFNRTTDVTQT-FGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPE 152
Query: 181 VLNNTYEDETGVVMGWGTLEE--SGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMM 238
+ + GWG L+E SG + +R+ VP++++ C + Y + IS NM+
Sbjct: 153 PGSTFPAGHKCQIAGWGHLDENVSGY-SSSLREALVPLVADHKCSSPEVYGAD-ISPNML 210
Query: 239 CAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
CAGY + D+CQGDSGGP+ E+ Y GI+SWG GCGR PGVYTR+ YV+WI
Sbjct: 211 CAGYFDCKSDACQGDSGGPLACEKNGVAY-LYGIISWGDGCGRLHKPGVYTRVANYVDWI 269
Query: 299 KEK 301
++
Sbjct: 270 NDR 272
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 130 bits (327), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 84/233 (36%), Positives = 124/233 (53%), Gaps = 21/233 (9%)
Query: 72 GGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDRCD 131
GG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI-- 63
Query: 132 TSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAG 121
Query: 189 ETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG K
Sbjct: 122 TQCLISGWGNTLSSGVNEPDLLKCLDAPLLPQADCEASY---PGKITDNMVCVGFLEGGK 178
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 179 DSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 226
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 130 bits (327), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 80/247 (32%), Positives = 121/247 (48%), Gaps = 16/247 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I GG Q+PW V ++Y CGG+L+++++VL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 130 CDTSSKPESRFVIRAIVGDFTF--SNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
D+ S+ ++ I+ ++ DIALL+L+ + I+P+ LP +
Sbjct: 61 LDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASFPN 120
Query: 188 DETGVVMGWGTLEES-----GRPACIIRDVEVPILSNQYCRTSTNYSSTR-----ISDNM 237
V GWG + S +P ++ +EVP++S + C N + + ++M
Sbjct: 121 GLHCTVTGWGHVAPSVSLLTPKP---LQQLEVPLISRETCNALYNIDAKPEEPHFVQEDM 177
Query: 238 MCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEW 297
+CAGY EG KD+CQGDSGGP+ E Y GIVSWG CG PGVYT + Y W
Sbjct: 178 VCAGYVEGGKDACQGDSGGPLSCPVEGLWY-LTGIVSWGDACGARNRPGVYTLASSYASW 236
Query: 298 IKEKSKE 304
I+ K E
Sbjct: 237 IQSKVTE 243
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 130 bits (326), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 87/240 (36%), Positives = 121/240 (50%), Gaps = 25/240 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFGEYD 128
+VGG ++P+MVRLS CGG L VLTAAHCV G I AT G D
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 129 RCDTSS-KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV---LNN 184
+S+ K S V++A ++ D AL++L +P+ PT+
Sbjct: 57 LQSSSAVKVRSTKVLQAP----GYNGTGKDWALIKL---------AQPINQPTLKIATTT 103
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
Y T V GWG E G + VP +S+ CR++ Y + +++ +CAGYP+
Sbjct: 104 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSA--YGNELVANEEICAGYPD 161
Query: 245 -GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G D CQGDSGGPM + + Q+GIVSWG GC R GYPGVYT ++ + I ++
Sbjct: 162 TGGVDPCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 130 bits (326), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 86/240 (35%), Positives = 121/240 (50%), Gaps = 25/240 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFGEYD 128
+VGG ++P+MVRLS CGG L VLTAAHCV G I AT G D
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 129 -RCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV---LNN 184
+ + K S V++A ++ D AL++L +P+ PT+
Sbjct: 57 LQSGAAVKVRSTKVLQAP----GYNGTGKDWALIKL---------AQPINQPTLKIATTT 103
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
Y T V GWG E G + VP +S+ CR++ Y + +++ +CAGYP+
Sbjct: 104 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSA--YGNELVANEEICAGYPD 161
Query: 245 -GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G D+CQGDSGGPM + + Q+GIVSWG GC R GYPGVYT ++ + I ++
Sbjct: 162 TGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 130 bits (326), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 84/233 (36%), Positives = 124/233 (53%), Gaps = 21/233 (9%)
Query: 72 GGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDRCD 131
GG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI-- 63
Query: 132 TSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAG 121
Query: 189 ETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG K
Sbjct: 122 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEGGK 178
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 179 DSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 226
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 129 bits (325), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 86/233 (36%), Positives = 127/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++++Y I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSY---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 129 bits (325), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 83/234 (35%), Positives = 123/234 (52%), Gaps = 21/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG E N P+ V L+ F CGG+LIN+++V++A HC K R I+ GE++
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYHF-CGGSLINEQWVVSAGHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +F+ A + + +NDI L++L+ R I + + LPT T
Sbjct: 56 --EVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPTAPPAT- 112
Query: 187 EDETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG ++ ++ P+LS C S +I+ NM C G+ EG
Sbjct: 113 -GTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASY---PGKITSNMFCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
KDSCQGD+GGP+V + G+VSWG GC + PGVYT++ YV+WIK
Sbjct: 169 GKDSCQGDAGGPVVCNGQLQ-----GVVSWGDGCAQKNKPGVYTKVYNYVKWIK 217
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 129 bits (324), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 79/235 (33%), Positives = 125/235 (53%), Gaps = 14/235 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF-YCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IV G+ +PW V L F +CGG+LIN+ +V+TAAHC ++ GE+D
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFD 57
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNF--DNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +S K + + I + + +++ +NDI LL+L+ + VCLP+ ++
Sbjct: 58 QGSSSEKIQ-KLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFA 116
Query: 187 EDETGVVMGWG-TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
T V GWG T + ++ +P+LSN C+ Y T+I D M+CAG G
Sbjct: 117 AGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCK---KYWGTKIKDAMICAG-ASG 172
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
+ SC GDSGGP+V ++ + + +GIVSWG+ PGVY R+T V W+++
Sbjct: 173 V-SSCMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ 225
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 128 bits (322), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 83/235 (35%), Positives = 121/235 (51%), Gaps = 19/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IVGG + + PW L + N +CGGT++++ Y+LTAAHC+ F ++ D
Sbjct: 1 IVGGYNCKDGEVPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----D 56
Query: 129 R-CDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
R + E+ + ++ FT +D DIA+LRL + + P LPT T
Sbjct: 57 RNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAPPAT 116
Query: 186 YEDETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
++ GWG SG ++ ++ P+LS C S +I+ NM C G+ E
Sbjct: 117 --GTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASY---PGKITSNMFCVGFLE 171
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
G KDSCQGDSGGP+V + G+VSWG GC + PGVYT++ YV+WIK
Sbjct: 172 GGKDSCQGDSGGPVVCNGQLQ-----GVVSWGDGCAQKNKPGVYTKVYNYVKWIK 221
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 128 bits (322), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 84/232 (36%), Positives = 120/232 (51%), Gaps = 20/232 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + P V L+ F CGG+L+N+ +V++AAHC K R ++ GE++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKSR----VEVRLGEHNI 55
Query: 130 CDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T + S VIR +++ N DNDI L++L+ + ++PV LPT
Sbjct: 56 KVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSC--AP 111
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG S + ++ + +PILS C S I++ M CAGY EG
Sbjct: 112 AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY---PGMITNAMFCAGYLEGG 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + +W+
Sbjct: 169 KDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 128 bits (322), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 81/242 (33%), Positives = 129/242 (53%), Gaps = 15/242 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVK-GRLWFLIKATFGEYD 128
I+GG + +PW+ + Y +C G+L++ +V++AAHC + G++
Sbjct: 1 IIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNF---DNDIALLRLN---DRVPI-VDIIKPVCLPTV 181
T+ ++ F I + +S F D+D+ L+RL DR ++P+CLP
Sbjct: 60 FNRTTDVTQT-FGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEP 118
Query: 182 LNNTYEDETGVVMGWGTLEE--SGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMC 239
+ + GWG L+E SG + + R+ VP++++ C + Y + IS NM+C
Sbjct: 119 GSTFPAGHKCQIAGWGHLDENVSGYSSSL-REALVPLVADHKCSSPEVYGAD-ISPNMLC 176
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
AGY + D+CQGDSGGP+ E+ Y GI+SWG GCGR PGVYTR+ YV+WI
Sbjct: 177 AGYFDCKSDACQGDSGGPLACEKNGVAY-LYGIISWGDGCGRLHKPGVYTRVANYVDWIN 235
Query: 300 EK 301
++
Sbjct: 236 DR 237
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 128 bits (322), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 81/242 (33%), Positives = 129/242 (53%), Gaps = 15/242 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVK-GRLWFLIKATFGEYD 128
I+GG + +PW+ + Y +C G+L++ +V++AAHC + G++
Sbjct: 1 IIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNF---DNDIALLRLN---DRVPI-VDIIKPVCLPTV 181
T+ ++ F I + +S F D+D+ L+RL DR ++P+CLP
Sbjct: 60 FNRTTDVTQT-FGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEP 118
Query: 182 LNNTYEDETGVVMGWGTLEE--SGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMC 239
+ + GWG L+E SG + + R+ VP++++ C + Y + IS NM+C
Sbjct: 119 GSTFPAGHKCQIAGWGHLDENVSGYSSSL-REALVPLVADHKCSSPEVYGAD-ISPNMLC 176
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
AGY + D+CQGDSGGP+ E+ Y GI+SWG GCGR PGVYTR+ YV+WI
Sbjct: 177 AGYFDCKSDACQGDSGGPLACEKNGVAY-LYGIISWGDGCGRLHKPGVYTRVANYVDWIN 235
Query: 300 EK 301
++
Sbjct: 236 DR 237
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 128 bits (322), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 84/233 (36%), Positives = 121/233 (51%), Gaps = 20/233 (8%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
+IVGG + P V L+ F CGG+L+N+ +V++AAHC K R ++ GE++
Sbjct: 20 KIVGGYECKPYSQPHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKSR----VEVRLGEHN 74
Query: 129 RCDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
T + S VIR +++ N DNDI L++L+ + ++PV LPT
Sbjct: 75 IKVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSC--A 130
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
V GWG S + ++ + +PILS C S I++ M CAGY EG
Sbjct: 131 PAGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY---PGMITNAMFCAGYLEG 187
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + +W+
Sbjct: 188 GKDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFNDWL 235
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 128 bits (321), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 83/233 (35%), Positives = 124/233 (53%), Gaps = 21/233 (9%)
Query: 72 GGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDRCD 131
GG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI-- 63
Query: 132 TSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--APAG 121
Query: 189 ETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG K
Sbjct: 122 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEGGK 178
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQG+SGGP+V E GIVSWG GC PGVYT++ YV+WI++
Sbjct: 179 DSCQGNSGGPVVCNGELQ-----GIVSWGYGCALPDNPGVYTKVCNYVDWIQD 226
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 127 bits (320), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 86/233 (36%), Positives = 123/233 (52%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAG 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ + + SS I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSD---SSCKSASSAIITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 127 bits (320), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 85/233 (36%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAG 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSW---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 127 bits (320), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 84/235 (35%), Positives = 124/235 (52%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + N P+ V L+ F CGG+LIND++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +FV A + +F +NDI L++L+ V + + V LP+
Sbjct: 56 --NVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG SG +++ ++ P+L C S +I+DNM+C G+ EG
Sbjct: 112 AGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASY---PGKITDNMVCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
K SCQGDSGGP+V E GIVSWG GC P VYT++ YV+WI++
Sbjct: 169 GKGSCQGDSGGPVVCNGELQ-----GIVSWGYGCALPDNPDVYTKVCNYVDWIQD 218
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 127 bits (320), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 83/245 (33%), Positives = 124/245 (50%), Gaps = 20/245 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF---YCGGTLINDRYVLTAAHCVKGRLWFL--IKATF 124
IVGGQ +++PW V L +R+ +CGG+LI+ ++VLTAAHC+ + L ++
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPDVKDLATLRVQL 60
Query: 125 GE-YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
E + P SR ++ F DIALL L + V I + V LP
Sbjct: 61 REQHLYYQDQLLPVSRIIVHP---QFYIIQTGADIALLELEEPVNISSRVHTVMLPPASE 117
Query: 184 NTYEDETGVVMGWGTLE--ESGRPACIIRDVEVPILSNQYCRTSTNYSSTR------ISD 235
V GWG ++ E P ++ V+VPI+ N C + + I D
Sbjct: 118 TFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRD 177
Query: 236 NMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYV 295
+M+CAG +DSC+GDSGGP+V + + + Q G+VSW GC + PG+YTR+T Y+
Sbjct: 178 DMLCAG--NSQRDSCKGDSGGPLVC-KVNGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYL 234
Query: 296 EWIKE 300
+WI
Sbjct: 235 DWIHH 239
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 127 bits (319), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 93/266 (34%), Positives = 132/266 (49%), Gaps = 27/266 (10%)
Query: 55 PMCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV-- 112
P+C RI+GGQ ++ +PW V + R GG L+ DR++LTAAH +
Sbjct: 75 PVCGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYP 132
Query: 113 -------KGRLWFLIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLND 165
L + T E + + P R + NF+ DIALL L +
Sbjct: 133 KEHEAQSNASLDVFLGHTNVE-ELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELEN 191
Query: 166 RVPIVDIIKPVCLPTVLNNTYEDE--TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCR 223
V + + P+CLP N+T+ D G V G+G +EE + A +R V +P+ + Q C
Sbjct: 192 SVTLGPNLLPICLPD--NDTFYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACE 247
Query: 224 TSTNYSSTR--ISDNMMCAGYPEGMKDSCQGDSGGPMVFERED---SRYEQIGIVSWGAG 278
+ S NM CAG+P +D+CQGDSGG VF D R+ GIVSWG G
Sbjct: 248 NWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGG--VFAVRDPNTDRWVATGIVSWGIG 305
Query: 279 CGRAGYPGVYTRITRYVEWIKEKSKE 304
C R GY G YT++ YV+WIK++ +E
Sbjct: 306 CSR-GY-GFYTKVLNYVDWIKKEMEE 329
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 127 bits (319), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 84/232 (36%), Positives = 120/232 (51%), Gaps = 20/232 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + P V L+ F CGG+L+N+ +V++AAHC K R ++ GE++
Sbjct: 1 IVGGYECKPYSQPHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKSR----VEVRLGEHNI 55
Query: 130 CDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T + S VIR +++ N DNDI L++L+ + ++PV LPT
Sbjct: 56 KVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSC--AP 111
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG S + ++ + +PILS C S I++ M CAGY EG
Sbjct: 112 AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY---PGMITNAMFCAGYLEGG 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + +W+
Sbjct: 169 KDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 127 bits (319), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 85/233 (36%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 127 bits (319), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 82/233 (35%), Positives = 127/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 127 bits (319), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 83/232 (35%), Positives = 119/232 (51%), Gaps = 20/232 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + P V L+ F CGG+L+N+ +V++AAHC K R ++ GE++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKSR----VEVRLGEHNI 55
Query: 130 CDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T + S VIR +++ N DNDI L++L+ + ++PV LP+
Sbjct: 56 KVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKSATLNTYVQPVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG S ++ + +PILS C S I++ M CAGY EG
Sbjct: 112 AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY---PGMITNAMFCAGYLEGG 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + +W+
Sbjct: 169 KDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 127 bits (318), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 86/233 (36%), Positives = 123/233 (52%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAG 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ + + SS I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSD---SSCKSASSRIITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 127 bits (318), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 81/233 (34%), Positives = 127/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG+GC + PG+YT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGIYTKVCNYVSWIKQ 218
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 83/233 (35%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
+IVGG + V L+ F CGG+L+N+ +V++AAHC K R ++ GE++
Sbjct: 15 KIVGGYECKAYSQAHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKSR----VEVRLGEHN 69
Query: 129 RCDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
T + S VIR +++ N DNDI L++L+ + ++PV LPT
Sbjct: 70 IKVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSC--A 125
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
V GWG S + ++ + +PILS C S I++ M CAGY EG
Sbjct: 126 PAGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSY---PGMITNAMFCAGYLEG 182
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + +W+
Sbjct: 183 GKDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFNDWL 230
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 82/233 (35%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PG YT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQ 218
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 83/232 (35%), Positives = 119/232 (51%), Gaps = 20/232 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + P V L+ F CGG+L+N+ +V++AAHC K R ++ GE++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKSR----VEVRLGEHNI 55
Query: 130 CDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T + S VIR +++ N DNDI L++L+ + ++PV LP+
Sbjct: 56 KVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG S ++ + +PILS C S I++ M CAGY EG
Sbjct: 112 AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY---PGMITNAMFCAGYLEGG 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + +W+
Sbjct: 169 KDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 81/233 (34%), Positives = 127/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGD+GGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 171 DACQGDAGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 126 bits (316), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 82/233 (35%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG GC + PGVYT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 126 bits (316), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 81/241 (33%), Positives = 127/241 (52%), Gaps = 19/241 (7%)
Query: 70 IVGGQPTEVNQYPW-MVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
++ G+ T PW +V L + CG LI+ +VLTAAHC+ L++ GEYD
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVR--LGEYD 58
Query: 129 RCDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP-TVLNNT 185
K E I+ + +++ S DNDIALL L + I P+CLP + L
Sbjct: 59 -LRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAER 117
Query: 186 YEDETG---VVMGWGTLEESGRPA-----CIIRDVEVPILSNQYCRTSTNYSSTRISDNM 237
++ G +V GWG + A ++ +++P++ + C + S +S+NM
Sbjct: 118 ELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNEC---SEVMSNMVSENM 174
Query: 238 MCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEW 297
+CAG +D+C+GDSGGPMV + + +G+VSWG GCG GVYT+++RY++W
Sbjct: 175 LCAGILGDRQDACEGDSGGPMVASFHGTWF-LVGLVSWGEGCGLLHNYGVYTKVSRYLDW 233
Query: 298 I 298
I
Sbjct: 234 I 234
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 126 bits (316), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 81/241 (33%), Positives = 127/241 (52%), Gaps = 19/241 (7%)
Query: 70 IVGGQPTEVNQYPW-MVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
++ G+ T PW +V L + CG LI+ +VLTAAHC+ L++ GEYD
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVR--LGEYD 58
Query: 129 RCDTSSKPESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP-TVLNNT 185
K E I+ + +++ S DNDIALL L + I P+CLP + L
Sbjct: 59 -LRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAER 117
Query: 186 YEDETG---VVMGWGTLEESGRPA-----CIIRDVEVPILSNQYCRTSTNYSSTRISDNM 237
++ G +V GWG + A ++ +++P++ + C + S +S+NM
Sbjct: 118 ELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNEC---SEVMSNMVSENM 174
Query: 238 MCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEW 297
+CAG +D+C+GDSGGPMV + + +G+VSWG GCG GVYT+++RY++W
Sbjct: 175 LCAGILGDRQDACEGDSGGPMVASFHGTWF-LVGLVSWGEGCGLLHNYGVYTKVSRYLDW 233
Query: 298 I 298
I
Sbjct: 234 I 234
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 125 bits (315), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 80/233 (34%), Positives = 127/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+L+N ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLLNSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG+GC + PG+YT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGIYTKVCNYVSWIKQ 218
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 125 bits (315), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 81/233 (34%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG GC + PG+YT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGEGCAQKNKPGIYTKVCNYVSWIKQ 218
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 125 bits (315), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 92/266 (34%), Positives = 132/266 (49%), Gaps = 27/266 (10%)
Query: 55 PMCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV-- 112
P+C +I+GGQ ++ +PW V + R GG L+ DR++LTAAH +
Sbjct: 143 PVCGKPVNPVEQRQQIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYP 200
Query: 113 -------KGRLWFLIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLND 165
L + T E + + P R + NF+ DIALL L +
Sbjct: 201 KEHEAQSNASLDVFLGHTNVE-ELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELEN 259
Query: 166 RVPIVDIIKPVCLPTVLNNTYEDE--TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCR 223
V + + P+CLP N+T+ D G V G+G +EE + A +R V +P+ + Q C
Sbjct: 260 SVTLGPNLLPICLPD--NDTFYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACE 315
Query: 224 TSTNYSSTR--ISDNMMCAGYPEGMKDSCQGDSGGPMVFERED---SRYEQIGIVSWGAG 278
+ S NM CAG+P +D+CQGDSGG VF D R+ GIVSWG G
Sbjct: 316 NWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGG--VFAVRDPNTDRWVATGIVSWGIG 373
Query: 279 CGRAGYPGVYTRITRYVEWIKEKSKE 304
C R GY G YT++ YV+WIK++ +E
Sbjct: 374 CSR-GY-GFYTKVLNYVDWIKKEMEE 397
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 125 bits (315), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 81/234 (34%), Positives = 120/234 (51%), Gaps = 19/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N + L F CGG+LI+ +V++AAHC K R I+ GE++
Sbjct: 1 IVGGYECRKNSASYQASLQSGYHF-CGGSLISSTWVVSAAHCYKSR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++ I+ + N DNDI L++L+ + + V LP+ ++
Sbjct: 56 AVNEGTEQFIDSVKVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALPSSCASS--G 113
Query: 189 ETGVVMGWGTLE--ESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+V GWG L S P +R +++PILS+ C ++ +I+ NM CAG+ EG
Sbjct: 114 TRCLVSGWGNLSGSSSNYPD-TLRCLDLPILSSSSCNSAY---PGQITSNMFCAGFMEGG 169
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V + G+VSWG GC + PGVYT++ Y WI
Sbjct: 170 KDSCQGDSGGPVVCNGQLQ-----GVVSWGYGCAQRNKPGVYTKVCNYRSWISS 218
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 125 bits (315), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 83/232 (35%), Positives = 118/232 (50%), Gaps = 20/232 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + P V L+ F CGG+L+N+ +V++AAHC K R + GE++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKSR----VAVRLGEHNI 55
Query: 130 CDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T + S VIR +++ N DNDI L++L+ + ++PV LP+
Sbjct: 56 KVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG S ++ + +PILS C S I++ M CAGY EG
Sbjct: 112 AGTMCTVSGWGNTMSSTADGDKLQCLNIPILSYSDCNNSY---PGMITNAMFCAGYLEGG 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + +W+
Sbjct: 169 KDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 125 bits (315), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 86/239 (35%), Positives = 128/239 (53%), Gaps = 21/239 (8%)
Query: 70 IVGGQP-TEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC-VKGRLWFLIKATFGEY 127
IVGG + N P+ V L+ + F GG+LIN ++V++AAHC K R I+ GE+
Sbjct: 1 IVGGYTCSAANSIPYQVSLNSGSHFCSGGSLINSQWVVSAAHCSYKSR----IQVRLGEH 56
Query: 128 DRCDTSSKPESRFVIRAIVG--DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
+ D E I+ +F + DNDI L++L+ + + V LP
Sbjct: 57 NI-DVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC-AA 114
Query: 186 YEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
E ++ GWG + SG P+ + ++ P+LS+ C++S +I+ NM+C G+
Sbjct: 115 AGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSY---PGQITGNMICVGFL 171
Query: 244 EGMKDSC-QGDSGGPMVFEREDSRYEQIGIVSWGAGC-GRAGYPGVYTRITRYVEWIKE 300
EG KDSC QGDSGGP+V S + GIVSWG GC + PGVYT++ YV WI++
Sbjct: 172 EGGKDSCSQGDSGGPVVC----SNGQLQGIVSWGYGCSAQKNKPGVYTKVCNYVNWIQQ 226
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 125 bits (314), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 83/232 (35%), Positives = 118/232 (50%), Gaps = 20/232 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + P V L+ F CGG+L+N+ +V++AAHC K R ++ GE++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKTR----VEVRLGEHNI 55
Query: 130 CDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T + S VIR +++ N DNDI L++L+ + ++PV LP+
Sbjct: 56 KVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALPSSC--AP 111
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG S ++ + +PILS C S I++ M CAGY EG
Sbjct: 112 AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSY---PGMITNAMFCAGYLEGG 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + W+
Sbjct: 169 KDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFNNWL 215
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 125 bits (314), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 82/233 (35%), Positives = 121/233 (51%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CA EG
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAYGLEGKG 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC PGVYT++ YV WIK+
Sbjct: 171 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCQAKNKPGVYTKVCNYVSWIKQ 218
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 125 bits (314), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 81/233 (34%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG+GC + PG YT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQ 218
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 125 bits (314), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 81/233 (34%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGD+GGP+V + GIVSWG GC + PGVYT++ YV WIK+
Sbjct: 171 DACQGDAGGPVVCSGKLQ-----GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQ 218
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 125 bits (313), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 81/233 (34%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG+GC + PG YT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGFYTKLCNYVSWIKQ 218
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 125 bits (313), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 83/246 (33%), Positives = 130/246 (52%), Gaps = 25/246 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
+VGG+ N +PW V L Y + R CGGTL++ +VLTAAHC+ + + G
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCISSSRTY--RVVLG 58
Query: 126 EYDRCDTSSKPES------RFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP 179
+ ++++P S + V+ SN NDIALL+L V + D I+ CLP
Sbjct: 59 RHSL--STNEPGSLAVKVSKLVVHQDWNSNQLSN-GNDIALLKLASPVSLTDKIQLGCLP 115
Query: 180 ---TVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDN 236
T+L N Y V GWG L+ +G I++ ++ ++ C + ST + N
Sbjct: 116 AAGTILPNNY---VCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWGST-VKTN 171
Query: 237 MMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--GCGRAGYPGVYTRITRY 294
M+CAG +G+ SC GDSGGP+ + + +++ GIVS+G+ GC P V+TR++ Y
Sbjct: 172 MICAG-GDGIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSNY 230
Query: 295 VEWIKE 300
++WI
Sbjct: 231 IDWINS 236
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 91/263 (34%), Positives = 130/263 (49%), Gaps = 27/263 (10%)
Query: 55 PMCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV-- 112
P+C RI+GGQ ++ +PW V + R GG L+ DR++LTAAH +
Sbjct: 75 PVCGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYP 132
Query: 113 -------KGRLWFLIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLND 165
L + T E + + P R + NF+ DIALL L +
Sbjct: 133 KEHEAQSNASLDVFLGHTNVE-ELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELEN 191
Query: 166 RVPIVDIIKPVCLPTVLNNTYEDE--TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCR 223
V + + P+CLP N+T+ D G V G+G +EE + A +R V +P+ + Q C
Sbjct: 192 SVTLGPNLLPICLPD--NDTFYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACE 247
Query: 224 TSTNYSSTR--ISDNMMCAGYPEGMKDSCQGDSGGPMVFERED---SRYEQIGIVSWGAG 278
+ S NM CAG+P +D+CQGD+GG VF D R+ GIVSWG G
Sbjct: 248 NWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDAGG--VFAVRDPNTDRWVATGIVSWGIG 305
Query: 279 CGRAGYPGVYTRITRYVEWIKEK 301
C R GY G YT++ YV+WIK++
Sbjct: 306 CSR-GY-GFYTKVLNYVDWIKKE 326
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 84/239 (35%), Positives = 118/239 (49%), Gaps = 24/239 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFGEYD 128
+VGG ++P+MVRLS CGG L VLTAAHCV G I AT G D
Sbjct: 1 VVGGTRAAQGEFPFMVRLS----MGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 129 RCDTSS-KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV---LNN 184
+S+ K S V++A ++ D AL++L +P+ PT+
Sbjct: 57 LQSSSAVKVRSTKVLQAP----GYNGTGKDWALIKL---------AQPINQPTLKIATTT 103
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
Y T V GWG E G + VP +S+ CR++ Y + +++ +CAGY
Sbjct: 104 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSA--YGNELVANEEICAGYDT 161
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
G D+CQGDSGGPM + + Q+GIVSWG GC R G GVYT ++ + I ++
Sbjct: 162 GGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAAR 220
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 83/232 (35%), Positives = 119/232 (51%), Gaps = 20/232 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG + V L+ F CGG+L+N+ +V++AAHC K R ++ GE++
Sbjct: 1 IVGGYECKAYSQAHQVSLNSGYHF-CGGSLVNENWVVSAAHCYKSR----VEVRLGEHNI 55
Query: 130 CDTSSKPE---SRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T + S VIR +++ N DNDI L++L+ + ++PV LPT
Sbjct: 56 KVTEGSEQFISSSRVIRHP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSC--AP 111
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG S + ++ + +PILS C S I++ M CAGY EG
Sbjct: 112 AGTMCTVSGWGNTMSSTADSDKLQCLNIPILSYSDCNDSY---PGMITNAMFCAGYLEGG 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
KDSCQGDSGGP+V E G+VSWG GC G PGVY ++ + +W+
Sbjct: 169 KDSCQGDSGGPVVCNGELQ-----GVVSWGYGCAEPGNPGVYAKVCIFSDWL 215
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 79/241 (32%), Positives = 122/241 (50%), Gaps = 20/241 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKG--RLWF----LIKAT 123
IVGG E N PW V + + ++ CGG L++ +VLTAAHC ++W L K
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHCYDDNYKVWLGKNNLFKDE 60
Query: 124 FGEYDRCDTSSKPESRFVIRAIVGDFTFSNFD--NDIALLRLNDRVPIVDIIKPVCLPTV 181
R + + P F + + F +D ND+ LLRL+ I D +KP+ LPT
Sbjct: 61 PSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTVKPITLPT- 119
Query: 182 LNNTYEDETGVVMGWGTLEESG-RPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
T + GWG++ + + + V + +L N+ C + +++D M+CA
Sbjct: 120 -EEPKLGSTCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAKA---HIEKVTDAMLCA 175
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWG-AGCGRAGYPGVYTRITRYVEWIK 299
G +G KD+C+GDSGGP++ + GI SWG CG PGVYT++ ++ WIK
Sbjct: 176 GEMDGGKDTCKGDSGGPLICDGVLQ-----GITSWGHTPCGEPDMPGVYTKLNKFTSWIK 230
Query: 300 E 300
+
Sbjct: 231 D 231
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 124 bits (311), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 80/233 (34%), Positives = 126/233 (54%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGD+GGP+V + GIVSWG+GC + PG YT++ YV WIK+
Sbjct: 171 DACQGDAGGPVVCSGKLQ-----GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQ 218
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 124 bits (310), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 90/251 (35%), Positives = 128/251 (50%), Gaps = 27/251 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV---------KGRLWFLI 120
I+GGQ ++ +PW V + R GG L+ DR++LTAAH + L +
Sbjct: 1 IIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFL 58
Query: 121 KATFGEYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT 180
T E + + P R + NF+ DIALL L + V + + P+CLP
Sbjct: 59 GHTNVE-ELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPD 117
Query: 181 VLNNTYEDE--TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTR--ISDN 236
N+T+ D G V G+G +EE + A +R V +P+ + Q C + S N
Sbjct: 118 --NDTFYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQN 173
Query: 237 MMCAGYPEGMKDSCQGDSGGPMVFERED---SRYEQIGIVSWGAGCGRAGYPGVYTRITR 293
M CAG+P +D+CQGDSGG VF D R+ GIVSWG GC R GY G YT++
Sbjct: 174 MFCAGHPSLKQDACQGDSGG--VFAVRDPNTDRWVATGIVSWGIGCSR-GY-GFYTKVLN 229
Query: 294 YVEWIKEKSKE 304
YV+WIK++ +E
Sbjct: 230 YVDWIKKEMEE 240
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 124 bits (310), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 80/243 (32%), Positives = 126/243 (51%), Gaps = 14/243 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
+VGG+ + +PW + L Y R CGGTLI +VLTAAHC+ + + G
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTRTY--RVAVG 58
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSN---FDNDIALLRLNDRVPIVDIIKPVCLPTVL 182
+ + + + S FV + N NDIAL++L + V + D I+ CLP
Sbjct: 59 K-NNLEVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQVACLPEKD 117
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ +D V GWG L +G A ++ P++ + C + ++ R+ M+CAG
Sbjct: 118 SLLPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATC-SRIDWWGFRVKKTMVCAG- 175
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--GCGRAGYPGVYTRITRYVEWIKE 300
+G+ +C GDSGGP+ + E+ +E GIVS+G+ GC P VYTR++ Y++WI E
Sbjct: 176 GDGVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYIDWINE 235
Query: 301 KSK 303
K +
Sbjct: 236 KMQ 238
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 123 bits (309), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 74/247 (29%), Positives = 123/247 (49%), Gaps = 20/247 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN-RFYCGGTLINDRYVLTAAHCVKGRL------------ 116
I G+P + PW+ LS+ N + +CGG+L+ +++TAAHC+ L
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDL 60
Query: 117 --WFLIKATFGEYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDII 173
K G++ R + + V + + + F+ND+AL+ L + + +
Sbjct: 61 LSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLESPVLNAFV 120
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRI 233
P+CLP E +V GWG P ++ ++E+PI+ + C+ + ++
Sbjct: 121 MPICLPE--GPQQEGAMVIVSGWGKQFLQRFPETLM-EIEIPIVDHSTCQKAYAPLKKKV 177
Query: 234 SDNMMCAGYPEGMKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGAGCGRAGYPGVYTRIT 292
+ +M+CAG EG KD+C GDSGGPMV RE ++ +G VSWG CG+ GVY+ I
Sbjct: 178 TRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIH 237
Query: 293 RYVEWIK 299
+WI+
Sbjct: 238 HNKDWIQ 244
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 123 bits (309), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 80/233 (34%), Positives = 125/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM CAGY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCAGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGD+GGP+V + GIVSWG GC + PG YT++ YV WIK+
Sbjct: 171 DACQGDAGGPVVCSGKLQ-----GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQ 218
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 123 bits (309), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 80/233 (34%), Positives = 124/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLXSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM C GY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCVGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG GC + PG YT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQ 218
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 76/262 (29%), Positives = 127/262 (48%), Gaps = 20/262 (7%)
Query: 55 PMCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFN-RFYCGGTLINDRYVLTAAHCVK 113
P+C +I G+P + PW+ LS+ N + +CGG+L+ +++TAAHC+
Sbjct: 141 PVCGLPKFSRKLMAQIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLH 200
Query: 114 GRL--------------WFLIKATFGEYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDI 158
L K G++ R + + V + + + F+ND+
Sbjct: 201 QSLDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDV 260
Query: 159 ALLRLNDRVPIVDIIKPVCLPTVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILS 218
AL+ L + + + P+CLP E +V GWG P ++ ++E+PI+
Sbjct: 261 ALVELLESPVLNAFVMPICLPE--GPQQEGAMVIVSGWGKQFLQRFPETLM-EIEIPIVD 317
Query: 219 NQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMV-FEREDSRYEQIGIVSWGA 277
+ C+ + +++ +M+CAG EG KD+C GDSGGPMV RE ++ +G VSWG
Sbjct: 318 HSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGD 377
Query: 278 GCGRAGYPGVYTRITRYVEWIK 299
CG+ GVY+ I +WI+
Sbjct: 378 DCGKKDRYGVYSYIHHNKDWIQ 399
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 81/254 (31%), Positives = 136/254 (53%), Gaps = 15/254 (5%)
Query: 57 CDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCV 112
C + N + R+VGG+ + +PW + L Y R CGGTLI +VLTAAHC+
Sbjct: 1 CGAPIFQPNLSARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCI 60
Query: 113 KGRLWFLIKATFGEYDRCDTSSKPESRFV-IRAIVGDFTFSNF--DNDIALLRLNDRVPI 169
L + + G+ + + + S +V + I +++F NDIAL++L + V +
Sbjct: 61 SNTLTY--RVALGK-NNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVEL 117
Query: 170 VDIIKPVCLPTVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYS 229
D I+ CLP+ + +D V GWG L +G A ++ P++ C + ++
Sbjct: 118 GDTIQVACLPSEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVVDYATC-SQRDWW 176
Query: 230 STRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG--CGRAGYPGV 287
T + + M+CAG +G+ +C GDSGGP+ + D +++ GIVS+G+G C P V
Sbjct: 177 GTTVKETMVCAG-GDGVISACNGDSGGPLNCQ-ADGQWDVRGIVSFGSGLSCNTFKKPTV 234
Query: 288 YTRITRYVEWIKEK 301
+TR++ Y++WI +K
Sbjct: 235 FTRVSAYIDWINQK 248
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 122 bits (307), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 80/233 (34%), Positives = 124/233 (53%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV + ++NDI L++L + + + LPT +
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVASISLPTSCASA--G 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C++++++ I+ NM C GY EG K
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF---IITSNMFCVGYLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
D+CQGDSGGP+V + GIVSWG GC + PG YT++ YV WIK+
Sbjct: 171 DACQGDSGGPVVCSGKLQ-----GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQ 218
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 122 bits (306), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 78/233 (33%), Positives = 119/233 (51%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+V G P + +P+ L CGG LI+ +VLTAAHC K L + G+++
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL----GKHNL 56
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
S E V+RA++ D+ ++ D DI LLRL + ++I+P LP + +
Sbjct: 57 RQRESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSANT 114
Query: 189 ETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKD 248
+ ++GWG + P I+ + ++S + C + +I+ NM+CAG + KD
Sbjct: 115 TSCHILGWGKTADGDFPD-TIQCAYIHLVSREECEHAY---PGQITQNMLCAGDEKYGKD 170
Query: 249 SCQGDSGGPMVFEREDSRYEQIGIVSWG-AGCGRAGYPGVYTRITRYVEWIKE 300
SCQGDSGGP+V G+VSWG CG PGVYT + RY WI++
Sbjct: 171 SCQGDSGGPLVCGDHLR-----GLVSWGNIPCGSKEKPGVYTNVCRYTNWIQK 218
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 121 bits (304), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 82/233 (35%), Positives = 121/233 (51%), Gaps = 20/233 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ F CGG+LIN ++V++AAHC K I+ GE +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 55
Query: 130 CDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++IV SN +NDI L++L + + + LPT
Sbjct: 56 NVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSC--ASAG 113
Query: 189 ETGVVMGWGTLEESGRP-ACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG + SG +++ ++ PILS+ C+++ +I+ NM CAG G
Sbjct: 114 TQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAY---PGQITSNMFCAGLEGG-- 168
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V + GIVSWG+GC + PGVYT++ YV WIK+
Sbjct: 169 DSCQGDSGGPVVCSGKLQ-----GIVSWGSGCAK-NKPGVYTKVCNYVSWIKQ 215
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 121 bits (304), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 79/233 (33%), Positives = 122/233 (52%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG E N P+ V L+ + F CGG+LI++++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHF-CGGSLISEQWVVSAAHCYKTR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ ++ I + DNDI L++L+ I + + LPT
Sbjct: 56 KVLEGNEQFINAVKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTA--PPAAG 113
Query: 189 ETGVVMGWG-TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
++ GWG TL ++ ++ P+L+ C+ S +I+++M C G+ EG K
Sbjct: 114 TECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY---PGKITNSMFCVGFLEGGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
DSCQ DSGGP+V + G+VSWG GC PGVYT++ YV+WIK+
Sbjct: 171 DSCQRDSGGPVVCNGQLQ-----GVVSWGHGCAWKNRPGVYTKVYNYVDWIKD 218
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 120 bits (301), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 84/251 (33%), Positives = 127/251 (50%), Gaps = 25/251 (9%)
Query: 71 VGGQPTEVNQYPWMV------RLSYFNRFYCGGTLINDRYVLTAAHCVK-GRLWFLIKAT 123
GG T++ +PW R S RF CGG LI+ +VLTAAHC + L +K
Sbjct: 15 TGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHCFQESYLPDQLKVV 74
Query: 124 FGEYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIV----DIIKPVCL 178
G R + ++ V + IV +F ++NDIALL+L P D ++ +CL
Sbjct: 75 LGRTYRVKPGEEEQTFKVKKYIVHKEFDDDTYNNDIALLQLKSDSPQCAQESDSVRAICL 134
Query: 179 PTVLNNTYEDETGVVMGWGTLEESGRP--ACIIRDVEVPILSNQYCRTSTNYSSTRISDN 236
P N D T + +S P + +++ V + + C ++ T +++N
Sbjct: 135 PEA-NLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKFLFNKT-VTNN 192
Query: 237 MMCAG-------YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYT 289
M+CAG YP + D+CQGDSGGP+V D+ +GI+SWG GCG PGVYT
Sbjct: 193 MLCAGDTRSGEIYPN-VHDACQGDSGGPLVC-MNDNHMTLLGIISWGVGCGEKDVPGVYT 250
Query: 290 RITRYVEWIKE 300
++T Y+ WI++
Sbjct: 251 KVTNYLGWIRD 261
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 120 bits (300), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 84/260 (32%), Positives = 126/260 (48%), Gaps = 31/260 (11%)
Query: 67 ATRIVGGQPTEVNQYPWMVRLSYF----NRFYCGGTLINDRYVLTAAHCVKGRLWFLIKA 122
+ R+ G +++ PWM L Y +RF CGG +I++RY+LTAAHCV G L +
Sbjct: 116 SQRVSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCVHGLQNDLYEI 175
Query: 123 TFGEY-----DRCDTSSKPES---RFVIRAIVGDFTFSNFD-----NDIALLRLNDRVPI 169
GE+ + C + + V I +D +DIALL+LN VP
Sbjct: 176 RLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIMHDIALLKLNRSVPF 235
Query: 170 VDIIKPVCLPTV--LNNTYED-ETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTST 226
IKP+CLP L E T V GWGT E+G + ++ VP+ C +
Sbjct: 236 QKHIKPICLPITDELKEKAEQISTYFVTGWGT-TENGSSSDVLLQANVPLQPRSACSQAY 294
Query: 227 NYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFERE-----DSRYEQIGIVSWG-AGCG 280
+ + + +C G + ++DSC+GDSGGP+ + + + GIVS G CG
Sbjct: 295 RRA---VPLSQLCVGGGD-LQDSCKGDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVTCG 350
Query: 281 RAGYPGVYTRITRYVEWIKE 300
+ PG+YT + YV+WI +
Sbjct: 351 QISLPGLYTNVGEYVQWITD 370
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 120 bits (300), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 79/235 (33%), Positives = 124/235 (52%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG E N P+ V L+ + F CGG+LI++++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHF-CGGSLISEQWVVSAAHCYKTR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +F+ A + + DNDI L++L+ I + + LPT
Sbjct: 56 --KVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTA--PPA 111
Query: 187 EDETGVVMGWG-TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG TL ++ ++ P+L+ C+ S +I+++M C G+ EG
Sbjct: 112 AGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY---PGKITNSMFCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQ D+GGP+V + G+VSWG GC PGVYT++ YV+WIK+
Sbjct: 169 GKDSCQRDAGGPVVCNGQLQ-----GVVSWGHGCAWKNRPGVYTKVYNYVDWIKD 218
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 119 bits (299), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 83/254 (32%), Positives = 129/254 (50%), Gaps = 21/254 (8%)
Query: 69 RIVGGQPTEVNQYPWMV------RLSYFNRFYCGGTLINDRYVLTAAHCVKGRLW-FLIK 121
RI GG ++ +PW R S RF CGG LI+ ++L+AAHC + R +
Sbjct: 13 RIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLT 72
Query: 122 ATFGEYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDR----VPIVDIIKPV 176
G R + + V + IV +F +DNDIALL+L +++ V
Sbjct: 73 VILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTV 132
Query: 177 CLPTVLNNTYEDETGVVMGWGTLEE-SGRPACIIRDVEVPILSNQYCRTSTNYSSTRISD 235
CLP + + G+G E S + +++ V + + C TS + + ++D
Sbjct: 133 CLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRC-TSQHLLNRTVTD 191
Query: 236 NMMCAG-----YPEG-MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYT 289
NM+CAG P+ + D+CQGDSGGP+V D R +GI+SWG GCG+ PGVYT
Sbjct: 192 NMLCAGDTRSGGPQANLHDACQGDSGGPLVC-LNDGRMTLVGIISWGLGCGQKDVPGVYT 250
Query: 290 RITRYVEWIKEKSK 303
++T Y++WI++ +
Sbjct: 251 KVTNYLDWIRDNMR 264
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 119 bits (299), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 78/234 (33%), Positives = 121/234 (51%), Gaps = 17/234 (7%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
++V G P + +P+ L CGG LI+ +VLTAAHC K L + G+++
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL----GKHN 56
Query: 129 RCDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYE 187
S E V+RA++ D+ ++ D DI LLRL + ++I+P LP + + +
Sbjct: 57 LRQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQ 114
Query: 188 DETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
+ ++GWG + P I+ + ++S + C + +I+ NM+CAG + K
Sbjct: 115 TTSCHILGWGKTADGDFPD-TIQCAYIHLVSREECEHAY---PGQITQNMLCAGDEKYGK 170
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWG-AGCGRAGYPGVYTRITRYVEWIKE 300
DSCQGDSGGP+V G+VSWG CG PGVYT + RY WI++
Sbjct: 171 DSCQGDSGGPLVCGDHLR-----GLVSWGNIPCGSKEKPGVYTNVCRYTNWIQK 219
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 78/233 (33%), Positives = 120/233 (51%), Gaps = 17/233 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+V G P + +P+ L CGG LI+ +VLTAAHC K L + G+++
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL----GKHNL 56
Query: 130 CDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
S E V+RA++ D+ ++ D DI LLRL + ++I+P LP + + +
Sbjct: 57 GQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQT 114
Query: 189 ETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKD 248
+ ++GWG + P I+ + ++S + C + +I+ NM+CAG + KD
Sbjct: 115 TSCHILGWGKTADGDFPD-TIQCAYIHLVSREECEHAY---PGQITQNMLCAGDEKYGKD 170
Query: 249 SCQGDSGGPMVFEREDSRYEQIGIVSWG-AGCGRAGYPGVYTRITRYVEWIKE 300
SCQGDSGGP+V G+VSWG CG PGVYT + RY WI++
Sbjct: 171 SCQGDSGGPLVCGDHLR-----GLVSWGNIPCGSKEKPGVYTNVCRYTNWIQK 218
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 119 bits (297), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 79/235 (33%), Positives = 123/235 (52%), Gaps = 21/235 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG E N P+ V L+ F CGG+LI++++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGYHF-CGGSLISEQWVVSAAHCYKTR----IQVRLGEHNI 55
Query: 130 CDTSSKPESRFVIRAIV---GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +F+ A + + DNDI L++L+ I + + LPT
Sbjct: 56 --KVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTA--PPA 111
Query: 187 EDETGVVMGWG-TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
++ GWG TL ++ ++ P+L+ C+ S +I+++M C G+ EG
Sbjct: 112 AGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY---PGKITNSMFCVGFLEG 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQ D+GGP+V + G+VSWG GC PGVYT++ YV+WIK+
Sbjct: 169 GKDSCQRDAGGPVVCNGQLQ-----GVVSWGHGCAWKNRPGVYTKVYNYVDWIKD 218
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 117 bits (294), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 82/253 (32%), Positives = 128/253 (50%), Gaps = 21/253 (8%)
Query: 70 IVGGQPTEVNQYPWMV------RLSYFNRFYCGGTLINDRYVLTAAHCVKGRLW-FLIKA 122
I GG ++ +PW R S RF CGG LI+ ++L+AAHC + R +
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTV 60
Query: 123 TFGEYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDR----VPIVDIIKPVC 177
G R + + V + IV +F +DNDIALL+L +++ VC
Sbjct: 61 ILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVC 120
Query: 178 LPTVLNNTYEDETGVVMGWGTLEE-SGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDN 236
LP + + G+G E S + +++ V + + C TS + + ++DN
Sbjct: 121 LPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRC-TSQHLLNRTVTDN 179
Query: 237 MMCAG-----YPEG-MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTR 290
M+CAG P+ + D+CQGDSGGP+V D R +GI+SWG GCG+ PGVYT+
Sbjct: 180 MLCAGDTRSGGPQANLHDACQGDSGGPLVC-LNDGRMTLVGIISWGLGCGQKDVPGVYTK 238
Query: 291 ITRYVEWIKEKSK 303
+T Y++WI++ +
Sbjct: 239 VTNYLDWIRDNMR 251
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 117 bits (293), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 71/233 (30%), Positives = 120/233 (51%), Gaps = 14/233 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+GG+ E + P+M + CGG L+ +++VL+AAHC++ ++ G +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 130 CDTSSKPESRF--VIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +P R V+RA+ D+ D+D+ LL+L+++ + ++P+ V +
Sbjct: 61 --SQPEPSKRLYDVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 118
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG + +GR ++ V +P+L C T++ I++ +MCA
Sbjct: 119 PGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-ITERLMCA--ESNR 175
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWI 298
+DSC+GDSGGP+V E G+VSWG+ CG PG+YTR+ Y WI
Sbjct: 176 RDSCKGDSGGPLVC---GGVLE--GVVSWGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 116 bits (291), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 79/239 (33%), Positives = 121/239 (50%), Gaps = 21/239 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKA-TFGEYD 128
I+ G P +PW V L N+ +CGG L+N+R+VLTAAHC + + T G D
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLG--D 58
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
R K F ++ ND+ L++LN + + ++K V LP+
Sbjct: 59 RRAQRIKASKSFRHPG----YSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEP--PG 112
Query: 189 ETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
T V GWGT P+ ++ V+V ++S Q C T + ++M+CAG P+
Sbjct: 113 TTCTVSGWGTTTSPDVTFPSDLMC-VDVKLISPQDC---TKVYKDLLENSMLCAGIPDSK 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIKEKSKE 304
K++C GDSGGP+V R G+VSWG CG+ PGVYT++ ++ +WI + K+
Sbjct: 169 KNACNGDSGGPLV-----CRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKK 222
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 115 bits (289), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 79/238 (33%), Positives = 120/238 (50%), Gaps = 21/238 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKA-TFGEYD 128
I+ G P +PW V L N+ +CGG L+N+R+VLTAAHC + + T G D
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLG--D 58
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
R K F ++ ND+ L++LN + + ++K V LP+
Sbjct: 59 RRAQRIKASKSFRHPG----YSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEP--PG 112
Query: 189 ETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
T V GWGT P+ ++ V+V ++S Q C T + ++M+CAG P+
Sbjct: 113 TTCTVSGWGTTTSPDVTFPSDLMC-VDVKLISPQDC---TKVYKDLLENSMLCAGIPDSK 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIKEKSK 303
K++C GDSGGP+V R G+VSWG CG+ PGVYT++ ++ +WI + K
Sbjct: 169 KNACNGDSGGPLV-----CRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMK 221
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 114 bits (286), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 83/249 (33%), Positives = 127/249 (51%), Gaps = 27/249 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKG--RLWFLIKATFGEY 127
IVGG E + PW L +F+ F CGG L++ ++VLTAAHC+ +LW F +
Sbjct: 1 IVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDE 60
Query: 128 DRCD----TSSKPESRFVIRAIVGDFTFSNFD--NDIALLRLNDRV-PIVDIIKPVCLPT 180
+ + S P F + + ++ D +D+ LLRL + I D +K V LP
Sbjct: 61 NTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELP- 119
Query: 181 VLNNTYEDETG---VVMGWGTLE-ESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDN 236
T E E G + GWG++E E+ ++ V++ IL N C+ + +++D
Sbjct: 120 ----TEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKA---HVQKVTDF 172
Query: 237 MMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWG-AGCGRAGYPGVYTRITRYV 295
M+C G+ EG KD+C GDSGGP++ D + G+ SWG CG P V R+ YV
Sbjct: 173 MLCVGHLEGGKDTCVGDSGGPLMC---DGVLQ--GVTSWGYVPCGTPNKPSVAVRVLSYV 227
Query: 296 EWIKEKSKE 304
+WI++ E
Sbjct: 228 KWIEDTIAE 236
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 114 bits (286), Expect = 8e-26, Method: Compositional matrix adjust.
Identities = 77/276 (27%), Positives = 138/276 (50%), Gaps = 24/276 (8%)
Query: 47 RPSAKEDYPMCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLIN 101
+PS+ + C +I+GG+ T + PW + +R + CGG+L++
Sbjct: 1 KPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMS 60
Query: 102 DRYVLTAAHCVKGRLWFLIKATFGEY---DRCDTSSKPESRFVIRAIVGDFTFSN----F 154
+V++A HC + + K + Y R +++++ E +F + ++ +S
Sbjct: 61 PCWVISATHCF---IDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAH 117
Query: 155 DNDIALLRLNDR----VPIVDIIKPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACI 208
NDIALL++ + I+ +CLP++ N+ + + G+G + P +
Sbjct: 118 HNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQL 177
Query: 209 IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYE 268
V V ++S++ C+ +Y + ++ M+CA P+ DSCQGDSGGP+V + R
Sbjct: 178 KMTV-VKLISHRECQ-QPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMT 234
Query: 269 QIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSKE 304
GIVSWG GC PGVYTR++ ++ WI+ +KE
Sbjct: 235 LTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 270
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 75/253 (29%), Positives = 131/253 (51%), Gaps = 24/253 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+LI+ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ +CLP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSKE 304
+ ++ WI+ +KE
Sbjct: 235 SHFLPWIRSHTKE 247
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 114 bits (284), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 80/238 (33%), Positives = 121/238 (50%), Gaps = 32/238 (13%)
Query: 79 NQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV--KGRLWFLIKATFGEYDRCDTSSKP 136
N PW V + FN++ CGG L++ +VLTAAHC K ++W L K F E + D
Sbjct: 13 NSQPWHVAVYRFNKYQCGGVLLDRNWVLTAAHCYNDKYQVW-LGKNNFLEDEPSD----- 66
Query: 137 ESRFVIRAIV-GDFTFS-----------NFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
+ R V +AI DF S ++ ND+ LLRL+ I D++KP+ LPT
Sbjct: 67 QHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPT--EE 124
Query: 185 TYEDETGVVMGWG-TLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
T + GWG T + ++ V + +L N+ C + +++D M+CAG
Sbjct: 125 PKLGSTCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDCDKA---HEMKVTDAMLCAGEM 181
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIKE 300
+G +C+ DSGGP++ D + GI SWG CG P VYT++ ++ WI+E
Sbjct: 182 DGGSYTCEHDSGGPLIC---DGILQ--GITSWGPEPCGEPTEPSVYTKLIKFSSWIRE 234
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 79/239 (33%), Positives = 118/239 (49%), Gaps = 25/239 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+ G+ + PW L R CGG L+ DR+VLTAAHC K + G++
Sbjct: 1 ILEGRECIPHSQPWQAALFQGERLICGGVLVGDRWVLTAAHCKKQKY----SVRLGDHSL 56
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFD-----NDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
+ +PE + + ++N + +DI L+RL + + D +KPV L +
Sbjct: 57 -QSRDQPEQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQLANLCPK 115
Query: 185 TYEDETGVVMGWGTL--EESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ ++ GWGT+ + P + EV I S C + +I++ M+CAG
Sbjct: 116 V--GQKCIISGWGTVTSPQENFPN-TLNCAEVKIYSQNKCERAY---PGKITEGMVCAGS 169
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWIKE 300
G D+CQGDSGGP+V D + GI SWG+ CG+ PGVYT+I RY WIK+
Sbjct: 170 SNGA-DTCQGDSGGPLVC---DGMLQ--GITSWGSDPCGKPEKPGVYTKICRYTTWIKK 222
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 36/265 (13%)
Query: 62 GETNDATRIVGGQPTEVNQYPWMVRLSYFN--------RFYCGGTLINDRYVLTAAHCVK 113
G+TN+A E ++PWMV + N + CGG+LI VLT AHCV
Sbjct: 132 GQTNEA---------EYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTGAHCVN 182
Query: 114 GRLWFL--IKATFGEYDRCDTSSK-PESRFVIRAIV--GDFTFSNFDNDIALLRLNDRVP 168
L IK GE+D + P IR ++ +F ND+ALL L+ +
Sbjct: 183 SYQSNLDAIKIRAGEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLV 242
Query: 169 IVDIIKPVCLPTVLNNTYEDETGVVMGWGTLEESGRP--ACIIRDVEVPILSNQYCRTST 226
D I +CLP + ++ GWG E R + I++ +++P + C+
Sbjct: 243 QADNIGTICLPQ-QSQIFDSTECFASGWGKKEFGSRHRYSNILKKIQLPTVDRDKCQA-- 299
Query: 227 NYSSTRIS------DNMMCAGYPEGMKDSCQGDSGGPMVFE--REDSRYEQIGIVSWGAG 278
+ +TR+ +CAG +G KD+C GD G P+ R SRY Q+GIV+WG G
Sbjct: 300 DLRNTRLGLKFVLDQTFVCAGGEQG-KDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIG 358
Query: 279 CGRAGYPGVYTRITRYVEWIKEKSK 303
CG PGVY + + WI ++ +
Sbjct: 359 CGDENVPGVYANVAHFRNWIDQEMQ 383
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 113 bits (282), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 131/253 (51%), Gaps = 24/253 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+L++ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ +CLP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSKE 304
+ ++ WI+ +KE
Sbjct: 235 SHFLPWIRSHTKE 247
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 131/253 (51%), Gaps = 24/253 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+L++ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ +CLP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSKE 304
+ ++ WI+ +KE
Sbjct: 235 SHFLPWIRSHTKE 247
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 112 bits (279), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 73/253 (28%), Positives = 131/253 (51%), Gaps = 24/253 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+L++ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ +CLP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ D+CQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDACQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSKE 304
+ ++ WI+ +KE
Sbjct: 235 SHFLPWIRSHTKE 247
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 112 bits (279), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 131/253 (51%), Gaps = 24/253 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+LI+ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ + LP++ N+ + + G+G + + P + V V ++S++ C+ +Y +
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSKE 304
+ ++ WI+ +KE
Sbjct: 235 SHFLPWIRSHTKE 247
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 112 bits (279), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 70/234 (29%), Positives = 119/234 (50%), Gaps = 14/234 (5%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
RI+GG+ E + P+M + CGG L+ +++VL+AAHC++ ++ G +
Sbjct: 7 RILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHS 66
Query: 129 RCDTSSKPESRF--VIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
+ +P R V+RA+ D D+D+ LL+L+++ + ++P+ V +
Sbjct: 67 L--SQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDV 124
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
V GWG + +GR ++ V +P+L C T++ I++ +MCA
Sbjct: 125 APGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-ITERLMCA--ESN 181
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWI 298
+DSC+GDSGGP+V E G+V+ G+ CG PG+YTR+ Y WI
Sbjct: 182 RRDSCKGDSGGPLVC---GGVLE--GVVTSGSRVCGNRKKPGIYTRVASYAAWI 230
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 111 bits (278), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 74/254 (29%), Positives = 131/254 (51%), Gaps = 24/254 (9%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKAT 123
+I+GG+ T + PW + +R + CGG+LI+ +V++A HC + + K
Sbjct: 15 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF---IDYPKKED 71
Query: 124 FGEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDI 172
+ Y R +++++ E +F + ++ +S NDIALL++ +
Sbjct: 72 YIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 131
Query: 173 IKPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSS 230
I+ + LP++ N+ + + G+G + P + V V ++S++ C+ +Y
Sbjct: 132 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYG 189
Query: 231 TRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTR 290
+ ++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR
Sbjct: 190 SEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTR 248
Query: 291 ITRYVEWIKEKSKE 304
++ ++ WI+ +KE
Sbjct: 249 VSHFLPWIRSHTKE 262
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 111 bits (277), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 68/232 (29%), Positives = 116/232 (50%), Gaps = 12/232 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+GG+ E + P+M + CGG L+ +++VL+AAHC++ ++ G +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 130 CDTSSKPESRF--VIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +P R V+RA+ D D+D+ LL+L+++ + ++P+ V +
Sbjct: 61 --SQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 118
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG + +GR ++ V +P+L C T++ I++ +MCA
Sbjct: 119 PGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-ITERLMCA--ESNR 175
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
+DSC+GDSGGP+V E + + S A CG PG+YTR+ Y WI
Sbjct: 176 RDSCKGDSGGPLVC---GGVLEGV-VTSGSAVCGNRKKPGIYTRVASYAAWI 223
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 73/253 (28%), Positives = 131/253 (51%), Gaps = 24/253 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+LI+ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ + LP++ N+ + + G+G + + P + V V ++S++ C+ +Y +
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGD+GGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSKE 304
+ ++ WI+ +KE
Sbjct: 235 SHFLPWIRSHTKE 247
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 130/253 (51%), Gaps = 24/253 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+LI+ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ + LP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSKE 304
+ ++ WI+ +KE
Sbjct: 235 SHFLPWIRSHTKE 247
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 130/253 (51%), Gaps = 24/253 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+LI+ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ + LP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSKE 304
+ ++ WI+ +KE
Sbjct: 235 SHFLPWIRSHTKE 247
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 110 bits (274), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 72/251 (28%), Positives = 130/251 (51%), Gaps = 24/251 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+L++ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ +CLP++ N+ + + G+G + + P + V V ++S++ C+ +Y +
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKS 302
+ ++ WI+ +
Sbjct: 235 SHFLPWIRSHT 245
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 110 bits (274), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 70/233 (30%), Positives = 117/233 (50%), Gaps = 14/233 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+GG+ E + P+M + CGG L+ +++VL+AAHC++ ++ G +
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 130 CDTSSKPESRF--VIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +P R V+RA+ D D+D+ LL+L+++ + ++P+ V +
Sbjct: 61 --SQPEPSKRLYDVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVE 118
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG + +GR ++ V +P+L C T++ I+ MMCA
Sbjct: 119 PGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGA-ITQRMMCA--ESNR 175
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWI 298
+DSC+GDSGGP+V E G+V+ G+ CG PG+YTR+ Y WI
Sbjct: 176 RDSCKGDSGGPLVC---GGVLE--GVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 110 bits (274), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 73/252 (28%), Positives = 130/252 (51%), Gaps = 24/252 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+LI+ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ + LP++ N+ + + G+G + + P + V V ++S++ C+ +Y +
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSK 303
+ ++ WI+ +K
Sbjct: 235 SHFLPWIRSHTK 246
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 109 bits (273), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 69/233 (29%), Positives = 118/233 (50%), Gaps = 14/233 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+GG+ E + P+M + CGG L+ +++VL+AAHC++ ++ G +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 130 CDTSSKPESRF--VIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +P R V+RA+ D D+D+ LL+L+++ + ++P+ V +
Sbjct: 61 --SQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 118
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG + +GR ++ V +P+L C T++ I++ +MCA
Sbjct: 119 PGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-ITERLMCA--ESNR 175
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWI 298
+DSC+GDSGGP+V E G+V+ G+ CG PG+YTR+ Y WI
Sbjct: 176 RDSCKGDSGGPLVC---GGVLE--GVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 109 bits (273), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 77/234 (32%), Positives = 116/234 (49%), Gaps = 20/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD- 128
IVGG + V L+ F CGG+L++ +V++AAHC K +++ GE+
Sbjct: 1 IVGGYECTKHSQAHQVSLNSGYHF-CGGSLVSKDWVVSAAHCYKS----VLRVRLGEHHI 55
Query: 129 RCDTSSKP--ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
R + ++ S VIR +++ N +NDI L++L + + V LPT
Sbjct: 56 RVNEGTEQYISSSSVIRHP--NYSSYNINNDIMLIKLTKPATLNQYVHAVALPT--ECAA 111
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+ V GWG S ++ + +PILS+ C N I+ +M CAGY EG
Sbjct: 112 DATMCTVSGWGNTMSSVADGDKLQCLSLPILSHADC---ANSYPGMITQSMFCAGYLEGG 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
KDSCQGDSGGP+V G+VSWG GC +PGVY ++ W+++
Sbjct: 169 KDSCQGDSGGPVVCNGVLQ-----GVVSWGYGCAERDHPGVYAKVCVLSGWVRD 217
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 109 bits (272), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 72/251 (28%), Positives = 129/251 (51%), Gaps = 24/251 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+L++ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ +CLP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKS 302
+ ++ WI+ +
Sbjct: 235 SHFLPWIRSHT 245
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 108 bits (271), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 72/251 (28%), Positives = 129/251 (51%), Gaps = 24/251 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+L++ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ +CLP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKS 302
+ ++ WI+ +
Sbjct: 235 SHFLPWIRSHT 245
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 108 bits (271), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 73/252 (28%), Positives = 129/252 (51%), Gaps = 24/252 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+LI+ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ + LP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKSK 303
+ ++ WI+ +K
Sbjct: 235 SHFLPWIRSHTK 246
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 108 bits (270), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 68/233 (29%), Positives = 118/233 (50%), Gaps = 14/233 (6%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+GG+ E + P+M + CGG L+ +++VL+AAHC++ ++ G +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 130 CDTSSKPESRF--VIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +P R V+RA+ D D+D+ LL+L+++ + ++P+ V +
Sbjct: 61 --SQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVA 118
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
V GWG + +GR ++ V +P+L C T++ I++ +MCA
Sbjct: 119 PGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-ITERLMCA--ESNR 175
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWI 298
+DSC+GD+GGP+V E G+V+ G+ CG PG+YTR+ Y WI
Sbjct: 176 RDSCKGDAGGPLVC---GGVLE--GVVTSGSRVCGNRKKPGIYTRVASYAAWI 223
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 108 bits (270), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 73/241 (30%), Positives = 117/241 (48%), Gaps = 20/241 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCV--KGRLWFLIKATFGE- 126
+VGG E N PW V + Y CGG L++ +VLTAAHC + +W F E
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHCYVDQYEVWLGKNKLFQEE 60
Query: 127 ---YDRCDTSSKPESRFVIRAIVGDF--TFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV 181
R + S P F + ++ ++F +D+ LLRL+ I D++KP+ LPT
Sbjct: 61 PSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKPIALPT- 119
Query: 182 LNNTYEDETGVVMGWGTLEES--GRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMC 239
+ GWG++ + +P ++ V + +L N+ C +++D M+C
Sbjct: 120 -KEPKPGSKCLASGWGSITPTRWQKPD-DLQCVFITLLPNENC---AKVYLQKVTDVMLC 174
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
AG G KD+C+ DSGGP++ + G V CG+ G P +YT + ++ WIK
Sbjct: 175 AGEMGGGKDTCRDDSGGPLICDGILQGTTSYGPVP----CGKPGVPAIYTNLIKFNSWIK 230
Query: 300 E 300
+
Sbjct: 231 D 231
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 107 bits (268), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 78/250 (31%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 60 SCGETNDA----TRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGR 115
SCG N RIVGG+ ++ PW V + + CGG I ++LTAAHC++
Sbjct: 308 SCGVKNRMHIRRKRIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILTAAHCLRAS 367
Query: 116 LW--FLIKATFGEYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRL----NDRVP 168
+ I T ++ D + +V R I + + + NDIAL+ + N +
Sbjct: 368 KTHRYQIWTTVVDWIHPDLK-RIVIEYVDRIIFHENYNAGTYQNDIALIEMKKDGNKKDC 426
Query: 169 IVDIIKPVCLPTVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNY 228
+ P C+P ++T +V GWG +++ R ++ EV ++SN S Y
Sbjct: 427 ELPRSIPACVPWSPYLFQPNDTCIVSGWGREKDNERVF-SLQWGEVKLISN----CSKFY 481
Query: 229 SSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVY 288
+ M CAG +G D+C+GDSGGP+V ++ G+VSWG CG+ +PGVY
Sbjct: 482 GNRFYEKEMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVY 541
Query: 289 TRITRYVEWI 298
T++ Y +WI
Sbjct: 542 TKVANYFDWI 551
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 76/242 (31%), Positives = 124/242 (51%), Gaps = 21/242 (8%)
Query: 69 RIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC----VKGRLWFLIKATF 124
I+GG+ + P+M + Y CGG LI+ ++VLTAAHC KG+ ++
Sbjct: 2 EIIGGKEVSPHSRPFMASIQYGGHHVCGGVLIDPQWVLTAAHCQYRFTKGQSPTVV---L 58
Query: 125 GEYDRCDTSSKPESRFVIRAI-VGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCL--PTV 181
G + + ++ + + I T NDI L++L + +K + + T
Sbjct: 59 GAHSLSKNEASKQTLEIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIRSKTS 118
Query: 182 LNNTYEDETGVVMGWGTLE-ESGRPACIIRDVEVPILSNQYCRTSTNYSSTR-ISDNMMC 239
L + + + V GWG + +S RP+ +R+V V +LS + C + + Y+ I+ +M+C
Sbjct: 119 LRSGTKCK---VTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVC 175
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRIT-RYVEWI 298
AG +G KDSC+GD+GGP++ + IVS G CG A PG+YT +T +Y WI
Sbjct: 176 AGDAKGQKDSCKGDAGGPLICKGVFH-----AIVSGGHECGVATKPGIYTLLTKKYQTWI 230
Query: 299 KE 300
K
Sbjct: 231 KS 232
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 72/244 (29%), Positives = 121/244 (49%), Gaps = 25/244 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSY--FNRFY--CGGTLINDRYVLTAAHCV-KGRLWFLIKATF 124
+VGG+ + N +PW + L Y + +Y CGG+LI +V+TAAHCV R W ++
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVDSARTWRVV---L 57
Query: 125 GEYDRCDTSSKPESRFVIRAIVGDFTFSNFDN-------DIALLRLNDRVPIVDIIKPVC 177
GE++ +T+ E + ++ F S +++ DIALLRLN + + ++
Sbjct: 58 GEHNL-NTNEGKEQIMTVNSV---FIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLAA 113
Query: 178 LPTVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNM 237
LP + + GWG G + ++ +P + + C +S + ST + M
Sbjct: 114 LPPSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWGST-VKTTM 172
Query: 238 MCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSW--GAGCGRAGYPGVYTRITRYV 295
+CAG G C GDSGGP+ + S Y G+ S+ +GC + P V+TR++ Y+
Sbjct: 173 VCAG--GGANSGCNGDSGGPLNCQVNGSYYVH-GVTSFVSSSGCNASKKPTVFTRVSAYI 229
Query: 296 EWIK 299
W+
Sbjct: 230 SWMN 233
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 105 bits (263), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 71/251 (28%), Positives = 128/251 (50%), Gaps = 24/251 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR-----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATF 124
I+GG+ T + PW + +R + CGG+L++ +V++A HC + + K +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF---IDYPKKEDY 57
Query: 125 GEY---DRCDTSSKPESRFVIRAIVGDFTFSN----FDNDIALLRLNDR----VPIVDII 173
Y R +++++ E +F + ++ +S NDIALL++ + I
Sbjct: 58 IVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 117
Query: 174 KPVCLPTVLNNTYEDETGVVMGWGTLEESGR--PACIIRDVEVPILSNQYCRTSTNYSST 231
+ + LP++ N+ + + G+G + P + V V ++S++ C+ +Y +
Sbjct: 118 QTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV-VKLISHRECQ-QPHYYGS 175
Query: 232 RISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRI 291
++ M+CA P+ DSCQGDSGGP+V + R GIVSWG GC PGVYTR+
Sbjct: 176 EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQ-GRMTLTGIVSWGRGCALKDKPGVYTRV 234
Query: 292 TRYVEWIKEKS 302
+ ++ WI+ +
Sbjct: 235 SHFLPWIRSHT 245
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 105 bits (261), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 76/245 (31%), Positives = 124/245 (50%), Gaps = 24/245 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
+VGG + N +P + L Y + CGGTLI +V+TAAHCV L F + G
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTF--RVVVG 58
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFDN-----DIALLRLNDRVPIVDIIKPVCLP- 179
E++ + + V + +V + N D+ DIALLRL V + ++ LP
Sbjct: 59 EHNLNQNNGTEQYVGVQKIVV--HPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPR 116
Query: 180 --TVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNM 237
T+L N + + GWG +G+ A ++ +P + C +S+ + ST + ++M
Sbjct: 117 AGTILRN---NSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGST-VKNSM 172
Query: 238 MCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--GCGRAGYPGVYTRITRYV 295
+CAG +G++ CQGDSGGP+ + +Y G+ S+ + GC P V+TR++ Y+
Sbjct: 173 VCAG-GDGVRSGCQGDSGGPL-HCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYI 230
Query: 296 EWIKE 300
WI
Sbjct: 231 SWINN 235
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 104 bits (260), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 73/242 (30%), Positives = 120/242 (49%), Gaps = 18/242 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
+VGG + N +P + L Y + CGGTLI +V+TAAHCV L F + G
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTF--RVVVG 58
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFDN-----DIALLRLNDRVPIVDIIKPVCLPT 180
E++ + + V + +V + N D+ DIALLRL V + ++ LP
Sbjct: 59 EHNLNQNNGTEQYVGVQKIVV--HPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPR 116
Query: 181 VLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+ + GWG +G+ A ++ +P + C +S+ + ST + ++M+CA
Sbjct: 117 AGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGST-VKNSMVCA 175
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--GCGRAGYPGVYTRITRYVEWI 298
G +G++ CQGDSGGP+ + +Y G+ S+ + GC P V+TR++ Y+ WI
Sbjct: 176 G-GDGVRSGCQGDSGGPL-HCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWI 233
Query: 299 KE 300
Sbjct: 234 NN 235
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 104 bits (260), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 71/242 (29%), Positives = 118/242 (48%), Gaps = 27/242 (11%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKG-----RLWFLIKATF 124
IVGG+ V +YP+ V L CG +++++ VLTAAHCV G RL + +
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSHRCGASILDNNNVLTAAHCVDGLSNLNRLKVHVGTNY 60
Query: 125 GEYDRCDTSSKPESRFVIRAIVGDFTFSNF--DNDIALLRLNDRVPIVDIIKPVCLPTVL 182
S+ + + V + + +F ND+AL+ L + + D+++P+ L T
Sbjct: 61 --------LSESGDVYDVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQPIKLSTN- 111
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGY 242
+ E + GWG+ G ++++E+ + + C R+ D+ +C
Sbjct: 112 DEDLESNPCTLTGWGSTRLGGNTPNALQEIELIVHPQKQCER----DQWRVIDSHICTLT 167
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKS 302
G + +C GDSGGP+V + QIGIVS+G+ C G P VYTR++ +V WI
Sbjct: 168 KRG-EGACHGDSGGPLV-----ANGAQIGIVSFGSPCA-LGEPDVYTRVSSFVSWINANL 220
Query: 303 KE 304
K+
Sbjct: 221 KK 222
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 104 bits (260), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 74/241 (30%), Positives = 117/241 (48%), Gaps = 20/241 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLI--KATFGEY 127
IVGG E + PW V ++ R CGG L++ ++VLTAAHC++ + L+ + F
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKSVILLGRHSLFHPE 60
Query: 128 DRCD----TSSKPESRFVIRAIVGDFTFSNFD--NDIALLRLNDRVPIVDIIKPVCLPTV 181
D + S P + + + F D +D+ LLRL++ + D +K + LPT
Sbjct: 61 DTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVMDLPT- 119
Query: 182 LNNTYEDETGVVMGWGTLE-ESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
T GWG++E E ++ V++ ++SN C +++ M+CA
Sbjct: 120 -QEPALGTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVC---AQVHPQKVTKFMLCA 175
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIK 299
G G K +C GDSGGP+V GI SWG+ C P +YT++ Y +WIK
Sbjct: 176 GRWTGGKSTCSGDSGGPLVCNGVLQ-----GITSWGSEPCALPERPSLYTKVVHYRKWIK 230
Query: 300 E 300
+
Sbjct: 231 D 231
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 104 bits (260), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 18/242 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
+VGG + N +P + L Y + CGGTLI +V+TAAHCV L F + G
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTF--RVVVG 58
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFDN-----DIALLRLNDRVPIVDIIKPVCLPT 180
E++ + V + +V + N D+ DIALLRL V + ++ LP
Sbjct: 59 EHNLNQNDGTEQYVGVQKIVV--HPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPR 116
Query: 181 VLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+ + GWG +G+ A ++ +P + C +S+ + ST + ++M+CA
Sbjct: 117 AGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGST-VKNSMVCA 175
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--GCGRAGYPGVYTRITRYVEWI 298
G +G++ CQGDSGGP+ + +Y G+ S+ + GC P V+TR++ Y+ WI
Sbjct: 176 G-GDGVRSGCQGDSGGPL-HCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWI 233
Query: 299 KE 300
Sbjct: 234 NN 235
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 73/244 (29%), Positives = 114/244 (46%), Gaps = 14/244 (5%)
Query: 70 IVGGQPTEVNQYPWMV---RLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
++GG ++PW + R S CG +L++ L+A+HCV G L I+ G
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNIRVIAGL 60
Query: 127 YDRCDTSSKPESR---FVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLN 183
+ + DTS + + + G T S + NDIA+L L + + I+ LP N
Sbjct: 61 WQQSDTSGTQTANVDSYTMHENYGAGTAS-YSNDIAILHLATSISLGGNIQAAVLPANNN 119
Query: 184 NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTS-TNYSSTRISDNMMCAGY 242
N Y T V+ GWG + + I++ +P+++ C + I DN +C
Sbjct: 120 NDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGGANIWDNHICVQD 179
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSW----GAGCGRAGYPGVYTRITRYVEWI 298
P G +C GDSGGP+ +R +G+ SW G G YP VYTR++ Y+ WI
Sbjct: 180 PAGNTGACNGDSGGPLNCPDGGTRV--VGVTSWVVSSGLGACLPDYPSVYTRVSAYLGWI 237
Query: 299 KEKS 302
+ S
Sbjct: 238 GDNS 241
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 102 bits (254), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 75/243 (30%), Positives = 119/243 (48%), Gaps = 24/243 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + P+M + + +CGG L+ D++VLTAAHC KGR + T G
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC-KGR---SMTVTLG 56
Query: 126 EYDRCDTSSKPESRFVI---RAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV 181
+ + +K E++ +I +AI D+ + NDI LL+L ++P+ LP
Sbjct: 57 AH---NIKAKEETQQIIPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRR 113
Query: 182 LNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAG 241
+ + V GWG + G + +V++ + +Q C + S R N +C G
Sbjct: 114 NAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRA--NEICVG 171
Query: 242 YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEK 301
+ S +GDSGGP+V +R + GIVS+G G A P V+TR+ +V WIK+
Sbjct: 172 DSKIKGASFRGDSGGPLVCKRAAA-----GIVSYGQTDGSA--PQVFTRVLSFVSWIKKT 224
Query: 302 SKE 304
K
Sbjct: 225 MKH 227
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 102 bits (253), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 70/241 (29%), Positives = 118/241 (48%), Gaps = 20/241 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF----YCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + + P+M L + + CGG LI + +VLTAAHC + I+ T G
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSK----IQVTLG 56
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + V++ I + NDI LL+L + +KP+ LP
Sbjct: 57 AHNIKEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPLNLPRRNVK 116
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTS-TNYSSTRISDNMMCAGYP 243
+ V GWG L G+ + +++VE+ + +Q C + NY N +CAG P
Sbjct: 117 VKPGDVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLKNYFD---KANEICAGDP 173
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
+ + S +GDSGGP+V ++ + GIVS+G G P +T+++ ++ WIK+ K
Sbjct: 174 KIKRASFRGDSGGPLVCKKVAA-----GIVSYGQNDGST--PRAFTKVSTFLSWIKKTMK 226
Query: 304 E 304
+
Sbjct: 227 K 227
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 102 bits (253), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 66/235 (28%), Positives = 117/235 (49%), Gaps = 13/235 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+GG+ + P+M L CGG L++ ++VLTAAHC+ R+ L + G +
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQL-RLVLGLH-- 57
Query: 130 CDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T P F I+A + + +ND+ALL+L+ +V I+P+ LP+
Sbjct: 58 --TLDSPGLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVVA 115
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+ GWG + GR + ++R++++ +L + C S ++ + +S +M+C
Sbjct: 116 AGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGS-LSPSMVCLAADSKD 174
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWIKE 300
+ C+GDSGGP+V + G++S+ + C P V T + YV WI++
Sbjct: 175 QAPCKGDSGGPLVCGKG---RVLAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRK 226
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 102 bits (253), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 77/237 (32%), Positives = 119/237 (50%), Gaps = 23/237 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+ GG +N++ +V L N F CGGTLIN +V+TAAHC L +
Sbjct: 1 VFGGDECNINEHRSLVVLFNSNGFLCGGTLINQDWVVTAAHCDSNNFQLLFGVHSKKILN 60
Query: 130 CDTSSK-PESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
D ++ P+ +F D D DI L++L+ V + I P+ LP+ +
Sbjct: 61 EDEQTRDPKEKFFCPNRKKD---DEVDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSV--G 115
Query: 189 ETGVVMGWGTLEESGR-----PACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
+MGWG + P C + IL + CRT+ YS ++++ +CAG
Sbjct: 116 SVCRIMGWGKTIPTKEIYPDVPHC----ANINILDHAVCRTA--YSWRQVANTTLCAGIL 169
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWIK 299
+G +D+C DSGGP++ + ++ GIVSWG CG+ G PGVYT++ Y++WIK
Sbjct: 170 QGGRDTCHFDSGGPLIC---NGIFQ--GIVSWGGHPCGQPGEPGVYTKVFDYLDWIK 221
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 101 bits (252), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 70/237 (29%), Positives = 118/237 (49%), Gaps = 22/237 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYF-NRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
I+ G +++ PW L N+ YCG L++ +++LTAAHC K + + G Y
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKK----VFRVRLGHYS 56
Query: 129 RCDTSSKPESRFV-IRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ F +++I ++ ND+ L++LN R+ ++P+ + + +
Sbjct: 57 LSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSS--HCPS 114
Query: 187 EDETGVVMGWGTLE--ESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+V GWGT + + P +++ + + +LS + C + +I D M CAG
Sbjct: 115 AGTKCLVSGWGTTKSPQVHFPK-VLQCLNISVLSQKRCEDAY---PRQIDDTMFCAGDKA 170
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIKE 300
G +DSCQGDSGGP+V G+VSWG C R PGVYT + ++ +WI+E
Sbjct: 171 G-RDSCQGDSGGPVVCNGSLQ-----GLVSWGDYPCARPNRPGVYTNLCKFTKWIQE 221
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 101 bits (252), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 73/236 (30%), Positives = 120/236 (50%), Gaps = 22/236 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+ G+ + PW L N +C G L++ ++VL+AAHC + + E D+
Sbjct: 1 IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQ 60
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCL----PTVLNNT 185
S E+ +R ++ ND+ L++L++ V D I+ + + PT N+
Sbjct: 61 EPGSQMVEASLSVRHP--EYNRPLLANDLMLIKLDESVSESDTIRSISIASQCPTAGNSC 118
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
+V GWG L +GR +++ V V ++S + C + +M CAG +
Sbjct: 119 ------LVSGWGLL-ANGRMPTVLQCVNVSVVSEEVC---SKLYDPLYHPSMFCAGGGQD 168
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWG-AGCGRAGYPGVYTRITRYVEWIKE 300
KDSC GDSGGP++ + Y Q G+VS+G A CG+ G PGVYT + ++ EWI++
Sbjct: 169 QKDSCNGDSGGPLIC----NGYLQ-GLVSFGKAPCGQVGVPGVYTNLCKFTEWIEK 219
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 77/245 (31%), Positives = 116/245 (47%), Gaps = 22/245 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC-------VKGRLWFLIKA 122
IVGG E N PW V + N + CGG LI+ +V+TAAHC + GR
Sbjct: 1 IVGGYKCEKNSQPWQV--AVINEYLCGGVLIDPSWVITAAHCYSNNYQVLLGRNNLFKDE 58
Query: 123 TFGEYDRCDTSSK-PESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV 181
F + S + P+ +I + + ND+ LL L++ I +K + LPT
Sbjct: 59 PFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITGGVKVIDLPT- 117
Query: 182 LNNTYEDETGVVMGWGTLEESGRPACI-IRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
T + GWG+ S ++ V + +LSN+ C + ++D M+CA
Sbjct: 118 -KEPKVGSTCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEKCIETY---KDNVTDVMLCA 173
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIK 299
G EG KD+C GDSGGP++ D + GI S GA C + P +Y ++ ++ WIK
Sbjct: 174 GEMEGGKDTCAGDSGGPLIC---DGVLQ--GITSGGATPCAKPKTPAIYAKLIKFTSWIK 228
Query: 300 EKSKE 304
+ KE
Sbjct: 229 KVMKE 233
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 65/235 (27%), Positives = 117/235 (49%), Gaps = 13/235 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+GG+ + P+M L CGG L++ ++VLTAAHC+ R+ L + G +
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQL-RLVLGLH-- 57
Query: 130 CDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
T P F I+A + + +N++ALL+L+ +V I+P+ LP+
Sbjct: 58 --TLDSPGLTFHIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQVVA 115
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+ GWG + GR + ++R++++ +L + C S ++ + +S +M+C
Sbjct: 116 AGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGS-LSPSMVCLAADSKD 174
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWIKE 300
+ C+GDSGGP+V + G++S+ + C P V T + YV WI++
Sbjct: 175 QAPCKGDSGGPLVCGKGRV---LAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRK 226
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 75/242 (30%), Positives = 115/242 (47%), Gaps = 29/242 (11%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEY-- 127
IVGG N +P L + ++CGG+LI+ ++LTAAHC+ G + G +
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGA--GFVDVVLGAHNI 58
Query: 128 --DRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
D + + F + F S NDIA++RL V + I V LP+
Sbjct: 59 REDEATQVTIQSTDFTVHENYNSFVIS---NDIAVIRLPVPVTLTAAIATVGLPST---- 111
Query: 186 YEDETGVVM---GWGTLEESGRPAC-IIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAG 241
+ G V+ GWG +S ++R V+VPI+SN C ++D +C
Sbjct: 112 -DVGVGTVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGI----VTDGNICID 166
Query: 242 YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCG-RAGYPGVYTRITRYVEWIKE 300
G K +C GDSGGP+ + GI S+GA G AGYP +TR+T +++WI+
Sbjct: 167 -STGGKGTCNGDSGGPLNYNG-----LTYGITSFGAAAGCEAGYPDAFTRVTYFLDWIQT 220
Query: 301 KS 302
++
Sbjct: 221 QT 222
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 72/241 (29%), Positives = 124/241 (51%), Gaps = 33/241 (13%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC----VKGRLWFLIKATFG 125
++GG ++N++P++ L Y + ++CG TLIN +V+TAAHC + +L K
Sbjct: 1 VLGGDECDINEHPFLAFL-YSHGYFCGLTLINQEWVVTAAHCDSTNFQMQLGVHSKKVLN 59
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
E ++ + P+ +F I + S D DI L++L+ + I P+ LP+ N
Sbjct: 60 EDEQ---TRNPKEKF----ICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLPS--NP 110
Query: 185 TYEDETGVVMGWGTLEESGR-----PACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMC 239
+MGWG++ P C + ++ + C+ + N + + +C
Sbjct: 111 PSVGSVCRIMGWGSITIPNETYPDVPYC----ANINLVDYEVCQGAYNGLPAKTT---LC 163
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWI 298
AG EG KD+C GDSGGP++ + +++ GIVS+GA CG+ PG+YT + Y +WI
Sbjct: 164 AGVLEGGKDTCVGDSGGPLIC---NGQFQ--GIVSYGAHSCGQGPKPGIYTNVFDYTDWI 218
Query: 299 K 299
+
Sbjct: 219 Q 219
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 74/243 (30%), Positives = 118/243 (48%), Gaps = 24/243 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + P+M + + +CGG L+ D++VLTAAHC KGR + T G
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC-KGR---SMTVTLG 56
Query: 126 EYDRCDTSSKPESRFVI---RAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTV 181
+ + +K E++ +I +AI D+ + NDI LL+L ++P+ LP
Sbjct: 57 AH---NIKAKEETQQIIPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRR 113
Query: 182 LNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAG 241
+ + V GWG + G + +V++ + +Q C + S R N +C G
Sbjct: 114 NAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRA--NEICVG 171
Query: 242 YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEK 301
+ S + DSGGP+V +R + GIVS+G G A P V+TR+ +V WIK+
Sbjct: 172 DSKIKGASFEEDSGGPLVCKRAAA-----GIVSYGQTDGSA--PQVFTRVLSFVSWIKKT 224
Query: 302 SKE 304
K
Sbjct: 225 MKH 227
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 99.8 bits (247), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 72/236 (30%), Positives = 113/236 (47%), Gaps = 22/236 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRL-WFLIKATFGEYD 128
++GG +N++ ++ L Y N CGGTLIN +VLTA HC +G + +L +
Sbjct: 1 VIGGDECNINEHRFLA-LVYANGSLCGGTLINQEWVLTARHCDRGNMRIYLGMHNLKVLN 59
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ P+ ++ D +D DI L+RLN V I P+ LP+ N
Sbjct: 60 KDALRRFPKEKYFCLNTRNDTI---WDKDIMLIRLNRPVRNSAHIAPLSLPS--NPPSVG 114
Query: 189 ETGVVMGWGTLEESGRPACIIRDV----EVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+MGWGT+ P + DV + IL C+ + Y ++ +CAG E
Sbjct: 115 SVCRIMGWGTITS---PNATLPDVPHCANINILDYAVCQAA--YKG--LAATTLCAGILE 167
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
G KD+C+GDSGGP++ + +G G C + PG+YT++ Y +WI+
Sbjct: 168 GGKDTCKGDSGGPLICNGQFQGILSVG----GNPCAQPRKPGIYTKVFDYTDWIQS 219
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 73/240 (30%), Positives = 116/240 (48%), Gaps = 21/240 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFY---CGGTLINDRYVLTAAHCVKGRLW-FLIKATFG 125
I+GG + + P+M L +++ CGG LI D +VLTAAHC W I T G
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHC-----WGSSINVTLG 55
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + V R I + NF NDI LL+L + ++P+ LP+
Sbjct: 56 AHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQ 115
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTST-NYSSTRISDNMMCAGYP 243
+T V GWG G+ + +++V++ + ++ C + +Y + I +C G P
Sbjct: 116 VKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIE---LCVGDP 172
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
E K S +GDSGGP+V + GIVS+G G P T+++ +V WIK+ K
Sbjct: 173 EIKKTSFKGDSGGPLVCNKVAQ-----GIVSYGRNNGMP--PRACTKVSSFVHWIKKTMK 225
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 99.0 bits (245), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 73/240 (30%), Positives = 116/240 (48%), Gaps = 21/240 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFY---CGGTLINDRYVLTAAHCVKGRLW-FLIKATFG 125
I+GG + + P+M L +++ CGG LI D +VLTAAHC W I T G
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHC-----WGSSINVTLG 55
Query: 126 EYDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + V R I + NF NDI LL+L + ++P+ LP+
Sbjct: 56 AHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQ 115
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTST-NYSSTRISDNMMCAGYP 243
+T V GWG G+ + +++V++ + ++ C + +Y + I +C G P
Sbjct: 116 VKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIE---LCVGDP 172
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
E K S +GDSGGP+V + GIVS+G G P T+++ +V WIK+ K
Sbjct: 173 EIKKTSFKGDSGGPLVCNKVAQ-----GIVSYGRNNGMP--PRACTKVSSFVHWIKKTMK 225
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 75/234 (32%), Positives = 107/234 (45%), Gaps = 20/234 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYF---NRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
I+GG + + P+M L + CGG L+ + +VLTAAHC L I T G
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHC----LGSSINVTLGA 56
Query: 127 YDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
++ + + V R I D+ NDI LL+L + I D + P+ LP L
Sbjct: 57 HNIMERERTQQVIPVRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPINLPRSLAEV 116
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTS-TNYSSTRISDNMMCAGYPE 244
V GWG L + +++V++ + S + C NY I +CAG P
Sbjct: 117 KPGMMCSVAGWGRLGVNMPSTDKLQEVDLEVQSEEKCIARFKNY----IPFTQICAGDPS 172
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
K+S GDSGGP+V GIVS+G G P VYTRI+ ++ WI
Sbjct: 173 KRKNSFSGDSGGPLVCNGVAQ-----GIVSYGRNDGTT--PDVYTRISSFLSWI 219
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 29/240 (12%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC----VKGRLWFLIKATFG 125
++GG +N++ +V F+C GTLIN+ +VLTAAHC + +L K
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHCDNTNFQMKLGVHSKKVLN 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
E ++ + P+ +F+ D D DI L++L+ RV + I V L +
Sbjct: 61 EDEQ---TRNPKEKFICPNKKNDEV---LDKDIMLIKLDSRVSNSEHI--VPLSLPSSPP 112
Query: 186 YEDETGVVMGWGTLEE-----SGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+MGWG++ P C + +L + C+ Y +CA
Sbjct: 113 SVGSVCHIMGWGSITPIKVTYPDVPYC----AYINLLDDAVCQAG--YPELLTEYRTLCA 166
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWIK 299
G EG KD+C GDSGGP++ + +++ GIVS+GA CG+ PGVYT++ Y WI+
Sbjct: 167 GILEGGKDTCGGDSGGPLIC---NGQFQ--GIVSFGAHPCGQGLKPGVYTKVFDYNHWIQ 221
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 13/234 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+V G PT N WMV L Y N+ CGG+LI + +VLTA C R +A G +
Sbjct: 1 VVNGIPTRTN-IGWMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIH-- 57
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
D + + + V + +D+ L++L + D + + LP + E
Sbjct: 58 -DVHGRGDEKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKT 116
Query: 190 TGVVMGW---GTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+ V GW G + G ++R + I+ N+ C + + ++++ +CAG +
Sbjct: 117 SCSVYGWGYTGLINYDG----LLRVAHLYIMGNEKC-SQHHRGKVTLNESEICAGAEKIG 171
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
C+GD GGP+V E+ R +G++ G GC PG++ R+ Y +WI +
Sbjct: 172 SGPCEGDYGGPLVCEQHKMRM-VLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHK 224
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 13/234 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
+V G PT N WMV L Y N+ CGG+LI + +VLTA C R +A G +
Sbjct: 1 VVNGIPTRTN-IGWMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIH-- 57
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
D + + + V + +D+ L++L + D + + LP + E
Sbjct: 58 -DVHGRGDEKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKT 116
Query: 190 TGVVMGW---GTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+ V GW G + G ++R + I+ N+ C + + ++++ +CAG +
Sbjct: 117 SCSVYGWGYTGLINYDG----LLRVAHLYIMGNEKC-SQHHRGKVTLNESEICAGAEKIG 171
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
C+GD GGP+V E+ R +G++ G GC PG++ R+ Y +WI +
Sbjct: 172 SGPCEGDYGGPLVCEQHKMRM-VLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHK 224
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 94.4 bits (233), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 22/248 (8%)
Query: 67 ATRIVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKA 122
++R+V G+ + W V L Y CGG+LI +V+TA HC+ + +
Sbjct: 9 SSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTY--QV 66
Query: 123 TFGEYDRCDTSSKPESRFVIRAIVGDFTFSNF--------DNDIALLRLNDRVPIVDIIK 174
GEYDR S S VI GD NDIAL++L+ + D ++
Sbjct: 67 VLGEYDR---SVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQ 123
Query: 175 PVCLPTVLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRIS 234
LP + + + GWG L G +++ +P++ ++C + ++ +
Sbjct: 124 LANLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHC-SQYDWWGITVK 182
Query: 235 DNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSW--GAGCGRAGYPGVYTRIT 292
M+CAG + C GDSGGP+ D ++ G+ S+ GC P V+TR++
Sbjct: 183 KTMVCAG--GDTRSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVS 240
Query: 293 RYVEWIKE 300
+++WI E
Sbjct: 241 AFIDWINE 248
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 70/239 (29%), Positives = 113/239 (47%), Gaps = 23/239 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC-VKGRLWFLIKATFGEYD 128
I+GG + P+MV LS + C G LI +VLTAAHC + R ++ A
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRSQVILGA------ 54
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNFD-----NDIALLRLNDRVPIVDIIKPVCLPTVLN 183
+ ++ E I + +F + +D D+ LL+L ++ I + + LP +
Sbjct: 55 --HSITREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGD 112
Query: 184 NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYS-STRISDNMMCAGY 242
+ V GWG S + +R+VE+ I+ + C +Y+ + I NM+CAG
Sbjct: 113 DVKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGS 172
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--GCGRAGYPGVYTRIT-RYVEWI 298
G +DSC GDSG P++ E G+ S+G CG PGVY ++ +++ WI
Sbjct: 173 LRGGRDSCNGDSGSPLLCEGVFR-----GVTSFGLENKCGDPRGPGVYILLSKKHLNWI 226
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 65/235 (27%), Positives = 113/235 (48%), Gaps = 15/235 (6%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEY 127
I+GG +N++ ++V L S +CGGTLIN +VLTAAHC + + +
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHCDRKNFRIKLGMHSKKV 60
Query: 128 DRCDTSSK-PESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
D ++ P+ +F + ++ +D DI L+RL+ P+ + +
Sbjct: 61 PNEDEQTRVPKEKFFC---LSSKNYTLWDKDIMLIRLDS--PVKNSKHIAPFSLPSSPPS 115
Query: 187 EDETGVVMGWGTLEES-GRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
+MGWG + + G + V + +L + CR + +CAG EG
Sbjct: 116 VGSVCRIMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEG 175
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWIK 299
KD+C+GDSGGP++ + +++ GI SWG C + P YT++ +++WI+
Sbjct: 176 GKDTCKGDSGGPLIC---NGQFQ--GIASWGDDPCAQPHKPAAYTKVFDHLDWIE 225
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 93.2 bits (230), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 71/241 (29%), Positives = 123/241 (51%), Gaps = 23/241 (9%)
Query: 70 IVGGQPTEVNQYPWM----VRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+ G +P+ + L R +CGG+LI+++++LTAAHCV + ++ G
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVHDAVSVVVY--LG 58
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPT--VLN 183
+ + + S +I + F + ND+AL+++ V D I+P+ LP+ LN
Sbjct: 59 SAVQYEGEAVVNSERIISHSM--FNPDTYLNDVALIKI-PHVEYTDNIQPIRLPSGEELN 115
Query: 184 NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
N +E+ V GWG +S I++ ++ N C + Y I ++ +C
Sbjct: 116 NKFENIWATVSGWG---QSNTDTVILQYTYNLVIDNDRC--AQEYPPGIIVESTICGDTS 170
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSW--GAGCGRAGYPGVYTRITRYVEWIKEK 301
+G K C GDSGGP V ++ IG+VS+ GAGC +G P ++R+T Y++WI++
Sbjct: 171 DG-KSPCFGDSGGPFVLSDKNLL---IGVVSFVSGAGC-ESGKPVGFSRVTSYMDWIQQN 225
Query: 302 S 302
+
Sbjct: 226 T 226
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 73/237 (30%), Positives = 113/237 (47%), Gaps = 21/237 (8%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEY 127
+VGG +N++P++V L S + +C G LIN +VLTAAHC + I+ G +
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRN----IRIKLGMH 56
Query: 128 DRCDTSSKPESRFVIRA--IVGDFTFSN-FDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
+ + ++ E V R + F N D DI L+RL V I PV LP+
Sbjct: 57 SK-NIRNEDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVSLPSRSRG 115
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
+MGWG + + P + + I+ +++C Y +CAG +
Sbjct: 116 V--GSRCRIMGWGKISTTTYPD-VPHCTNIFIVKHKWCEPL--YPWVPADSRTLCAGILK 170
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIKE 300
G +D+C GDSGGP++ E GIV+ G+ CG+ P VYT++ Y WI+
Sbjct: 171 GGRDTCHGDSGGPLICNG-----EMHGIVAGGSEPCGQHLKPAVYTKVFDYNNWIQS 222
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 69/239 (28%), Positives = 112/239 (46%), Gaps = 23/239 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC-VKGRLWFLIKATFGEYD 128
I+GG + P+MV LS + C G LI +VLTAAHC + R ++ A
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRSQVILGA------ 54
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNFD-----NDIALLRLNDRVPIVDIIKPVCLPTVLN 183
+ ++ E I + +F + +D D+ LL+L ++ I + + LP +
Sbjct: 55 --HSITREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGD 112
Query: 184 NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYS-STRISDNMMCAGY 242
+ V GWG S + +R+V + I+ + C +Y+ + I NM+CAG
Sbjct: 113 DVKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGS 172
Query: 243 PEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--GCGRAGYPGVYTRIT-RYVEWI 298
G +DSC GDSG P++ E G+ S+G CG PGVY ++ +++ WI
Sbjct: 173 LRGGRDSCNGDSGSPLLCEGVFR-----GVTSFGLENKCGDPRGPGVYILLSKKHLNWI 226
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 68/240 (28%), Positives = 115/240 (47%), Gaps = 29/240 (12%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC----VKGRLWFLIKATFG 125
++GG ++N++ ++V F+CGGTLIN +V+TAAHC + +L K
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTNFQMQLGVHSKKVLN 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
E ++ + P+ +F+ + D DI L++L+ PI + L +
Sbjct: 61 EDEQ---TRNPKEKFICPNKNNNEV---LDKDIMLIKLDK--PISNSKHIAPLSLPSSPP 112
Query: 186 YEDETGVVMGWGTLEESGR-----PACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+MGWG++ P C + +L + C+ Y +CA
Sbjct: 113 SVGSVCRIMGWGSITPVKETFPDVPYC----ANINLLDHAVCQAG--YPELLAEYRTLCA 166
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIK 299
G +G KD+C GDSGGP++ + +++ GIVS+GA CG+ PG+YT + Y +WI+
Sbjct: 167 GIVQGGKDTCGGDSGGPLIC---NGQFQ--GIVSYGAHPCGQGPKPGIYTNVFDYTDWIQ 221
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 68/240 (28%), Positives = 115/240 (47%), Gaps = 29/240 (12%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC----VKGRLWFLIKATFG 125
++GG ++N++ ++V F+CGGTLIN +V+TAAHC + +L K
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTDFQMQLGVHSKKVLN 60
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
E ++ + P+ +F+ + D DI L++L+ PI + L +
Sbjct: 61 EDEQ---TRNPKEKFICPNKNNNEV---LDKDIMLIKLDK--PISNSKHIAPLSLPSSPP 112
Query: 186 YEDETGVVMGWGTLEESGR-----PACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
+MGWG++ P C + +L + C+ Y +CA
Sbjct: 113 SVGSVCRIMGWGSITPVKETFPDVPYC----ANINLLDHAVCQAG--YPELLAEYRTLCA 166
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA-GCGRAGYPGVYTRITRYVEWIK 299
G +G KD+C GDSGGP++ + +++ GIVS+GA CG+ PG+YT + Y +WI+
Sbjct: 167 GIVQGGKDTCGGDSGGPLIC---NGQFQ--GIVSYGAHPCGQGPKPGIYTNVFDYTDWIQ 221
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 21/238 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR---FYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
IVGG + + P+M L +CGGTLI+ +VLTAAHC++ L+ G
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQRLVNVVLGA 60
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
++ + V + + ++ N NDI L++L+ + + V LP
Sbjct: 61 HNVRTQEPTQQHFSVAQVFLNNYDAENKLNDILLIQLSSPANLSASVATVQLPQQDQPVP 120
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+ MGWG + PA +++++ V +++ +CR +C P
Sbjct: 121 HGTQCLAMGWGRVGAHDPPAQVLQELNVTVVTF-FCRPHN-----------ICTFVPRRK 168
Query: 247 KDSCQGDSGGPMVFEREDSRYEQI-GIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
C GDSGGP++ D + I V W GC +P +TR+ YV+WI+ +
Sbjct: 169 AGICFGDSGGPLIC---DGIIQGIDSFVIW--GCATRLFPDFFTRVALYVDWIRSTLR 221
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 112/238 (47%), Gaps = 18/238 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYF---NRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
I+GG + + P+M + + +R CGG L+ +VLTAAHC I T G
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSS----INVTLGA 56
Query: 127 YDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
++ + + V R I + NF NDI LL+L + ++P+ LP+
Sbjct: 57 HNIKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSKAQV 116
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
+ V GWG + S A +++V + + + C + + +R ++ +C G P+
Sbjct: 117 KPGQLCSVAGWGYVSMSTL-ATTLQEVLLTVQKDCQCERLFHGNYSRATE--ICVGDPKK 173
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
+ +GDSGGP+V + GI+S+G G PGVY +++ ++ WIK K
Sbjct: 174 TQTGFKGDSGGPLVCKDVAQ-----GILSYGNKKGTP--PGVYIKVSHFLPWIKRTMK 224
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 18/238 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYF---NRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGE 126
I+GG + + P+M + + +R CGG L+ +VLTAAHC I T G
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSS----INVTLGA 56
Query: 127 YDRCDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
++ + + V R I + NF N+I LL+L + ++P+ LP+
Sbjct: 57 HNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQV 116
Query: 186 YEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG 245
+ V GWG + S A +++V + + + C + + +R ++ +C G P+
Sbjct: 117 KPGQLCSVAGWGYVSMSTL-ATTLQEVLLTVQKDCQCERLFHGNYSRATE--ICVGDPKK 173
Query: 246 MKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSK 303
+ +GDSGGP+V + GI+S+G G PGVY +++ ++ WIK K
Sbjct: 174 TQTGFKGDSGGPLVCKDVAQ-----GILSYGNKKGTP--PGVYIKVSHFLPWIKRTMK 224
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 87.8 bits (216), Expect = 1e-17, Method: Composition-based stats.
Identities = 41/93 (44%), Positives = 61/93 (65%), Gaps = 8/93 (8%)
Query: 208 IIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRY 267
+++ ++ P+LSN C++S +I+ NM+C G+ +G KDSCQGDSGGP+V +
Sbjct: 9 LLQCLKAPVLSNSSCKSSY---PGQITGNMICVGFLQGGKDSCQGDSGGPVVCNGQLQ-- 63
Query: 268 EQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
GIVSWG GC + PGVYT++ YV WI++
Sbjct: 64 ---GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 93
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 22/234 (9%)
Query: 81 YPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDRCDTSSKP 136
+ W V L Y CGG+LI +V+TA HC+ + + GEYDR S
Sbjct: 10 WSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTY--QVVLGEYDR---SVLE 64
Query: 137 ESRFVIRAIVGDFTFSNF--------DNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
S VI GD NDIAL++L+ + D ++ LP + +
Sbjct: 65 GSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLPPAGDILPNE 124
Query: 189 ETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKD 248
+ GWG L G ++ +P + ++C + ++ + M+CAG +
Sbjct: 125 APCYISGWGRLYTGGPLPDKLQQALLPTVDYEHC-SQWDWWGITVKKTMVCAG--GDTRS 181
Query: 249 SCQGDSGGPMVFEREDSRYEQIGIVSW--GAGCGRAGYPGVYTRITRYVEWIKE 300
C GDSGGP+ D ++ G+ S+ GC P V+TR++ +++WI E
Sbjct: 182 GCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDWIDE 235
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 87.0 bits (214), Expect = 2e-17, Method: Composition-based stats.
Identities = 41/93 (44%), Positives = 61/93 (65%), Gaps = 8/93 (8%)
Query: 208 IIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRY 267
+++ ++ P+LS+ C++S +I+ NM+C G+ EG KDSCQGDSGGP+V +
Sbjct: 9 LLQCLKAPVLSDSSCKSSY---PGQITGNMICVGFLEGGKDSCQGDSGGPVVCNGQLQ-- 63
Query: 268 EQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
GIVSWG GC + PGVYT++ YV WI++
Sbjct: 64 ---GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQ 93
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 55/282 (19%)
Query: 52 EDYPMCDCSCGE----TNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLT 107
E P C+ CG+ + RI+GG +PW ++ + G TLIN++++LT
Sbjct: 81 EKLPECEAVCGKPKNPVDQVQRIMGGSLDAKGSFPWQAKMISHHNLTSGATLINEQWLLT 140
Query: 108 AAHCVKGRLWFLIKATFGEYDRCDTSSKPESRFVIRAIVGD----------FTFSNFDND 157
A ++ G + DT +K + +R VG F N D
Sbjct: 141 TAKNLR----------LGH--KNDTKAK-DIAPTLRLYVGKKQEVEIEKVIFHPDNSTVD 187
Query: 158 IALLRLNDRVPIVDIIKPVCLPTVLNNTYEDETGVVMGWGTLEESGRPACI-----IRDV 212
I L++L +VP+ + + P+CLP+ + G V GW GR A + ++ V
Sbjct: 188 IGLIKLKQKVPVNERVMPICLPS-KDYVNVGLVGYVSGW------GRNANLNFTEHLKYV 240
Query: 213 EVPILSNQYCRTSTNYSSTR--------------ISDNMMCAGYPEGMKDSCQGDSGGPM 258
+P+ + C S+ ++++ CAG + +D+C GD+G
Sbjct: 241 MLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDAGSAF 300
Query: 259 -VFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
V +++D + GI+S+ C A Y GVY R+T ++WI+
Sbjct: 301 AVHDKDDDTWYAAGILSFDKSCRTAEY-GVYVRVTSILDWIQ 341
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/241 (26%), Positives = 116/241 (48%), Gaps = 20/241 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKG--RLWFLIKATFGEY 127
I+GG E + PW V + + F CGG L++ ++VLTAAHC+ ++W +
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHFQCGGVLVHPQWVLTAAHCMSDDYQIWLGRHNLSKDE 60
Query: 128 DRCD----TSSKPESRFVIRAIVGDFT--FSNFDNDIALLRLNDRVPIVDIIKPVCLPTV 181
D + S + +F + + + + + +D+ LLRL I D +K + LPT
Sbjct: 61 DTAQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITDAVKILDLPT- 119
Query: 182 LNNTYEDETGVVMGWGTLEE-SGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
T GWG + + R + ++ VE+ + SN+ C + ++++ ++CA
Sbjct: 120 -QEPKLGSTCYTSGWGLISTFTNRGSGTLQCVELRLQSNEKCARAY---PEKMTEFVLCA 175
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWG-AGCGRAGYPGVYTRITRYVEWIK 299
+ + C GDSGG ++ D ++ GI SWG + C V+T++ + +WIK
Sbjct: 176 THRDDSGSICLGDSGGALIC---DGVFQ--GITSWGYSECADFNDNFVFTKVMPHKKWIK 230
Query: 300 E 300
E
Sbjct: 231 E 231
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 68/235 (28%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + + P+M L R CGG LI+ ++VLTAAHC KGR I G
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHC-KGR---EITVILG 56
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFDN--DIALLRLNDRVPIVDIIKPVCLPTVLN 183
+D S + V + I+ + ++++ N DI LL+L +V + + V LP+ +
Sbjct: 57 AHDVRKRESTQQKIKVEKQIIHE-SYNSVPNLHDIMLLKLEKKVELTPAVNVVPLPSPSD 115
Query: 184 NTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP 243
+ GWG + +R+VE+ I+ + C Y +C G P
Sbjct: 116 FIHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKACVDYRYYE----YKFQVCVGSP 171
Query: 244 EGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWI 298
++ + GDSGGP++ GIVS+G + P ++TR++ YV WI
Sbjct: 172 TTLRAAFMGDSGGPLLCAGVAH-----GIVSYGHPDAKP--PAIFTRVSTYVPWI 219
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ Q+P++ + R +CGG LI+ R+V+TAA C + + + G YD
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 130 CDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ F I ++ + + ND+ LL+L+ + + + LP + N T E
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLP-LQNATVEA 119
Query: 189 ETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
T V GWG+ GR + R V V + CR N +C G
Sbjct: 120 GTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP-----------NNVCTGVLTRRG 168
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWI 298
C GD G P+V E G+ S+ G CGR P +TR+ + +WI
Sbjct: 169 GICNGDQGTPLVCEGLAH-----GVASFSLGPCGRG--PDFFTRVALFRDWI 213
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ Q+P++ + R +CGG LI+ R+V+TAA C + + + G YD
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 130 CDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ F I ++ + + ND+ LL+L+ + + + LP + N T E
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLP-LQNATVEA 119
Query: 189 ETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
T V GWG+ GR + R V V + CR N +C G
Sbjct: 120 GTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP-----------NNVCTGVLTRRG 168
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWI 298
C GD G P+V E G+ S+ G CGR P +TR+ + +WI
Sbjct: 169 GICNGDGGTPLVCEGLAH-----GVASFSLGPCGRG--PDFFTRVALFRDWI 213
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 20/159 (12%)
Query: 153 NFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDETGV---VMGWGTLEESGRPACI- 208
++ +D+ LLRL I D +K + LPT E E G GWG++E
Sbjct: 5 DYSHDLMLLRLQSPAKITDAVKVLELPT-----QEPELGSTCEASGWGSIEPGPDDFEFP 59
Query: 209 --IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSR 266
I+ V++ +L N +C + +++++M+CAGY G KD+C GDSGGP++ +
Sbjct: 60 DEIQCVQLTLLQNTFC---ADAHPDKVTESMLCAGYLPGGKDTCMGDSGGPLIC---NGM 113
Query: 267 YEQIGIVSWG-AGCGRAGYPGVYTRITRYVEWIKEKSKE 304
++ GI SWG CG A P +YT++ Y++WI + E
Sbjct: 114 WQ--GITSWGHTPCGSANKPSIYTKLIFYLDWIDDTITE 150
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 46/102 (45%), Positives = 67/102 (65%), Gaps = 8/102 (7%)
Query: 203 GRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMV 259
G+P+ +++ V +PI+ C+ ST RI+DNM CAGY EG + D+C+GDSGGP V
Sbjct: 1 GQPS-VLQVVNLPIVERPVCKDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFV 56
Query: 260 FERE-DSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
+ ++R+ Q+GIVSWG GC R G G YT + R +WI++
Sbjct: 57 MKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 98
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 46/102 (45%), Positives = 67/102 (65%), Gaps = 8/102 (7%)
Query: 203 GRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYP--EGMK-DSCQGDSGGPMV 259
G+P+ +++ V +PI+ C+ ST RI+DNM CAGY EG + D+C+GDSGGP V
Sbjct: 1 GQPS-VLQVVNLPIVERPVCKDSTR---IRITDNMFCAGYKPDEGKRGDACEGDSGGPFV 56
Query: 260 FERE-DSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
+ ++R+ Q+GIVSWG GC R G G YT + R +WI++
Sbjct: 57 MKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 98
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 20/236 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG ++ + P+M L +CGG LI +VLTAAHC GR I T G
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-GR---SITVTLG 56
Query: 126 EYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + VI+ + S +DI LL+L ++ + + + P+ N
Sbjct: 57 AHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNF 116
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + +++V++ ++ Q C ++ + +C G P
Sbjct: 117 VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD----HNLQLCVGNPR 172
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
K + +GDSGGP++ GIVS+G + P V+TRI+ Y WI +
Sbjct: 173 KTKSAFKGDSGGPLLCAGVAQ-----GIVSYGRSDAKP--PAVFTRISHYRPWINQ 221
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + + P+M L +CGG LI +VLTAAHC GR I T G
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-GR---SITVTLG 56
Query: 126 EYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + VI+ + S +DI LL+L ++ + + + P+ N
Sbjct: 57 AHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNF 116
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + +++V++ ++ Q C ++ + +C G P
Sbjct: 117 VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD----HNLQLCVGNPR 172
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
K + +GDSGGP++ GIVS+G A P V+TRI+ Y WI +
Sbjct: 173 KTKSAFKGDSGGPLLCAGAAQ-----GIVSYGR--SDAKPPAVFTRISHYQPWINQ 221
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 42/97 (43%), Positives = 61/97 (62%), Gaps = 7/97 (7%)
Query: 208 IIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEG---MKDSCQGDSGGPMVFERE- 263
+++ V +P++ C+ ST RI+DNM CAGY G D+C+GDSGGP V +
Sbjct: 9 VLQVVNLPLVERPVCKASTR---IRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPY 65
Query: 264 DSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
++R+ Q+GIVSWG GC R G G YT + R +WI++
Sbjct: 66 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 102
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + + P+M L +CGG LI +VLTAAHC GR I T G
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-GR---SITVTLG 56
Query: 126 EYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + VI+ + S +DI LL+L ++ + + + P+ N
Sbjct: 57 AHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNF 116
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + +++V++ ++ Q C ++ + +C G P
Sbjct: 117 VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD----HNLQLCVGNPR 172
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
K + +GDSGGP++ GIVS+G A P V+TRI+ Y WI +
Sbjct: 173 KTKSAFKGDSGGPLLCAGVAQ-----GIVSYGR--SDAKPPAVFTRISHYRPWINQ 221
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + + P+M L +CGG LI +VLTAAHC GR I T G
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-GR---SITVTLG 58
Query: 126 EYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + VI+ + S +DI LL+L ++ + + + P+ N
Sbjct: 59 AHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQFNF 118
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + +++V++ ++ Q C ++ + +C G P
Sbjct: 119 VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD----HNLQLCVGNPR 174
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
K + +GDSGGP++ GIVS+G A P V+TRI+ Y WI +
Sbjct: 175 KTKSAFKGDSGGPLLCAGVAQ-----GIVSYGR--SDAKPPAVFTRISHYRPWINQ 223
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 20/236 (8%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNR----FYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + + P+M L +CGG LI +VLTAAHC GR I T G
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-GR---SITVTLG 56
Query: 126 EYDRCDTSSKPESRFVIRAIV-GDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNN 184
++ + + VI+ + S +DI LL+L ++ + + + P+ N
Sbjct: 57 AHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNF 116
Query: 185 TYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPE 244
V GWG + +++V++ ++ Q C ++ + +C G P
Sbjct: 117 VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD----HNLQLCVGNPR 172
Query: 245 GMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
K + +GDSGGP++ GIVS+G A P V+TRI+ Y WI +
Sbjct: 173 KTKSAFKGDSGGPLLCAGAAQ-----GIVSYGR--SDAKPPAVFTRISHYQPWINQ 221
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 78.6 bits (192), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 65/232 (28%), Positives = 99/232 (42%), Gaps = 22/232 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ Q+P++ + CGG LI+ R+V+TAA C + + + G YD
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 130 CDTSSKPESRFVIRAIVGD-FTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYED 188
+ F I ++ + + ND+ LL+L+ + + + LP + N T E
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLP-LQNATVEA 119
Query: 189 ETGV-VMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
T V GWG+ GR + R V V + CR N +C G
Sbjct: 120 GTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP-----------NNVCTGVLTRRG 168
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAG-CGRAGYPGVYTRITRYVEWI 298
C GD G P+V E G+ S+ G CGR P +TR+ + +WI
Sbjct: 169 GICNGDGGTPLVCEGLAH-----GVASFSLGPCGRG--PDFFTRVALFRDWI 213
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 18/230 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ + +P+MV L +CG TLI +V++AAHCV ++ G ++
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
+ V R + N NDI +L+LN I ++ LP
Sbjct: 61 SRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGV 120
Query: 190 TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDS 249
+ MGWG L + A +++++ V ++++ CR S + R G G+
Sbjct: 121 QCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRRSNVCTLVR--------GRQAGV--- 168
Query: 250 CQGDSGGPMVFEREDSRYEQIGIVSW-GAGCGRAGYPGVYTRITRYVEWI 298
C GDSG P+V GI S+ GC YP + + ++V WI
Sbjct: 169 CFGDSGSPLVCNGLIH-----GIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 18/230 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ + +P+MV L +CG TLI +V++AAHCV ++ G ++
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
+ V R + N NDI +L+LN I ++ LP
Sbjct: 61 SRREPTRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGV 120
Query: 190 TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDS 249
+ MGWG L + A +++++ V ++++ CR S + R G G+
Sbjct: 121 QCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRRSNVCTLVR--------GRQAGV--- 168
Query: 250 CQGDSGGPMVFEREDSRYEQIGIVSW-GAGCGRAGYPGVYTRITRYVEWI 298
C GDSG P+V GI S+ GC YP + + ++V WI
Sbjct: 169 CFGDSGSPLVCNGLIH-----GIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 18/230 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ + +P+MV L +CG TLI +V++AAHCV ++ G ++
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
+ V R + N NDI +L+LN I ++ LP
Sbjct: 61 SRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGV 120
Query: 190 TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDS 249
+ MGWG L + A +++++ V ++++ CR S + R G G+
Sbjct: 121 QCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRRSNVCTLVR--------GRQAGV--- 168
Query: 250 CQGDSGGPMVFEREDSRYEQIGIVSW-GAGCGRAGYPGVYTRITRYVEWI 298
C GDSG P+V GI S+ GC YP + + ++V WI
Sbjct: 169 CFGDSGSPLVCNGLIH-----GIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 18/230 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ + +P+MV L +CG TLI +V++AAHCV ++ G ++
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
+ V R + N NDI +L+LN I ++ LP
Sbjct: 61 SRREPTRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGV 120
Query: 190 TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDS 249
+ MGWG L + A +++++ V ++++ CR S + R G G+
Sbjct: 121 QCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRRSNVCTLVR--------GRQAGV--- 168
Query: 250 CQGDSGGPMVFEREDSRYEQIGIVSW-GAGCGRAGYPGVYTRITRYVEWI 298
C GDSG P+V GI S+ GC YP + + ++V WI
Sbjct: 169 CFGDSGSPLVCNGLIH-----GIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 18/230 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG+ + +P+MV L +CG TLI +V++AAHCV ++ G ++
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 130 CDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDE 189
+ V R + N NDI +L+LN I ++ LP
Sbjct: 61 SRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGV 120
Query: 190 TGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDS 249
+ MGWG L + A +++++ V ++++ CR S + R G G+
Sbjct: 121 QCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRRSNVCTLVR--------GRQAGV--- 168
Query: 250 CQGDSGGPMVFEREDSRYEQIGIVSW-GAGCGRAGYPGVYTRITRYVEWI 298
C GD G P+V GI S+ GC YP + + ++V WI
Sbjct: 169 CFGDXGSPLVCNGLIH-----GIASFVRGGCASGLYPDAFAPVAQFVNWI 213
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 27/238 (11%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFG 125
I+GG+ + + P+M L S + CGG L+ + +VLTAAHC W I T G
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHC-----WGSNINVTLG 55
Query: 126 EYD---RCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVL 182
++ R +T +R IR + NDI LL+L+ RV + PV LP
Sbjct: 56 AHNIQRRENTQQHITARRAIRH--PQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQ 113
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYC-RTSTNYSSTRISDNMMCAG 241
V GWG + R +R+V++ + ++ C R +Y R +C G
Sbjct: 114 EGLRPGTLCTVAGWGRVSMR-RGTDTLREVQLRVQRDRQCLRIFGSYDPRR----QICVG 168
Query: 242 YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
K + +GDSGGP++ GIVS+G G P V+TR++ ++ WI+
Sbjct: 169 DRRERKAAFKGDSGGPLLCNNVAH-----GIVSYGKSSGVP--PEVFTRVSSFLPWIR 219
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 27/238 (11%)
Query: 70 IVGGQPTEVNQYPWMVRL---SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFL-IKATFG 125
I+GG+ + + P+M L S + CGG L+ + +VLTAAHC W I T G
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHC-----WGSNINVTLG 55
Query: 126 EYD---RCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVL 182
++ R +T +R IR + NDI LL+L+ RV + PV LP
Sbjct: 56 AHNIQRRENTQQHITARRAIRH--PQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQ 113
Query: 183 NNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYC-RTSTNYSSTRISDNMMCAG 241
V GWG + R +R+V++ + ++ C R +Y R +C G
Sbjct: 114 EGLRPGTLCTVAGWGRVSMR-RGTDTLREVQLRVQRDRQCLRIFGSYDPRR----QICVG 168
Query: 242 YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
K + +GDSGGP++ GIVS+G G P V+TR++ ++ WI+
Sbjct: 169 DRRERKAAFKGDSGGPLLCNNVAH-----GIVSYGKSSGVP--PEVFTRVSSFLPWIR 219
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 14/239 (5%)
Query: 70 IVGGQPTEVNQYPWMVRL-SYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLI--KATFGE 126
+VGG P PW V L + + +CGG+L+ ++++LTA C L + G
Sbjct: 1 VVGGHP---GNSPWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSCHMPLTGYEVWLGT 57
Query: 127 YDRCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +P + R V + + LL+L V + + +CLP
Sbjct: 58 LFQNPQHGEPSLQ---RVPVAKMVCGPSGSQLVLLKLERSVTLNQRVALICLPPEWYVVP 114
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGM 246
+ GWG + +G ++ + ++SNQ C R+ ++ MC
Sbjct: 115 PGTKCEIAGWGETKGTGNDT-VLNVALLNVISNQECNIK---HRGRVRESEMCTEGLLAP 170
Query: 247 KDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKEKSKEG 305
+C+GD GGP+ +S + GI+ C R+ +P V+TR++ +V+WI + + G
Sbjct: 171 VGACEGDYGGPLACFTHNSWVLE-GIIIPNRVCARSRWPAVFTRVSVFVDWIHKVMRLG 228
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 28/244 (11%)
Query: 70 IVGGQPTEVNQYPWMVRLSYF----NRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFG 125
I+GG + P+M L + C G LI +V+TAAHC GR ++
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCA-GRSITVLLGAHN 59
Query: 126 EYDRCDTSSKPESRFVIRAIVGDFTFSNFD-----NDIALLRLNDRVPIVDIIKPVCLPT 180
+ + DT K E + F +D NDI LL+L ++ + + + +
Sbjct: 60 KKVKEDTWQKLE-------VEKQFPHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPISA 112
Query: 181 VLNNTYEDETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCA 240
N+ +GWG + P+ +++V++ IL Q C+ ++ + +C
Sbjct: 113 KSNSIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKHFEDFH----QEPQLCV 168
Query: 241 GYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
G P+ +++ +GDSGGP++ GI S+ A P V+TRI+ Y WI +
Sbjct: 169 GNPKKIRNVYKGDSGGPLLCAGIAQ-----GIASY--VLRNAKPPSVFTRISHYRPWINK 221
Query: 301 KSKE 304
+E
Sbjct: 222 ILRE 225
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 52/149 (34%), Positives = 69/149 (46%), Gaps = 18/149 (12%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV GQ EV PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R K E ++ I ++ N D DIALL+L + + D I PV
Sbjct: 61 VR--IGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
Query: 177 CLP---TVLNNTYEDETGVVMGWGTLEES 202
CLP T + G V GWG E+
Sbjct: 119 CLPDKQTAAKLLHAGFKGRVTGWGNRRET 147
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 71.2 bits (173), Expect = 9e-13, Method: Composition-based stats.
Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 6/92 (6%)
Query: 209 IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYE 268
++ +P+LSN C+ Y T+I D M+CAG G+ SC GDSGGP+V ++ + +
Sbjct: 7 LQQASLPLLSNTNCK---KYWGTKIKDAMICAG-ASGVS-SCMGDSGGPLVCKK-NGAWT 60
Query: 269 QIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
+GIVSWG+ PGVY R+T V W+++
Sbjct: 61 LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ 92
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 71.2 bits (173), Expect = 1e-12, Method: Composition-based stats.
Identities = 37/92 (40%), Positives = 56/92 (60%), Gaps = 6/92 (6%)
Query: 209 IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYE 268
++ +P+LSN C+ Y T+I D M+CAG G+ SC GDSGGP+V ++ + +
Sbjct: 6 LQQASLPLLSNTNCK---KYWGTKIKDAMICAG-ASGVS-SCMGDSGGPLVCKK-NGAWT 59
Query: 269 QIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
+GIVSWG+ PGVY R+T V W+++
Sbjct: 60 LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQ 91
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 51/152 (33%), Positives = 71/152 (46%), Gaps = 24/152 (15%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCVKGRLW--------FL 119
IV G E+ PW V L CG +LI+DR+VLTAAHC+ W L
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 120 IKATFGEYDRCDTSSKPESRFVIRAIVGDFTFS---NFDNDIALLRLNDRVPIVDIIKPV 176
++ G++ R E ++ I ++ N D DIAL++L V D I PV
Sbjct: 61 VR--IGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 177 CLP------TVLNNTYEDETGVVMGWGTLEES 202
CLP ++L Y+ G V GWG L+E+
Sbjct: 119 CLPDRETAASLLQAGYK---GRVTGWGNLKET 147
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 69.7 bits (169), Expect = 3e-12, Method: Composition-based stats.
Identities = 37/92 (40%), Positives = 57/92 (61%), Gaps = 6/92 (6%)
Query: 209 IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYE 268
++ +PI+S C+ S ++I+D M CAG G+ DSC GDSGGP+V ++ D +
Sbjct: 9 LQQAALPIVSEADCKKSW---GSKITDVMTCAG-ASGV-DSCMGDSGGPLVCQK-DGVWT 62
Query: 269 QIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
GIVSWG+G PGVY+R+T + W+++
Sbjct: 63 LAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQ 94
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 46/255 (18%)
Query: 56 MCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVK-G 114
+ D CG N + ++ + PW V + ++ C G LI+D++VLTAAHC + G
Sbjct: 215 LTDTICGVGN-----MSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDG 269
Query: 115 RLWFLIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFSNF-----------DNDIALLRL 163
L + G D S+ F+I V F F +DIALL+L
Sbjct: 270 NDHSLWRVNVG-----DPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKL 324
Query: 164 NDRVPIVDIIKPVCLPTVL-----------------NNTYEDETGVVMGWGTLEESGRPA 206
+V + +P+CLP + N ++ V + L S
Sbjct: 325 AQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNI 384
Query: 207 CIIRDVEVPILSNQYCRTST---NYSSTR--ISDNMMCAGYPEGMKDSCQGDSGGPMVFE 261
+ VE + + T N + R ++D +C+G E + C+G+SGG + E
Sbjct: 385 NLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQED-ESPCKGESGGAVFLE 443
Query: 262 REDSRYEQIGIVSWG 276
R R+ Q+G+VSWG
Sbjct: 444 RR-FRFFQVGLVSWG 457
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 46/255 (18%)
Query: 56 MCDCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVK-G 114
+ D CG N + ++ + PW V + ++ C G LI+D++VLTAAHC + G
Sbjct: 223 LTDTICGVGN-----MSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDG 277
Query: 115 RLWFLIKATFGEYDRCDTSSKPESRFVIRAIVGDFTFSNF-----------DNDIALLRL 163
L + G D S+ F+I V F F +DIALL+L
Sbjct: 278 NDHSLWRVNVG-----DPKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKL 332
Query: 164 NDRVPIVDIIKPVCLPTVL-----------------NNTYEDETGVVMGWGTLEESGRPA 206
+V + +P+CLP + N ++ V + L S
Sbjct: 333 AQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVALNGSKLNI 392
Query: 207 CIIRDVEVPILSNQYCRTST---NYSSTR--ISDNMMCAGYPEGMKDSCQGDSGGPMVFE 261
+ VE + + T N + R ++D +C+G E + C+G+SGG + E
Sbjct: 393 NLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQED-ESPCKGESGGAVFLE 451
Query: 262 REDSRYEQIGIVSWG 276
R R+ Q+G+VSWG
Sbjct: 452 RR-FRFFQVGLVSWG 465
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 67.8 bits (164), Expect = 1e-11, Method: Composition-based stats.
Identities = 36/92 (39%), Positives = 56/92 (60%), Gaps = 6/92 (6%)
Query: 209 IRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMKDSCQGDSGGPMVFEREDSRYE 268
++ +PI+S C+ S ++I+D M CAG G+ DSC GDSGGP+V ++ D +
Sbjct: 9 LQQAALPIVSEADCKKSW---GSKITDVMTCAG-ASGV-DSCMGDSGGPLVCQK-DGVWT 62
Query: 269 QIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
GIVSWG+G P VY+R+T + W+++
Sbjct: 63 LAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQ 94
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 64.3 bits (155), Expect = 1e-10, Method: Composition-based stats.
Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF-YCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IV G+ +PW V L F +CGG+LIN+ +V+TAAHC ++ GE+D
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDVVVA---GEFD 57
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNF--DNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ +S K + + I + + +++ +NDI LL+L+ + VCLP+ ++
Sbjct: 58 QGSSSEKIQ-KLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFA 116
Query: 187 EDETGVVMGWG 197
T V GWG
Sbjct: 117 AGTTCVTTGWG 127
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 15/233 (6%)
Query: 72 GGQPTEVNQYPWMVRLSYF---NRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
GG+ T++ Q PW V + + CGG +++ +VLTAAHCV + I + +
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPETIVIQYESTN 61
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDI-IKPVCLPTVLNNTYE 187
+ K + +V + + +NDIA+L L+ + + + KP LP +
Sbjct: 62 LWEDPGKSDP-YVSHVYLSFYRQETMENDIAILELSRPLKLDGLKSKPAKLPDIEFRPKT 120
Query: 188 DETGVVMGWGTLEESGRPACIIRDVEVPILSNQYCRTSTNYSSTRISDNMMCAGYPEGMK 247
+V G+G + ++ ++ ++ CR T Y +S + CA
Sbjct: 121 GSDVLVSGYGDGQTMDPKDHDLKSAQLTVVDLDECR--TKYGPIFLSLQVFCAQKVGVSL 178
Query: 248 DSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIKE 300
+S GD+G P V ++D+ +G+ ++ G P V+T++ YV WI++
Sbjct: 179 ES--GDAGDPTV--QQDTL---VGVAAYFPKRPE-GAPEVFTKVGSYVSWIQD 223
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 44/240 (18%)
Query: 76 TEVNQYPWMVRLSYFN----RFYCGGTLINDRYVLTAAHC--VKGRLWFLIKATFGEYDR 129
T+ ++ PW ++S C G ++++ +VLTAAHC V + + + GE
Sbjct: 22 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRD 81
Query: 130 CDTSS---KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ P + G F +D D+AL++L +++ I+P+CLP T
Sbjct: 82 LEIEVVLFHPNYNINGKKEAGIPEF--YDYDVALIKLKNKLKYGQTIRPICLPCTEGTTR 139
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQY------------------CRTSTNY 228
+E PA +D++ +S + C Y
Sbjct: 140 ALRLPPTTTCQQQKEELLPA---QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQY 196
Query: 229 S---------STRISDNMMCAG--YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA 277
+ S ++ +C G P ++C+GDSGGP++ + SR+ Q+G++SWG
Sbjct: 197 APGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 255
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 54/285 (18%)
Query: 76 TEVNQYPWMVRLSYF----NRFYCGGTLINDRYVLTAAHC--VKGRLWFLIKATFGEYDR 129
T+ ++ PW ++S C G ++++ +VLTAAHC V + + + GE
Sbjct: 229 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRD 288
Query: 130 CDTSS---KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ P + G F +D D+AL++L +++ I+P+CLP T
Sbjct: 289 LEIEVVLFHPNYNINGKKEAGIPEF--YDYDVALIKLKNKLKYGQTIRPICLPCTEGTTR 346
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQY------------------CRTSTNY 228
+E PA +D++ +S + C Y
Sbjct: 347 ALRLPPTTTCQQQKEELLPA---QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQY 403
Query: 229 S---------STRISDNMMCAG--YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA 277
+ S ++ +C G P ++C+GDSGGP++ + SR+ Q+G++SWG
Sbjct: 404 APGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 462
Query: 278 -----GCGRAGYPGVYTR-----ITRYVEWIKEKSKEGCFLFFVA 312
R + R + + + W+KEK ++ F A
Sbjct: 463 VDVCKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFLAA 507
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 48/282 (17%)
Query: 76 TEVNQYPWMVRLSYF----NRFYCGGTLINDRYVLTAAHC--VKGRLWFLIKATFGEYDR 129
T+ ++ PW ++S C G ++++ +VLTAAHC V + + + GE
Sbjct: 473 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRD 532
Query: 130 CDTSS---KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ P + G F +D D+AL++L +++ I+P+CLP T
Sbjct: 533 LEIEVVLFHPNYNINGKKEAGIPEF--YDYDVALIKLKNKLKYGQTIRPICLPCTEGTTR 590
Query: 187 EDETGVVMGWGTLEESGRPACIIRDV------------EVPILSNQY---CRTSTNYS-- 229
+E PA I+ + EV I + C Y+
Sbjct: 591 ALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPG 650
Query: 230 -------STRISDNMMCAG--YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--- 277
S ++ +C G P ++C+GDSGGP++ + SR+ Q+G++SWG
Sbjct: 651 YDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGVVDV 709
Query: 278 --GCGRAGYPGVYTR-----ITRYVEWIKEKSKEGCFLFFVA 312
R + R + + + W+KEK ++ F A
Sbjct: 710 CKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFLAA 751
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 58/241 (24%), Positives = 107/241 (44%), Gaps = 25/241 (10%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
I+GG+ +++ + PW V + + +CGG+++ +V+TAA CV G I +G R
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPFCGGSILTANFVITAAQCVDGTKPSDISIHYGSSYR 60
Query: 130 CD--TSSKPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVD-IIKPVCLPTVLNNTY 186
TS + +++R + N+ A++ + + D K + LP++L +
Sbjct: 61 TTKGTSVMAKKIYIVR-----YHPLTMQNNYAVIETEMPIKLDDKTTKKIELPSLLYDPE 115
Query: 187 EDETGVVMGWG-----TLEESGRPACIIRDVEVPILSNQYCRTSTNY--SSTRISDNMMC 239
D + +V GWG +LE SG + + ++ + C + I D + C
Sbjct: 116 PDTSVLVSGWGSTNFKSLEYSGD----LMEANFTVVDRKSCEEQYKQIEADKYIYDGVFC 171
Query: 240 AGYPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGAGCGRAGYPGVYTRITRYVEWIK 299
AG GD+G P V +G+ S+ + + +P V+ R+ YV IK
Sbjct: 172 AGGEYDETYIGYGDAGDPAV-----QNGTLVGVASYISSM-PSEFPSVFLRVGYYVLDIK 225
Query: 300 E 300
+
Sbjct: 226 D 226
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 48/282 (17%)
Query: 76 TEVNQYPWMVRLSYF----NRFYCGGTLINDRYVLTAAHC--VKGRLWFLIKATFGEYDR 129
T+ ++ PW ++S C G ++++ +VLTAAHC V + + + GE
Sbjct: 463 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRD 522
Query: 130 CDTSS---KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ P + G F +D D+AL++L +++ I+P+CLP T
Sbjct: 523 LEIEVVLFHPNYNINGKKEAGIPEF--YDYDVALIKLKNKLKYGQTIRPICLPCTEGTTR 580
Query: 187 EDETGVVMGWGTLEESGRPACIIRDV------------EVPILSNQY---CRTSTNYS-- 229
+E PA I+ + EV I + C Y+
Sbjct: 581 ALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPG 640
Query: 230 -------STRISDNMMCAG--YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA--- 277
S ++ +C G P ++C+GDSGGP++ + SR+ Q+G++SWG
Sbjct: 641 YDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGVVDV 699
Query: 278 --GCGRAGYPGVYTR-----ITRYVEWIKEKSKEGCFLFFVA 312
R + R + + + W+KEK ++ F A
Sbjct: 700 CKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFLAA 741
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 38/236 (16%)
Query: 76 TEVNQYPWMVRLSYF----NRFYCGGTLINDRYVLTAAHC--VKGRLWFLIKATFGEYDR 129
T+ ++ PW ++S C G ++++ +VLTAAHC V + + + GE
Sbjct: 454 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRD 513
Query: 130 CDTSS---KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ P + G F +D D+AL++L +++ I+P+CLP T
Sbjct: 514 LEIEVVLFHPNYNINGKKEAGIPEF--YDYDVALIKLKNKLKYGQTIRPICLPCTEGTTR 571
Query: 187 EDETGVVMGWGTLEESGRPACIIRDV------------EVPILSNQY---CRTSTNYS-- 229
+E PA I+ + EV I + C Y+
Sbjct: 572 ALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPG 631
Query: 230 -------STRISDNMMCAG--YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWG 276
S ++ +C G P ++C+GDSGGP++ + SR+ Q+G++SWG
Sbjct: 632 YDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWG 686
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 44/240 (18%)
Query: 76 TEVNQYPWMVRLSYF----NRFYCGGTLINDRYVLTAAHC--VKGRLWFLIKATFGEYDR 129
T+ ++ PW ++S C G ++++ +VLTAAHC V + + + GE
Sbjct: 221 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRD 280
Query: 130 CDTSS---KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTY 186
+ P + G F +D D+AL++L +++ I+P+CLP T
Sbjct: 281 LEIEVVLFHPNYNINGKKEAGIPEF--YDYDVALIKLKNKLKYGQTIRPICLPCTEGTTR 338
Query: 187 EDETGVVMGWGTLEESGRPACIIRDVEVPILSNQY------------------CRTSTNY 228
+E PA +D++ +S + C Y
Sbjct: 339 ALRLPPTTTCQQQKEELLPA---QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQY 395
Query: 229 S---------STRISDNMMCAG--YPEGMKDSCQGDSGGPMVFEREDSRYEQIGIVSWGA 277
+ S ++ +C G P ++C+GDSGGP++ + SR+ Q+G++SWG
Sbjct: 396 APGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 454
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 56.2 bits (134), Expect = 3e-08, Method: Composition-based stats.
Identities = 38/112 (33%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDR 129
IVGG N P+ V L+ + F CGG+LIN ++V++AAHC K R I+ GE++
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSR----IQVRLGEHN- 54
Query: 130 CDTSSKPESRFVIRAIVG--DFTFSNFDNDIALLRLNDRVPIVDIIKPVCLP 179
D E I+ +F + DNDI L++L+ + + V LP
Sbjct: 55 IDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLP 106
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 56.2 bits (134), Expect = 3e-08, Method: Composition-based stats.
Identities = 21/42 (50%), Positives = 31/42 (73%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHC 111
I+GG+ E N +PW V + +++ F CGG L+N ++VLTAAHC
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHC 42
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 50.1 bits (118), Expect = 2e-06, Method: Composition-based stats.
Identities = 37/123 (30%), Positives = 55/123 (44%), Gaps = 13/123 (10%)
Query: 81 YPWMVRLSYFNRF-YCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYDRCDTSSKPESR 139
+PW V L F +CGG+LI++ +V+TAAHC ++ GE+D+ E
Sbjct: 9 WPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDVVVA---GEFDQ----GSDEEN 61
Query: 140 FVIRAIVGDFTFSNFD-----NDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDETGVVM 194
+ I F F+ NDI LL+L + + VCLP V ++
Sbjct: 62 IQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPNVDDDFPPGTVCATT 121
Query: 195 GWG 197
GWG
Sbjct: 122 GWG 124
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 49.3 bits (116), Expect = 4e-06, Method: Composition-based stats.
Identities = 39/134 (29%), Positives = 58/134 (43%), Gaps = 13/134 (9%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRF-YCGGTLINDRYVLTAAHCVKGRLWFLIKATFGEYD 128
IV G+ +PW V L F +CGG+LI++ +V+TAAHC ++ GE+D
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDVVVA---GEFD 57
Query: 129 RCDTSSKPESRFVIRAIVGDFTFSNFD-----NDIALLRLNDRVPIVDIIKPVCLPTVLN 183
+ E + I F F+ NDI LL+L + + V LP V +
Sbjct: 58 Q----GSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVSLPNVDD 113
Query: 184 NTYEDETGVVMGWG 197
+ GWG
Sbjct: 114 DFPPGTVCATTGWG 127
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 2/45 (4%)
Query: 70 IVGGQPTEVNQYPWMVRL--SYFNRFYCGGTLINDRYVLTAAHCV 112
IV G E+ PW V L CG +LI+DR+VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 43.5 bits (101), Expect = 2e-04, Method: Composition-based stats.
Identities = 21/44 (47%), Positives = 29/44 (65%), Gaps = 1/44 (2%)
Query: 70 IVGGQPTEVNQYPWMVRLSYFNRFYCGGTLINDRYVLTAAHCVK 113
IVGG N P+ V L+ + F CGG+LIN ++V++AAHC K
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYK 43
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 43.1 bits (100), Expect = 3e-04, Method: Composition-based stats.
Identities = 24/56 (42%), Positives = 31/56 (55%), Gaps = 9/56 (16%)
Query: 153 NFDNDIALLRLNDRVPIVDIIKPVCLP------TVLNNTYEDETGVVMGWGTLEES 202
N D DIAL++L V D I PVCLP ++L Y+ G V GWG L+E+
Sbjct: 22 NLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYK---GRVTGWGNLKET 74
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 53/134 (39%), Gaps = 16/134 (11%)
Query: 52 EDYPMC----DCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFN-RFYCGGTLINDRYVL 106
ED+ C C+CG R ++ PW V+L+ + +CGG +I + +VL
Sbjct: 36 EDHKQCVPHDQCACGVLTSEKRA-----PDLQDLPWQVKLTNSEGKDFCGGVIIRENFVL 90
Query: 107 TAAHCVKGRLWFLIKATFGEYDRCDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLND 165
T A C +K F TS P + V + +ND++LL L
Sbjct: 91 TTAKCSLLHRNITVKTYFNR-----TSQDPLMIKITHVHVHMRYDADAGENDLSLLELEW 145
Query: 166 RVPIVDIIKPVCLP 179
+ PVC P
Sbjct: 146 PIQCPGAGLPVCTP 159
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 53/134 (39%), Gaps = 16/134 (11%)
Query: 52 EDYPMC----DCSCGETNDATRIVGGQPTEVNQYPWMVRLSYFN-RFYCGGTLINDRYVL 106
ED+ C C+CG R ++ PW V+L+ + +CGG +I + +VL
Sbjct: 77 EDHKQCVPHDQCACGVLTSEKRA-----PDLQDLPWQVKLTNSEGKDFCGGVIIRENFVL 131
Query: 107 TAAHCVKGRLWFLIKATFGEYDRCDTSSKPESRFVIRAIVG-DFTFSNFDNDIALLRLND 165
T A C +K F TS P + V + +ND++LL L
Sbjct: 132 TTAKCSLLHRNITVKTYFNR-----TSQDPLMIKITHVHVHMRYDADAGENDLSLLELEW 186
Query: 166 RVPIVDIIKPVCLP 179
+ PVC P
Sbjct: 187 PIQCPGAGLPVCTP 200
>pdb|2D31|A Chain A, Crystal Structure Of Disulfide-Linked Hla-G Dimer
pdb|2D31|D Chain D, Crystal Structure Of Disulfide-Linked Hla-G Dimer
Length = 276
Score = 32.7 bits (73), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 21/49 (42%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
E RF+ V D F FD+D A R+ R P V+ P NT
Sbjct: 19 EPRFIAMGYVDDTQFVRFDSDSACPRMEPRAPWVEQEGPEYWEEETRNT 67
>pdb|3JTS|A Chain A, Gy9-Mamu-A02-Hb2m
pdb|3JTS|D Chain D, Gy9-Mamu-A02-Hb2m
pdb|3JTS|G Chain G, Gy9-Mamu-A02-Hb2m
pdb|3JTT|A Chain A, Cystal Structure Of Rhesus Macaque Mhc Class I:mamu-A02
pdb|3JTT|D Chain D, Cystal Structure Of Rhesus Macaque Mhc Class I:mamu-A02
pdb|3JTT|G Chain G, Cystal Structure Of Rhesus Macaque Mhc Class I:mamu-A02
Length = 276
Score = 32.3 bits (72), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 15/39 (38%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P V+ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWVEQEGP 57
>pdb|2DYP|A Chain A, Crystal Structure Of Lilrb2(Lir2ILT4CD85D) COMPLEXED WITH
Hla-G
Length = 277
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 21/49 (42%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
E RF+ V D F FD+D A R+ R P V+ P NT
Sbjct: 20 EPRFIAMGYVDDTQFVRFDSDSASPRMEPRAPWVEQEGPEYWEEETRNT 68
>pdb|1YDP|A Chain A, 1.9a Crystal Structure Of Hla-G
Length = 275
Score = 32.3 bits (72), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 21/49 (42%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
E RF+ V D F FD+D A R+ R P V+ P NT
Sbjct: 18 EPRFIAMGYVDDTQFVRFDSDSASPRMEPRAPWVEQEGPEYWEEETRNT 66
>pdb|2BCK|A Chain A, Crystal Structure Of Hla-A2402 Complexed With A Telomerase
Peptide
pdb|2BCK|D Chain D, Crystal Structure Of Hla-A2402 Complexed With A Telomerase
Peptide
Length = 294
Score = 32.3 bits (72), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 18/57 (31%), Positives = 26/57 (45%), Gaps = 8/57 (14%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDETGVV 193
E RF+ V D F FD+D A R+ R P ++ P +++ETG V
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP--------EYWDEETGKV 67
>pdb|4F7M|A Chain A, Crystal Structure Of Hla-A2402 Complexed With A Newly
Identified Peptide From 2009 H1n1 Pa (649-658)
pdb|4F7M|D Chain D, Crystal Structure Of Hla-A2402 Complexed With A Newly
Identified Peptide From 2009 H1n1 Pa (649-658)
pdb|4F7P|A Chain A, Crystal Structure Of Hla-A2402 Complexed With A Newly
Identified Peptide From 2009h1n1 Pb1 (496-505)
pdb|4F7T|A Chain A, Crystal Structure Of Hla-A2402 Complexed With A Newly
Identified Peptide From 2009 H1n1 Pb1 (498-505)
pdb|4F7T|D Chain D, Crystal Structure Of Hla-A2402 Complexed With A Newly
Identified Peptide From 2009 H1n1 Pb1 (498-505)
Length = 275
Score = 32.3 bits (72), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 18/57 (31%), Positives = 26/57 (45%), Gaps = 8/57 (14%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDETGVV 193
E RF+ V D F FD+D A R+ R P ++ P +++ETG V
Sbjct: 20 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP--------EYWDEETGKV 68
>pdb|3I6L|D Chain D, Newly Identified Epitope N1 Derived From Sars-Cov N
Protein Complexed With Hla-A2402
pdb|3NFN|A Chain A, Recognition Of Peptide-Mhc By A V-DeltaV-Beta Tcr
pdb|3QZW|A Chain A, Plasticity Of Human Cd8 Binding To Peptide-Hla-A2402
pdb|3QZW|D Chain D, Plasticity Of Human Cd8 Binding To Peptide-Hla-A2402
Length = 274
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 18/57 (31%), Positives = 26/57 (45%), Gaps = 8/57 (14%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNTYEDETGVV 193
E RF+ V D F FD+D A R+ R P ++ P +++ETG V
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP--------EYWDEETGKV 67
>pdb|3KYN|A Chain A, Crystal Structure Of Hla-G Presenting Kgppaaltl Peptide
Length = 275
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 21/49 (42%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
E RF+ V D F FD+D A R+ R P V+ P NT
Sbjct: 19 EPRFIAMGYVDDTQFVRFDSDSASPRMEPRAPWVEQEGPEYWEEETRNT 67
>pdb|3KYO|A Chain A, Crystal Structure Of Hla-G Presenting Klpaqfyil Peptide
pdb|3KYO|C Chain C, Crystal Structure Of Hla-G Presenting Klpaqfyil Peptide
Length = 273
Score = 32.3 bits (72), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 21/49 (42%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKPVCLPTVLNNT 185
E RF+ V D F FD+D A R+ R P V+ P NT
Sbjct: 18 EPRFIAMGYVDDTQFVRFDSDSASPRMEPRAPWVEQEGPEYWEEETRNT 66
>pdb|3OX8|A Chain A, Crystal Structure Of Hla A02:03 Bound To Hbv Core 18-27
pdb|3OX8|D Chain D, Crystal Structure Of Hla A02:03 Bound To Hbv Core 18-27
Length = 275
Score = 32.3 bits (72), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|3OXR|A Chain A, Crystal Structure Of Hla A02:06 Bound To Hbv Core 18-27
Length = 275
Score = 32.3 bits (72), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|3OXS|A Chain A, Crystal Structure Of Hla A02:07 Bound To Hbv Core 18-27
Length = 275
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|1AKJ|A Chain A, Complex Of The Human Mhc Class I Glycoprotein Hla-A2 And
The T Cell Coreceptor Cd8
pdb|1OGA|A Chain A, A Structural Basis For Immunodominant Human T-Cell
Receptor Recognition.
pdb|1P7Q|A Chain A, Crystal Structure Of Hla-A2 Bound To Lir-1, A Host And
Viral Mhc Receptor
pdb|2BNQ|A Chain A, Structural And Kinetic Basis For Heightened Immunogenicity
Of T Cell Vaccines
pdb|2BNR|A Chain A, Structural And Kinetic Basis For Heightened Immunogenicity
Of T Cell Vaccines
pdb|2C7U|A Chain A, Conflicting Selective Forces Affect Cd8 T-Cell Receptor
Contact Sites In An Hla-A2 Immunodominant Hiv Epitope.
pdb|2C7U|D Chain D, Conflicting Selective Forces Affect Cd8 T-Cell Receptor
Contact Sites In An Hla-A2 Immunodominant Hiv Epitope.
pdb|2P5E|A Chain A, Crystal Structures Of High Affinity Human T-Cell Receptors
Bound To Pmhc Reveal Native Diagonal Binding Geometry
pdb|2P5W|A Chain A, Crystal Structures Of High Affinity Human T-Cell Receptors
Bound To Pmhc Reveal Native Diagonal Binding Geometry
pdb|2PYE|A Chain A, Crystal Structures Of High Affinity Human T-Cell Receptors
Bound To Pmhc Revealnative Diagonal Binding Geometry Tcr
Clone C5c1 Complexed With Mhc
pdb|2V2W|A Chain A, T Cell Cross-Reactivity And Conformational Changes During
Tcr Engagement
pdb|2V2W|D Chain D, T Cell Cross-Reactivity And Conformational Changes During
Tcr Engagement
pdb|2V2X|A Chain A, T Cell Cross-Reactivity And Conformational Changes During
Tcr Engagement.
pdb|2V2X|D Chain D, T Cell Cross-Reactivity And Conformational Changes During
Tcr Engagement.
pdb|2VLJ|A Chain A, The Structural Dynamics And Energetics Of An
Immunodominant T-Cell Receptor Are Programmed By Its
Vbeta Domain
pdb|2VLK|A Chain A, The Structural Dynamics And Energetics Of An
Immunodominant T-Cell Receptor Are Programmed By Its
Vbeta Domain
pdb|2VLL|A Chain A, The Structural Dynamics And Energetics Of An
Immunodominant T-Cell Receptor Are Programmed By Its
Vbeta Domain
pdb|2VLL|D Chain D, The Structural Dynamics And Energetics Of An
Immunodominant T-Cell Receptor Are Programmed By Its
Vbeta Domain
pdb|2VLR|A Chain A, The Structural Dynamics And Energetics Of An
Immunodominant T-cell Receptor Are Programmed By Its
Vbeta Domain
pdb|2VLR|F Chain F, The Structural Dynamics And Energetics Of An
Immunodominant T-cell Receptor Are Programmed By Its
Vbeta Domain
pdb|3GJF|A Chain A, Rational Development Of High-Affinity T-Cell Receptor-Like
Antibodies
pdb|3GJF|D Chain D, Rational Development Of High-Affinity T-Cell Receptor-Like
Antibodies
pdb|3HAE|A Chain A, Rational Development Of High-Affinity T-Cell Receptor-Like
Antibodies
pdb|3HAE|D Chain D, Rational Development Of High-Affinity T-Cell Receptor-Like
Antibodies
pdb|3HAE|J Chain J, Rational Development Of High-Affinity T-Cell Receptor-Like
Antibodies
pdb|3HAE|P Chain P, Rational Development Of High-Affinity T-Cell Receptor-Like
Antibodies
pdb|3HG1|A Chain A, Germline-Governed Recognition Of A Cancer Epitope By An
Immunodominant Human T Cell Receptor
pdb|3O4L|A Chain A, Genetic And Structural Basis For Selection Of A Ubiquitous
T Cell Receptor Deployed In Epstein-Barr Virus
pdb|3UTQ|A Chain A, Human Hla-A0201-Alwgpdpaaa
pdb|3UTS|A Chain A, 1e6-A0201-Alwgpdpaaa Complex, Monoclinic
pdb|3UTS|F Chain F, 1e6-A0201-Alwgpdpaaa Complex, Monoclinic
pdb|4GKN|A Chain A, A2-Mhc Complex Carrying Fatgigiitv
pdb|4GKN|D Chain D, A2-Mhc Complex Carrying Fatgigiitv
pdb|4GKS|A Chain A, A2-Mhc Complex Carrying Fltgigiitv
pdb|4GKS|D Chain D, A2-Mhc Complex Carrying Fltgigiitv
pdb|4I4W|A Chain A, Peptide Length Determines The Outcome Of T Cell
ReceptorPEPTIDE-Mhci Engagement
Length = 276
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|1HHG|A Chain A, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|1HHG|D Chain D, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|1HHH|A Chain A, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|1HHI|A Chain A, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|1HHI|D Chain D, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|1HHJ|A Chain A, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|1HHJ|D Chain D, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|1HHK|A Chain A, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|1HHK|D Chain D, The Antigenic Identity Of Peptide(Slash)mhc Complexes: A
Comparison Of The Conformation Of Five Peptides
Presented By Hla-A2
pdb|2CLR|A Chain A, Three Dimensional Structure Of A Peptide Extending Out One
End Of A Class I Mhc Binding Site
pdb|2CLR|D Chain D, Three Dimensional Structure Of A Peptide Extending Out One
End Of A Class I Mhc Binding Site
pdb|1AO7|A Chain A, Complex Between Human T-Cell Receptor, Viral Peptide
(Tax), And Hla-A 0201
pdb|1BD2|A Chain A, Complex Between Human T-Cell Receptor B7, Viral Peptide
(Tax) And Mhc Class I Molecule Hla-A 0201
pdb|1B0G|A Chain A, Class I Histocompatibility Antigen (Hla-A2.1)BETA 2-
MicroglobulinPEPTIDE P1049 COMPLEX
pdb|1B0G|D Chain D, Class I Histocompatibility Antigen (Hla-A2.1)BETA 2-
MicroglobulinPEPTIDE P1049 COMPLEX
pdb|1B0R|A Chain A, Crystal Structure Of Hla-A0201 Complexed With A Peptide
With The Carboxyl-Terminal Group Substituted By A Methyl
Group
pdb|1QR1|A Chain A, Poor Binding Of A Her-2NEU EPITOPE (GP2) TO HLA-A2.1 Is
Due To A Lack Of Interactions In The Center Of The
Peptide
pdb|1QR1|D Chain D, Poor Binding Of A Her-2NEU EPITOPE (GP2) TO HLA-A2.1 Is
Due To A Lack Of Interactions In The Center Of The
Peptide
pdb|1I1Y|A Chain A, Crystal Structure Of Human Class I Mhc (Hla-A2.1)
Complexed With Beta 2-Microglobulin And Hiv-Rt Variant
Peptide I1y
pdb|1I1Y|D Chain D, Crystal Structure Of Human Class I Mhc (Hla-A2.1)
Complexed With Beta 2-Microglobulin And Hiv-Rt Variant
Peptide I1y
pdb|1I1F|A Chain A, Crystal Structure Of Human Class I Mhc (Hla-A2.1)
Complexed With Beta 2-Microglobulin And Hiv-Rt Variant
Peptide I1y
pdb|1I1F|D Chain D, Crystal Structure Of Human Class I Mhc (Hla-A2.1)
Complexed With Beta 2-Microglobulin And Hiv-Rt Variant
Peptide I1y
pdb|1DUY|A Chain A, Crystal Structure Of Hla-A0201OCTAMERIC TAX PEPTIDE
Complex
pdb|1DUY|D Chain D, Crystal Structure Of Hla-A0201OCTAMERIC TAX PEPTIDE
Complex
pdb|1DUZ|A Chain A, Human Class I Histocompatibility Antigen (Hla-A 0201) In
Complex With A Nonameric Peptide From Htlv-1 Tax Protein
pdb|1DUZ|D Chain D, Human Class I Histocompatibility Antigen (Hla-A 0201) In
Complex With A Nonameric Peptide From Htlv-1 Tax Protein
pdb|1IM3|A Chain A, Crystal Structure Of The Human Cytomegalovirus Protein Us2
Bound To The Mhc Class I Molecule Hla-A2TAX
pdb|1IM3|E Chain E, Crystal Structure Of The Human Cytomegalovirus Protein Us2
Bound To The Mhc Class I Molecule Hla-A2TAX
pdb|1IM3|I Chain I, Crystal Structure Of The Human Cytomegalovirus Protein Us2
Bound To The Mhc Class I Molecule Hla-A2TAX
pdb|1IM3|M Chain M, Crystal Structure Of The Human Cytomegalovirus Protein Us2
Bound To The Mhc Class I Molecule Hla-A2TAX
pdb|1I4F|A Chain A, Crystal Structure Of Hla-A0201MAGE-A4-Peptide Complex
pdb|1JF1|A Chain A, Crystal Structure Of Hla-A20201 In Complex With A
Decameric Altered Peptide Ligand From The Mart-1MELAN-A
pdb|1JHT|A Chain A, Crystal Structure Of Hla-A20201 In Complex With A
Nonameric Altered Peptide Ligand (Algigiltv) From The
Mart- 1MELAN-A.
pdb|1I7R|A Chain A, Crystal Structure Of Class I Mhc A2 In Complex With
Peptide P1058
pdb|1I7R|D Chain D, Crystal Structure Of Class I Mhc A2 In Complex With
Peptide P1058
pdb|1I7T|A Chain A, Crystal Structure Of Class I Mhc A2 In Complex With
Peptide P1049-5v
pdb|1I7T|D Chain D, Crystal Structure Of Class I Mhc A2 In Complex With
Peptide P1049-5v
pdb|1I7U|A Chain A, Crystal Structure Of Class I Mhc A2 In Complex With
Peptide P1049-6v
pdb|1I7U|D Chain D, Crystal Structure Of Class I Mhc A2 In Complex With
Peptide P1049-6v
pdb|1EEY|A Chain A, Crystal Structure Determination Of Hla A2 Complexed To
Peptide Gp2 With The Substitution (I2lV5LL9V)
pdb|1EEY|D Chain D, Crystal Structure Determination Of Hla A2 Complexed To
Peptide Gp2 With The Substitution (I2lV5LL9V)
pdb|1EEZ|A Chain A, Crystal Structure Determination Of Hla-A2.1 Complexed To
Gp2 Peptide Variant(I2lV5L)
pdb|1EEZ|D Chain D, Crystal Structure Determination Of Hla-A2.1 Complexed To
Gp2 Peptide Variant(I2lV5L)
pdb|1LP9|A Chain A, Xenoreactive Complex Ahiii 12.2 Tcr Bound To P1049HLA-A2.1
pdb|1LP9|H Chain H, Xenoreactive Complex Ahiii 12.2 Tcr Bound To P1049HLA-A2.1
pdb|1QEW|A Chain A, Human Class I Histocompatibility Antigen (Hla-A 0201)
Complex With A Nonameric Peptide From
Melanoma-Associated Antigen 3 (Residues 271-279)
pdb|1TVB|A Chain A, Crystal Structure Of Melanoma Antigen Gp100(209-217) Bound
To Human Class I Mhc Hla-A2
pdb|1TVB|D Chain D, Crystal Structure Of Melanoma Antigen Gp100(209-217) Bound
To Human Class I Mhc Hla-A2
pdb|1TVH|A Chain A, Crystal Structure Of Modified Melanoma Antigen
Gp100(209-T2m) Bound To Human Class I Mhc Hla-A2
pdb|1TVH|D Chain D, Crystal Structure Of Modified Melanoma Antigen
Gp100(209-T2m) Bound To Human Class I Mhc Hla-A2
pdb|1S8D|A Chain A, Structural Basis For Degenerate Recognition Of Hiv Peptide
Variants By Cytotoxic Lymphocyte, Variant Sl9-3a
pdb|1T1W|A Chain A, Structural Basis For Degenerate Recognition Of Hiv Peptide
Variants By Cytotoxic Lymphocyte, Variant Sl9-3f6i8v
pdb|1T1X|A Chain A, Structural Basis For Degenerate Recognition Of Hiv Peptide
Variants By Cytotoxic Lymphocyte, Variant Sl9-4l
pdb|1T1Y|A Chain A, Structural Basis For Degenerate Recognition Of Hiv Peptide
Variants By Cytotoxic Lymphocyte, Variant Sl9-5v
pdb|1T1Z|A Chain A, Structural Basis For Degenerate Recognition Of Hiv Peptide
Variants By Cytotoxic Lymphocyte, Variant Sl9-6a
pdb|1T20|A Chain A, Structural Basis For Degenerate Recognition Of Hiv Peptide
Variants By Cytotoxic Lymphocyte, Variant Sl9-6i
pdb|1T21|A Chain A, Structural Basis For Degenerate Recognition Of Hiv Peptide
Variants By Cytotoxic Lymphocyte, Variant Sl9,
Monoclinic Crystal
pdb|1T22|A Chain A, Structural Basis For Degenerate Recognition Of Hiv Peptide
Variants By Cytotoxic Lymphocyte, Variant Sl9,
Orthorhombic Crystal
pdb|2F53|A Chain A, Directed Evolution Of Human T-Cell Receptor Cdr2 Residues
By Phage Display Dramatically Enhances Affinity For
Cognate Peptide-Mhc Without Apparent Cross-Reactivity
pdb|2GIT|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Modified
Htlv-1 Tax (Y5k- 4-[3-Indolyl]-Butyric Acid) Peptide
pdb|2GIT|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Modified
Htlv-1 Tax (Y5k- 4-[3-Indolyl]-Butyric Acid) Peptide
pdb|2GJ6|A Chain A, The Complex Between Tcr A6 And Human Class I Mhc Hla-a2
With The Modified Htlv-1 Tax (y5k-4-[3-indolyl]-butyric
Acid) Peptide
pdb|2GT9|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Decameric
Melan-AMART- 1(26-35) Peptide
pdb|2GT9|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Decameric
Melan-AMART- 1(26-35) Peptide
pdb|2GTW|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Nonameric
Melan-AMART- 1(27-35) Peptide Having A27l Substitution
pdb|2GTW|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Nonameric
Melan-AMART- 1(27-35) Peptide Having A27l Substitution
pdb|2GTZ|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Nonameric
Melan-AMART- 1(27-35) Peptide Having A28l Substitution
pdb|2GTZ|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Nonameric
Melan-AMART- 1(27-35) Peptide Having A28l Substitution
pdb|2GUO|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Native
Nonameric Melan- AMART-1(27-35) Peptide
pdb|2GUO|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Native
Nonameric Melan- AMART-1(27-35) Peptide
pdb|3BH9|A Chain A, Crystal Structure Of Rty Phosphopeptide Bound To Human
Class I Mhc Hla-A2
pdb|3FQN|A Chain A, Phosphorylation Of Self-Peptides Alters Human Leukocyte
Antigen Class I-Restricted Antigen Presentation And
Generates Tumor Specific Epitopes
pdb|3FQR|A Chain A, Phosphorylation Of Self-Peptides Alters Human Leukocyte
Antigen Class I-Restricted Antigen Presentation And
Generates Tumor Specific Epitopes
pdb|3FQT|A Chain A, Phosphorylation Of Self-Peptides Alters Human Leukocyte
Antigen Class I-Restricted Antigen Presentation And
Generates Tumor Specific Epitopes
pdb|3FQU|A Chain A, Phosphorylation Of Self-Peptides Alters Human Leukocyte
Antigen Class I-Restricted Antigen Presentation And
Generates Tumor Specific Epitopes
pdb|3FQW|A Chain A, Phosphorylation Of Self-Peptides Alters Human Leukocyte
Antigen Class I-Restricted Antigen Presentation And
Generates Tumor Specific Epitopes
pdb|3FQX|A Chain A, Phosphorylation Of Self-Peptides Alters Human Leukocyte
Antigen Class I-Restricted Antigen Presentation And
Generates Tumor Specific Epitopes
pdb|3D39|A Chain A, The Complex Between Tcr A6 And Human Class I Mhc Hla-A2
With The Modified Htlv-1 Tax (Y5(4-Fluorophenylalanine))
Peptide
pdb|3D3V|A Chain A, The Complex Between Tcr A6 And Human Class I Mhc Hla-A2
With The Modified Htlv-1 Tax
(Y5(3,4-Difluorophenylalanine)) Peptide
pdb|3GIV|A Chain A, Antigen Processing Influences Hiv-Specific Cytotoxic T
Lymphocyte Immunodominance
pdb|3GIV|D Chain D, Antigen Processing Influences Hiv-Specific Cytotoxic T
Lymphocyte Immunodominance
pdb|3H7B|A Chain A, Human Class I Mhc Hla-a2 In Complex With The Tel1p Peptide
pdb|3H7B|D Chain D, Human Class I Mhc Hla-a2 In Complex With The Tel1p Peptide
pdb|3H9S|A Chain A, The Complex Between Tcr A6 And Human Class I Mhc Hla-A2
With The Bound Tel1p Peptide
pdb|3KLA|A Chain A, Ca2+ Release From The Endoplasmic Reticulum Of Ny-Eso-1
Specific T Cells Is Modulated By The Affinity Of T Cell
Receptor And By The Use Of The Cd8 Co-Receptor
pdb|3KLA|D Chain D, Ca2+ Release From The Endoplasmic Reticulum Of Ny-Eso-1
Specific T Cells Is Modulated By The Affinity Of T Cell
Receptor And By The Use Of The Cd8 Co-Receptor
pdb|2X4N|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To
Residual Fragments Of A Photocleavable Peptide That Is
Cleaved Upon Uv-Light Treatment
pdb|2X4N|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To
Residual Fragments Of A Photocleavable Peptide That Is
Cleaved Upon Uv-Light Treatment
pdb|2X4O|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1
Envelope Peptide Env120-128
pdb|2X4O|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1
Envelope Peptide Env120-128
pdb|2X4P|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Photocleavable Peptide
pdb|2X4P|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Photocleavable Peptide
pdb|2X4Q|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Photocleavable Peptide
pdb|2X4Q|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Photocleavable Peptide
pdb|2X4R|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To
Cytomegalovirus (Cmv) Pp65 Epitope
pdb|2X4R|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To
Cytomegalovirus (Cmv) Pp65 Epitope
pdb|2X4S|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Peptide Representing The Epitope Of The H5n1 (Avian Flu)
Nucleoprotein
pdb|2X4S|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Peptide Representing The Epitope Of The H5n1 (Avian Flu)
Nucleoprotein
pdb|2X4T|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Peiodate-Cleavable Peptide
pdb|2X4T|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Peiodate-Cleavable Peptide
pdb|2X4U|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1
Peptide Rt468-476
pdb|2X4U|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To Hiv-1
Peptide Rt468-476
pdb|3MGO|A Chain A, Crystal Structure Of A H5-Specific Ctl Epitope Derived
From Influenza Virus In Complex With Hla-A0201
pdb|3MGO|D Chain D, Crystal Structure Of A H5-Specific Ctl Epitope Derived
From Influenza Virus In Complex With Hla-A0201
pdb|3MGO|G Chain G, Crystal Structure Of A H5-Specific Ctl Epitope Derived
From Influenza Virus In Complex With Hla-A0201
pdb|3MGO|J Chain J, Crystal Structure Of A H5-Specific Ctl Epitope Derived
From Influenza Virus In Complex With Hla-A0201
pdb|3MGT|A Chain A, Crystal Structure Of A H5-Specific Ctl Epitope Variant
Deriv H5n1 Influenza Virus In Complex With Hla-A0201
pdb|3MGT|D Chain D, Crystal Structure Of A H5-Specific Ctl Epitope Variant
Deriv H5n1 Influenza Virus In Complex With Hla-A0201
pdb|3MGT|G Chain G, Crystal Structure Of A H5-Specific Ctl Epitope Variant
Deriv H5n1 Influenza Virus In Complex With Hla-A0201
pdb|3MGT|J Chain J, Crystal Structure Of A H5-Specific Ctl Epitope Variant
Deriv H5n1 Influenza Virus In Complex With Hla-A0201
pdb|3I6G|A Chain A, Newly Identified Epitope Mn2 From Sars-Cov M Protein
Complexed Withhla-A0201
pdb|3I6G|D Chain D, Newly Identified Epitope Mn2 From Sars-Cov M Protein
Complexed Withhla-A0201
pdb|3I6K|A Chain A, Newly Identified Epitope From Sars-Cov Membrane Protein
Complexed With Hla-A0201
pdb|3I6K|E Chain E, Newly Identified Epitope From Sars-Cov Membrane Protein
Complexed With Hla-A0201
pdb|3HPJ|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Wt-1
(126-134) Peptide
pdb|3HPJ|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Wt-1
(126-134) Peptide
pdb|3MYJ|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Wt-1
(126-134) (R1y) Peptide Variant.
pdb|3MYJ|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Wt-1
(126-134) (R1y) Peptide Variant.
pdb|2X70|A Chain A, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Photocleavable Peptide
pdb|2X70|D Chain D, Crystal Structure Of Mhc Class I Hla-A2.1 Bound To A
Photocleavable Peptide
pdb|3O3A|A Chain A, Human Class I Mhc Hla-A2 In Complex With The
Peptidomimetic Ela-1
pdb|3O3A|D Chain D, Human Class I Mhc Hla-A2 In Complex With The
Peptidomimetic Ela-1
pdb|3O3B|A Chain A, Human Class I Mhc Hla-A2 In Complex With The
Peptidomimetic Ela-1.1
pdb|3O3B|D Chain D, Human Class I Mhc Hla-A2 In Complex With The
Peptidomimetic Ela-1.1
pdb|3O3D|A Chain A, Human Class I Mhc Hla-A2 In Complex With The
Peptidomimetic Ela-2
pdb|3O3D|D Chain D, Human Class I Mhc Hla-A2 In Complex With The
Peptidomimetic Ela-2
pdb|3O3E|A Chain A, Human Class I Mhc Hla-A2 In Complex With The
Peptidomimetic Ela-2.1
pdb|3O3E|D Chain D, Human Class I Mhc Hla-A2 In Complex With The
Peptidomimetic Ela-2.1
pdb|3PWJ|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Hud (G2l,I9v)
Peptide Variant
pdb|3PWJ|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Hud (G2l,I9v)
Peptide Variant
pdb|3PWL|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Hud Peptide
pdb|3PWL|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Hud Peptide
pdb|3PWN|A Chain A, Human Class I Mhc Hla-A2 In Complex With The Hud (G2l)
Peptide Variant
pdb|3PWN|D Chain D, Human Class I Mhc Hla-A2 In Complex With The Hud (G2l)
Peptide Variant
pdb|3PWP|A Chain A, The Complex Between Tcr A6 And Human Class I Mhc Hla-A2
With The Bound Hud Peptide
pdb|3QDG|A Chain A, The Complex Between Tcr Dmf5 And Human Class I Mhc Hla-A2
With The Bound Mart-1(26-35)(A27l) Peptide
pdb|3QDJ|A Chain A, The Complex Between Tcr Dmf5 And Human Class I Mhc Hla-A2
With The Bound Mart-1(27-35) Nonameric Peptide
pdb|3QDM|A Chain A, The Complex Between Tcr Dmf4 And Human Class I Mhc Hla-A2
With The Bound Mart-1(26-35)(A27l) Decameric Peptide
pdb|3QEQ|A Chain A, The Complex Between Tcr Dmf4 And Human Class I Mhc Hla-A2
With The Bound Mart-1(27-35) Nonameric Peptide
pdb|3QFD|A Chain A, Human Class I Mhc Hla-A2 In Complex With Mart-1(27-35)
Nonameric Peptide
pdb|3QFD|D Chain D, Human Class I Mhc Hla-A2 In Complex With Mart-1(27-35)
Nonameric Peptide
pdb|3QFJ|A Chain A, The Complex Between Tcr A6 And Human Class I Mhc Hla-A2
With The Modified Tax (Y5f) Peptide
pdb|3REW|A Chain A, Crystal Structure Of An Lmp2a-Derived Peptide Bound To
Human Class I Mhc Hla-A2
pdb|3REW|D Chain D, Crystal Structure Of An Lmp2a-Derived Peptide Bound To
Human Class I Mhc Hla-A2
pdb|3UTT|A Chain A, 1e6-A0201-Alwgpdpaaa Complex, Triclinic
pdb|3UTT|F Chain F, 1e6-A0201-Alwgpdpaaa Complex, Triclinic
pdb|3TO2|A Chain A, Structure Of Hla-A0201 Complexed With Peptide Md3-C9
Derived From A Clustering Region Of Restricted Cytotoxic
T Lymphocyte Epitope From Sars-Cov M Protein
pdb|4E5X|A Chain A, Crystal Structure Of A Complex Between The Human
Adenovirus Type 2 E3- 19k Protein And Mhc Class I
Molecule Hla-A2TAX
pdb|4E5X|D Chain D, Crystal Structure Of A Complex Between The Human
Adenovirus Type 2 E3- 19k Protein And Mhc Class I
Molecule Hla-A2TAX
pdb|3V5D|A Chain A, Hla-A2.1 Kvaelvhfl
pdb|3V5D|D Chain D, Hla-A2.1 Kvaelvhfl
pdb|3V5H|A Chain A, Hla-A2.1 Kvaeivhfl
pdb|3V5H|D Chain D, Hla-A2.1 Kvaeivhfl
pdb|3V5K|A Chain A, Hla2.1 Kvaelvwfl
pdb|3V5K|D Chain D, Hla2.1 Kvaelvwfl
Length = 275
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|1QSF|A Chain A, Structure Of A6-Tcr Bound To Hla-A2 Complexed With Altered
Htlv-1 Tax Peptide Y8a
Length = 274
Score = 32.0 bits (71), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|2AV1|A Chain A, Crystal Structure Of Htlv-1 Tax Peptide Bound To Human
Class I Mhc Hla-A2 With The E63q And K66a Mutations In
The Heavy Chain.
pdb|2AV1|D Chain D, Crystal Structure Of Htlv-1 Tax Peptide Bound To Human
Class I Mhc Hla-A2 With The E63q And K66a Mutations In
The Heavy Chain
Length = 275
Score = 32.0 bits (71), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|2UWE|A Chain A, Large Cdr3a Loop Alteration As A Function Of Mhc Mutation
pdb|2UWE|H Chain H, Large Cdr3a Loop Alteration As A Function Of Mhc Mutation
Length = 275
Score = 32.0 bits (71), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|2AV7|A Chain A, Crystal Structure Of Htlv-1 Tax Peptide Bound To Human
Class I Mhc Hla-A2 With The K66a Mutation In The Heavy
Chain.
pdb|2AV7|D Chain D, Crystal Structure Of Htlv-1 Tax Peptide Bound To Human
Class I Mhc Hla-A2 With The K66a Mutation In The Heavy
Chain.
pdb|2J8U|A Chain A, Large Cdr3a Loop Alteration As A Function Of Mhc Mutation.
pdb|2J8U|H Chain H, Large Cdr3a Loop Alteration As A Function Of Mhc Mutation
Length = 275
Score = 32.0 bits (71), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|1QRN|A Chain A, Crystal Structure Of Human A6 Tcr Complexed With Hla-A2
Bound To Altered Htlv-1 Tax Peptide P6a
pdb|1QSE|A Chain A, Structure Of Human A6-Tcr Bound To Hla-A2 Complexed With
Altered Htlv-1 Tax Peptide V7r
pdb|1S9W|A Chain A, Crystal Structure Analysis Of Ny-eso-1 Epitope, Sllmwitqc,
In Complex With Hla-a2
pdb|1S9X|A Chain A, Crystal Structure Analysis Of Ny-Eso-1 Epitope Analogue,
Sllmwitqa, In Complex With Hla-A2
pdb|1S9Y|A Chain A, Crystal Structure Analysis Of Ny-Eso-1 Epitope Analogue,
Sllmwitqs, In Complex With Hla-A2
pdb|2F54|A Chain A, Directed Evolution Of Human T Cell Receptor Cdr2 Residues
By Phage Display Dramatically Enhances Affinity For
Cognate Peptide-Mhc Without Increasing Apparent
Cross-Reactivity
pdb|2F54|F Chain F, Directed Evolution Of Human T Cell Receptor Cdr2 Residues
By Phage Display Dramatically Enhances Affinity For
Cognate Peptide-Mhc Without Increasing Apparent
Cross-Reactivity
pdb|3BGM|A Chain A, Crystal Structure Of Pkd2 Phosphopeptide Bound To Human
Class I Mhc Hla-A2
pdb|3BH8|A Chain A, Crystal Structure Of Rqa_m Phosphopeptide Bound To Human
Class I Mhc Hla-A2
pdb|3BHB|A Chain A, Crystal Structure Of Kmd Phosphopeptide Bound To Human
Class I Mhc Hla-A2
pdb|3D25|A Chain A, Crystal Structure Of Ha-1 Minor Histocompatibility Antigen
Bound To Human Class I Mhc Hla-A2
Length = 274
Score = 32.0 bits (71), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|3H9H|A Chain A, Human Class I Mhc Hla-A2(A150p) In Complex With The Tel1p
Peptide
pdb|3H9H|D Chain D, Human Class I Mhc Hla-A2(A150p) In Complex With The Tel1p
Peptide
pdb|3IXA|A Chain A, Human Class I Mhc Hla-A2(A150p) In Complex With The Tax
Peptide
pdb|3IXA|D Chain D, Human Class I Mhc Hla-A2(A150p) In Complex With The Tax
Peptide
Length = 275
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|1HLA|A Chain A, Structure Of The Human Class I Histocompatibility Antigen,
Hla-A2
pdb|3HLA|A Chain A, Human Class I Histocompatibility Antigen A2.1
Length = 270
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|3GSN|H Chain H, Crystal Structure Of The Public Ra14 Tcr In Complex With
The Hcmv Dominant NlvHLA-A2 Epitope
pdb|3GSO|A Chain A, Crystal Structure Of The Binary Complex Between Hla-A2 And
Hcmv Nlv Peptide
pdb|3GSQ|A Chain A, Crystal Structure Of The Binary Complex Between Hla-A2 And
Hcmv Nlv-M5s Peptide Variant
pdb|3GSR|A Chain A, Crystal Structure Of The Binary Complex Between Hla-A2 And
Hcmv Nlv-M5v Peptide Variant
pdb|3GSW|A Chain A, Crystal Structure Of The Binary Complex Between Hla-A2 And
Hcmv Nlv-T8a Peptide Variant
pdb|3GSX|A Chain A, Crystal Structure Of The Binary Complex Between Hla-A2 And
Hcmv Nlv-T8v Peptide Variant
Length = 274
Score = 32.0 bits (71), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|2JCC|A Chain A, Ah3 Recognition Of Mutant Hla-A2 W167a
pdb|2JCC|H Chain H, Ah3 Recognition Of Mutant Hla-A2 W167a
Length = 275
Score = 32.0 bits (71), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|3MRB|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcmv Pp65-495-503 Nonapeptide A7h Variant
pdb|3MRC|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcmv Pp65-495-503 Nonapeptide V6c Variant
pdb|3MRD|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcmv Pp65-495-503 Nonapeptide V6g Variant
Length = 276
Score = 32.0 bits (71), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|3FT2|A Chain A, Crystal Structure Of A Citrulline Peptide Variant Of The
Minor Histocompatibility Peptide Ha-1 In Complex With
Hla- A2
pdb|3FT3|A Chain A, Crystal Structure Of The Minor Histocompatibility Peptide
Ha-1his In Complex With Hla-A2
pdb|3FT4|A Chain A, Crystal Structure Of The Minor Histocompatibility Peptide
Ha-1arg In Complex With Hla-A2
pdb|3GSU|A Chain A, Crystal Structure Of The Binary Complex Between Hla-A2 And
Hcmv Nlv-M5t Peptide Variant
pdb|3GSV|A Chain A, Crystal Structure Of The Binary Complex Between Hla-A2 And
Hcmv Nlv-M5q Peptide Variant
Length = 275
Score = 32.0 bits (71), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|3MR9|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcmv Pp65-495-503 Nonapeptide M5a Variant
pdb|3MRE|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Ebv Bmlf1-280-288 Nonapeptide
pdb|3MRF|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Ebv Bmlf1-280-288 Nonapeptide T4p Variant
pdb|3MRG|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcv Ns3-1073-1081 Nonapeptide
pdb|3MRH|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcv Ns3-1073-1081 Nonapeptide N3s Variant
pdb|3MRI|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcv Ns3-1073-1081 Nonapeptide G4m-V5w Variant
pdb|3MRJ|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcv Ns3-1073-1081 Nonapeptide V5m Variant
pdb|3MRK|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Afp137 Nonapeptide
pdb|3MRL|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcv Ns3-1073-1081 Nonapeptide C6v Variant
pdb|3MRM|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcv Ns3-1406-1415 Decapeptide
pdb|3MRN|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Hcv Ns4b-1807-1816 Decapeptide
pdb|3MRO|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Melan- A Mart1 Decapeptide Variant
pdb|3MRP|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Melan- A Mart1 Decapeptide Variant
pdb|3MRQ|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Melan- A Mart1 Decapeptide Variant
pdb|3MRR|A Chain A, Crystal Structure Of Mhc Class I Hla-A2 Molecule Complexed
With Human Prostaglandin Transporter Decapeptide
Length = 293
Score = 32.0 bits (71), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|2HLA|A Chain A, Specificity Pockets For The Side Chains Of Peptide
Antigens In Hla-Aw68
pdb|1HSB|A Chain A, Different Length Peptides Bind To Hla-Aw68 Similarly At
Their Ends But Bulge Out In The Middle
Length = 270
Score = 31.6 bits (70), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|1Q94|A Chain A, Structures Of Hla-A1101 In Complex With Immunodominant
Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The
Presence Of A Middle Anchor Residue
pdb|1Q94|D Chain D, Structures Of Hla-A1101 In Complex With Immunodominant
Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The
Presence Of A Middle Anchor Residue
pdb|1QVO|A Chain A, Structures Of Hla-A1101 In Complex With Immunodominant
Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The
Presence Of A Middle Anchor Residue
pdb|1QVO|D Chain D, Structures Of Hla-A1101 In Complex With Immunodominant
Nonamer And Decamer Hiv-1 Epitopes Clearly Reveal The
Presence Of A Middle Anchor Residue
pdb|1X7Q|A Chain A, Crystal Structure Of Hla-A1101 With Sars Nucleocapsid
Peptide
pdb|2HN7|A Chain A, Hla-A1101 In Complex With Hbv Peptide Homologue
Length = 275
Score = 31.6 bits (70), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|1TMC|A Chain A, The Three-Dimensional Structure Of A Class I Major
Histocompatibility Complex Molecule Missing The Alpha3
Domain Of The Heavy Chain
Length = 175
Score = 31.6 bits (70), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 14/41 (34%), Positives = 20/41 (48%)
Query: 135 KPESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
+ E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 17 RGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|2XPG|A Chain A, Crystal Structure Of A Mhc Class I-Peptide Complex
pdb|3RL1|A Chain A, Hiv Rt Derived Peptide Complexed To Hla-A0301
pdb|3RL2|A Chain A, Hiv Nef Derived Peptide Nef73 Complexed To Hla-A0301
Length = 274
Score = 31.6 bits (70), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
E RF+ V D F FD+D A R+ R P ++ P
Sbjct: 19 EPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGP 57
>pdb|1ZVS|A Chain A, Crystal Structure Of The First Class Mhc Mamu And Tat-Tl8
Complex
pdb|1ZVS|D Chain D, Crystal Structure Of The First Class Mhc Mamu And Tat-Tl8
Complex
Length = 278
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 137 ESRFVIRAIVGDFTFSNFDNDIALLRLNDRVPIVDIIKP 175
+ RF+ V D F FD+D A R+ R P V+ P
Sbjct: 19 QPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWVEQEGP 57
>pdb|2QDD|A Chain A, Crystal Structure Of A Member Of Enolase Superfamily From
Roseovarius Nubinhibens Ism
pdb|2QDD|B Chain B, Crystal Structure Of A Member Of Enolase Superfamily From
Roseovarius Nubinhibens Ism
pdb|3FVD|B Chain B, Crystal Structure Of A Member Of Enolase Superfamily From
Roseovarius Nubinhibens Ism Complexed With Magnesium
pdb|3FVD|A Chain A, Crystal Structure Of A Member Of Enolase Superfamily From
Roseovarius Nubinhibens Ism Complexed With Magnesium
Length = 378
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 254 SGGPMVFEREDSRYEQI----GIVSWGAGC 279
SGG + F+R DS Y +I G+ WG GC
Sbjct: 24 SGGRLKFDRLDSTYLRIDTDEGVTGWGEGC 53
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.137 0.443
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 13,334,831
Number of Sequences: 62578
Number of extensions: 578265
Number of successful extensions: 2650
Number of sequences better than 100.0: 386
Number of HSP's better than 100.0 without gapping: 382
Number of HSP's successfully gapped in prelim test: 4
Number of HSP's that attempted gapping in prelim test: 1049
Number of HSP's gapped (non-prelim): 413
length of query: 421
length of database: 14,973,337
effective HSP length: 101
effective length of query: 320
effective length of database: 8,652,959
effective search space: 2768946880
effective search space used: 2768946880
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 53 (25.0 bits)